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This Annual Report of the National Suicide Research 
Foundation (NSRF) serves a dual purpose. It contains 
the Members’ Report and Financial Statements for 
the year ended December 31st 2019, as tabled at the 
meeting of the Board of Directors on May 13th 2020 
and at the Annual General Meeting of the Board of 
Members on July 1st 2020. This Report also contains 
a summary report on the research and associated 
activities undertaken by the NSRF team. Throughout 
the report there is a focus on research undertaken in 
2019 but, as many research studies are not complet-
ed within a calendar year, there are also references to 
milestones and deliverables in 2020.
The mission of the NSRF when established, and now, 
is to provide a nationally and internationally recog-
nised body of reliable knowledge from a multi-disci-
plinary perspective on the risk and protective factors 
associated with suicidal behaviour with an ultimate 
aim of providing solid evidence to inform policy de-
velopment and intervention in the prevention of su-
icide and the management of patients presenting 
with self-harm. The members of the research team 
represent a broad range of disciplines, including psy-
chology, epidemiology, biostatistics, sociology, so-
cial science, applied social studies, public health and 
health services research.
The NSRF was established by the late Dr Michael J 
Kelleher in November 1994 as the Suicide Research 
Foundation Limited and, in 2001, the Registrar of 
Business Names granted permission for the use of 
the name of National Suicide Research Foundation. 
The NSRF relocated to the Western Gateway Build-
ing in University College Cork in 2012 as part of the 
National Health Services Research Institute, estab-
lished with capital funding from the Higher Education 
Authority’s (HEA) Programme for Research in Third 
Level Institutes V and has signed a Research Collab-
oration Agreement with University College Cork. In 
2015, the NSRF was designated by the World Health 
Organisation (WHO) as a Collaborating Centre for 
Surveillance and Research in Suicide Prevention and 
following a rigorous review process the designation 
was renewed by the WHO in 2019. 
The NSRF is constituted as a company limited by 
guarantee (Company Number 224676) as set out 
under the Companies Act 2014. Its purpose and ob-
jects and how it conducts its business are set out in 
its Constitution which is posted on its website www.
nsrf.ie under the About Us section. The organisa-
tion is governed by its Constitution and is managed 
by a Board of Directors. The Constitution is public-
ly available from the Companies Registration Office 
website www.cro.ie in addition to the Charities Reg-
ulatory Authority website www.charitiesregulator.ie. 
The Registered Charity Number (RCN) is 20030889. 
The NSRF has been granted charitable status under 
Sections 207 and 208 of the Taxes Consolidation Act 
1997; the Charity Tax Number is CHY11351. 
In line with requirements of the Companies Act 2014, 
the Financial Statements 2019 have been prepared 
by independent auditors H&A Accounting Services 
Limited t/a Hickey & Associates, Cork. The NSRF has 
opted to report in accordance with the accounting 
standards issued by the Financial Reporting Council, 
including FRS 102, the Financial Reporting Standard 
applicable in the UK and Republic of Ireland (FRS 
102) as modified by the Statement of Recommend-
ed Practice ‘Accounting and Reporting by Charities’ 
effective January 1st 2015. The Financial Statements 
2019 have been approved by the Board of Directors 
and have been submitted to the Companies Regis-
tration Office. The turnover in 2019 was ¤1,201,034 
and the net surplus for the year after taxation was 
¤5,705. The NSRF employed 36 people during 2019. 
Costs in respect of salaries and and social security 
costs were ¤940,258; total resources expended were 
¤1,195,329. We are grateful to Ms Shelley Meenehan 
of Hickey & Associates for her sterling work on the 
audit of the NSRF accounts.
In 2019, the NSRF co-ordinated the following sur-
veillance systems, the National Self-Harm Registry 
Ireland; the Suicide and Self-Harm Observatory and 
the Suicide Support and Information System and 
also worked collaboratively with the Northern Ireland 
Self-Harm Registry and the Surveillance and Monitor-
ing of Self-Harm in Irish Prisons. In addition, the NSRF 
co-ordinated seven research projects in the area of 
suicide, self-harm and related mental health issues 
including the evaluation of intervention and preven-
tion programmes for suicide and self-harm, for exam-
ple, the project entitled Intentional Drug Overdose: 
an Examination of Demographic, Clinical and Drug 
Related Factors; the Review of the Health Service 
Executive Suicide Crisis Assessment Nurse Service 
and the Self-Harm Assessment and Management in 
General Hospitals project. The NSRF continued the 
collaboration with the Donegal SSIS-PAM and the 
National Dialectical Behaviour Therapy Project.
The NSRF meets requests for information from a 
wide range of stakeholders in policy, health and so-
cial services as well as the general population. In 
2019, NSRF staff members were involved in 15 papers 
published in peer-review journals, including a num-
ber of high-impact journals. In addition, NSRF staff 
members presented more than 70 lectures at local, 
national and international seminars and conferences 
(Pages 40 to 43).
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Foreword
In 2019, the NSRF was represented on more than 60 
advisory and steering groups at national and interna-
tional level and NSRF staff members were involved 
in multiple international seminars, consultations and 
training programmes with the WHO and the Inter-
national Association for Suicide Prevention (IASP) 
(Pages 40 to 43).
At the request of the WHO, in 2019, the NSRF com-
pleted a Suicide Prevention Resource for Filmmak-
ers and Others Working on Stage and Screen, which 
was disseminated at global level and worked with the 
WHO Regional Office for Europe and the WHO Of-
fice in Moscow to establish a Multi-Centre Self-Harm 
Surveillance System in the Russian Federation. 
The NSRF works closely with the Health Service Exec-
utive’s National Office for Suicide Prevention (NOSP) 
in relation to providing research and evidence in line 
with the objectives of Connecting for Life, Ireland’s 
National Strategy to Reduce Suicide. The NSRF has 
an Overall Agreement with NOSP for the duration 
of Connecting for Life and receives annual funding, 
subject to a Service Arrangement, for the running of 
the National Self-Harm Registry Ireland and agreed 
research projects in the area of improved quality 
in suicide prevention. Additionally, the NSRF has a 
long track record in obtaining grant funding from re-
search-funding bodies and is happy to announce the 
commencement in January 2020 of the MENTUPP 
Project (Mental Health Promotion and Intervention in 
Occupational Settings, improving workplace mental 
health in the construction, health and ICT-sectors) 
funded by the EU’s H2020 programme. Of the 141 
submissions to the programme, the MENTUPP pro-
ject received the highest ranking. A breakdown of 
the Income and Expenditure 2019, in respect of the 
different tranches of funding, is contained in the Fi-
nancial Statements 2019 commencing on Page 50.
In connection with World Mental Health Day, October 
10th 2019, the NSRF hosted a Seminar in collabora-
tion with UCC; the NOSP; Athlone IT; the HEA and Ul-
ster University for Early Career Researchers who are 
working in the area of Suicide, Self-Harm and Men-
tal Health which was very well attended. In addition, 
NSRF staff members were involved in the Organising 
and Scientific committees of the 30th World Con-
gress of the IASP in Derry in September 2019 and 
in numerous lectures, presentations, symposia and 
workshops at the Congress. 
As this report is being compiled in May 2020, it would 
be remiss not to comment on the impact of the un-
precedented event that is the COVID-19 pandemic. 
Since the start of the public health movement restric-
tion measures in March 2020, NSRF staff members 
have been working at home and the NSRF has con-
tinued its operation in a virtual way. The vast majority 
of its projects and activities have progressed in ac-
cordance with planned time frames and, in addition, 
the NSRF has been responding to numerous requests 
relating to suicide prevention and research from na-
tional and international organisations on an on-going 
basis. The members of the NSRF team embraced the 
new ways of working enthusiastically and have en-
gaged in superhuman efforts to keep the Programme 
of Research on schedule whilst juggling home and 
work commitments. We would like to recognise 
these efforts and to thank staff members for their 
dedication and hard work in recent months as well 
as in 2019 and look forward to continuing to work to-
gether in efforts to provide the strong research base 
necessary to underpin efforts in addressing suicide 
and self-harm as significant public health issues.
Ms Eileen Williamson
Chief Executive Officer
Dr Paul Corcoran
Head of Research
Professor Ella Arensman
Chief Scientist/ 
Research Professor
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Highlights of the Year
17 Board Members
36 Staff Members
7 Directors
1,638
79
15
2,831
Scopus Citations
Google Scholar Citations
Journal Publications
Presentations The NSRF was re-designated as a WHO Collaborating Centre for Surveillance and Research in Suicide Prevention for the 
next four years, enabling the continuation of the international 
work to implement suicide and self-harm surveillance systems 
and national suicide prevention strategies.
The NSRF held an Early - Mid Career Researcher’s Seminar to 
mark World Mental Health Day, 10th October. 
Award of EU Horizon 2020 funding for MENTUPP project. 
See page 48 for further information.
The prestigious International Association of Suicide Prevention 
(IASP) World Congress took place in Derry in September. 
NSRF team members were involved in 16 presentations, 
including a keynote lecture by Professor Ella Arensman. 
NSRF staff member, Dr Eve Griffin was 
awarded one of the HRB Ireland’s Emerging 
Investigator Awards. Eve’s project will 
examine how routine management of 
self-harm in acute settings impacts on 
patient outcomes. See page 48 for further 
information. 
WHO Preventing Suicide. A Resource for Filmmakers and 
Others Working on Stage and Screen was launched in Geneva 
and presented at the Early – Mid Career Researchers Seminar 
on 10th October. See page 14 for further information.
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Structure, Governance and Management
Structure, Governance and Management of 
the National Suicide Research Foundation
The National Suicide Research Foundation is constituted 
as a company limited by guarantee (Company Number 
224676) as set out under the Companies Act 2014. Its 
purpose and objects and how it conducts its business are 
set out in its Constitution which is posted on its website 
www.nsrf.ie under the About Us section and is publicly 
available from the Companies Registration Office website 
www.cro.ie and also the Charities Regulatory Authority 
website www.charitiesregulator.ie The Registered Chari-
ty Number is 20030889 and the Charity Tax Number is 
CHY11351.
The National Suicide Research Foundation was initially 
established in 1994 as the Suicide Research Foundation 
Limited. Permission was subsequently granted, in 1997, 
by the Companies Registration Office to dispense with 
the word Limited in the title of the company and in 2001, 
the Registrar of Business Names granted permission to 
use the name of National Suicide Research Foundation. 
In late 2019 for the purposes of complying with The 
European Union (Anti-Money Laundering: Beneficial 
Ownership of Corporate Entities) Regulations 2019 (SI 
110 of 2019) the National Suicide Research Foundation 
filed required details of the Board of Directors, the Chief 
Executive Officer and the Head of Research on the RBO 
website – www.rbo.gov.ie 
In 2019 representatives from the National Suicide Re-
search Foundation attended training on the implications 
of The Charities Regulator Governance Code which will 
take effect in 2020. The NSRF is taking the necessary 
steps to ensure compliance with the Code.
Board of Directors
The National Suicide Research Foundation is governed by 
a Board of Directors with a minimum number of 5 and a 
maximum number of 11 people. The Board meets at least 
five times each year. Each Director’s term of office is three 
years. A Chairperson is elected by the Board of Directors 
whose term of office is also three years. At each Annual 
General Meeting one third of the Directors elected from 
the membership retire by rotation and may be eligible for 
re-election. The process for nominations and voting is laid 
out in the Election Rules document which is posted on 
the website and made available to all Members.
Policies and Procedures for the Induction 
and Training of board Members
All new Directors receive a Board Induction Folder on ap-
pointment. This contains the following documentation: a 
Board Handbook, the Board-member Code of Conduct, 
the NSRF Conflict of Interests Policy, the NSRF Govern-
ing Documents, the Strategic Plan, Board Minutes from 
the previous 12 months, Reports of the Chief Executive 
Officer from previous 12 months, the annual Budget and 
other relevant documentation. Board Members also get 
complete information on how the NSRF demonstrates its 
full compliance with the Governance Code. The Chief Ex-
ecutive Officer schedules a two hour Induction Meeting 
with each new Director in the first month following ap-
pointment, at which a sub-set of information customised 
for each new member is made available.
Board Subgroups
The National Suicide Research Foundation has three 
Standing Board Subgroups, namely: 
1)  Operations Subgroup (with responsibility for the 
development of Policies & Procedures for approval 
by the Board of Directors and Human Resources 
relating to staff members with salaries not exceeding 
¤40,000).
2) Research Advisory Subgroup.
3)  Audit, Finance and Risk Management Subgroup.
Organisational Structure and How Decisions 
are made
The National Suicide Research Foundation’s main office 
is in Cork and staff members are based in Cork or in 
locations throughout the country. The team is led by the 
Chief Executive Officer, the Head of Research and the 
Chief Scientist who report to the Board. 
Certain decisions are specifically reserved for the Board 
and include:
•  The Company’s strategic plans and annual operating 
Budgets.
• Projects outside the scope of the strategic plan.
• Business acquisitions and disposals.
National Suicide Research Foundation
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• Litigation.
•  Appointment/Removal of Subgroup Chairs and Mem-
bers.
•  Appointment/Removal of the Chief Executive Officer, 
the Head of Research, Chief Scientist.
•  Appointment/Removal of Auditors in accordance with 
decision taken by Company Members at the Annual 
General Meeting.
• Approval of Borrowing/Finance Facilities.
• Approval of all new staff positions.
•  Approval of Contracts exceeding ¤40,000 per annum 
and associated human resource issues for such staff 
members.
• Annual Review of Risk and Internal Control.
•  Approval of policies and procedures and Board nomi-
nations.
Although ultimate responsibility for the governance of 
the National Suicide Research Foundation rests with the 
Board of Directors, certain duties and responsibilities 
are delegated from the Board to the Chief Executive Of-
ficer, the Head of Research and the Chief Scientist and 
through them to the members of the staff team. These 
duties include implementation of the strategic plan; 
leading and managing the staff members, programmes, 
projects, finances and all other administrative aspects so 
that the NSRF’s on-going mission, vision, and strategies 
are fulfilled within the context of the National Suicide 
Research Foundation’s values as approved by the Board 
of Directors.
The Chief Executive Officer is responsible for preparing 
materials for Board consideration and for preparing ma-
terials for any strategic planning process.
When the National Suicide Research Foundation agrees 
to co-operate formally with other organisations on spe-
cific projects or in specific work areas, the agreements 
are determined by a Memorandum of Understanding/
Service Arrangement or a form of written agreement 
which is approved by the Board of Directors.
Internal Controls
The National Suicide Research Foundation conducts an 
annual Risk Review process that is assessed in detail by 
the Audit, Finance and Risk Management subgroup with 
senior management and ultimately reviewed and signed 
off by the Board of Directors. This process involves iden-
tification of the major risks to which the organisation is 
exposed, an assessment of their impact and likelihood of 
happening and risk mitigation actions for each. 
The quarterly report of the Operations Subgroup to the 
board contains a section on risk analysis updating the 
board regarding the status of the most acute risks to 
the National Suicide Research Foundation and this is re-
viewed at each meeting of the Board of Directors.
Transparency and Public Accountability
The Board believes that the National Suicide Research 
Foundation and all organisations with charitable status 
must be fully accountable to the general public, provid-
ing detailed information on where its funds come from 
and on what they are spent. The National Suicide Re-
search Foundation’s annual Financial Statements when 
approved by the Board of Directors are submitted to 
the Companies Registration Office, are published on the 
organisation’s website www.nsrf.ie, under the About Us 
section and are available on the Charities Regulatory 
Authority website www.charitiesregulator.ie 
7
Principles of Good Governance
We, the Executive Committee of National Suicide Re-
search Foundation commit to:
Principle 1.  
Leading our organisation 
We do this by:
1.1  Agreeing our vision, purpose and values and making 
sure that they remain relevant;
1.2  Developing, resourcing, monitoring and evaluating a 
plan to make sure that our organisation achieves its 
stated purpose;
1.3  Managing, supporting and holding to account staff, 
volunteers and all who act on behalf of the organisa-
tion.
Principle 2.  
Exercising control over our organisation
We do this by:
2.1  Identifying and complying with all relevant legal and 
regulatory requirements;
2.2  Making sure there are appropriate internal financial 
and management controls;
2.3  Identifying major risks for our organisation and de-
ciding ways of managing the risks.
Principle 3.  
Being transparent and accountable
We do this by:
3.1  Identifying those who have a legitimate interest in 
the work of our organisation (stakeholders) and 
making sure there is regular and effective communi-
cation with them about our organisation;
3.2  Responding to stakeholders’ questions or views 
about the work of our organisation and how we run it;
3.3  Encouraging and enabling the engagement of those 
who benefit from our organisation in the planning 
and decision-making of the organisation.
Principle 4.  
Working effectively
We do this by:
4.1  Making sure that our governing body, individual 
board members, committees, staff and volunteers 
understand their: role, legal duties, and delegated 
responsibility for decision-making;
4.2  Making sure that as a board we exercise our collec-
tive responsibility through board meetings that are 
efficient and effective;
4.3  Making sure that there is suitable board recruitment, 
development and retirement processes in place.
Principle 5.  
Behaving with integrity
We do this by:
5.1 Being honest, fair and independent;
5.2  Understanding, declaring and managing conflicts of 
interest and conflicts of loyalties;
5.3  Protecting and promoting our organisation’s reputa-
tion.
We confirm that our organisation is committed to the 
standards outlines in these principles. We commit 
to reviewing our organisational practice against the 
recommended actions for each principle every year. 
Margaret Kelleher Eileen Williamson
Chairperson of Board Secretary of the Board
Date: 13th September 2017 Date: 13th September 2017
Signed by Dr Margaret Kelleher and Eileen Williamson in the presence of, and on 
behalf of, the Board of Directors of the National Suicide Research Foundation. 
Principles of Good Governance
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Personnel in 2019
Company Members
 
Mrs Patricia Behan
Founder, Suicide Aware Ireland
Professor Colin Bradley
Professor/Head, Department of General 
Practice, University College Cork
Bishop John Buckley
Catholic Bishop, Cork and Ross (retired)
Professor Patricia Casey
Professor of Psychiatry University 
College Dublin; Consultant Psychiatrist 
the Mater Misericordiae University 
Hospital
Professor Eugene Cassidy
Consultant Liaison Psychiatrist,  
Cork University Hospital 
Clinical Professor, University  
College Cork
Bishop Paul Colton
Anglican Church of Ireland Bishop,  
Cork, Cloyne and Ross
Mr Dave Drohan
Former General Manager, HSE South
Dr Birgit Greiner
Senior Lecturer, School of Public Health, 
University College Cork
Mr Bertie Kelleher
Retired Principal, Colaiste an Spiorad 
Naomh Cork
Dr Margaret Kelleher
General Practitioner, Cork
Medical Director, National Suicide 
Research Foundation
Mr James McCarthy
Director, Transaction Advisory Services, 
Ernst & Young Cork
Mr Barry McGale
Former Suicide Liaison Officer,  
Western Health & Social Care Trust  
Derry Northern Ireland
Mr Dan Neville 
(appointed July 3rd 2019)
Former Teachtaire Daile
Founding Member of Irish Association  
of Suicidology
Mr Mark O’Callaghan 
(appointed June 25th 2019)
Solicitor, Dublin
Mr Tom O’ Dwyer
Former Programme Manager  
Community Care, HSE South
Professor Siobhan O’Neill 
(appointed July 3rd 2019)
Professor of Mental Health Sciences, 
University of Ulster
Mr Mike O’Sullivan 
(Resigned February 2019) 
CEO Nano Nagle Place Cork
Board of Directors
Professor Eugene Cassidy
Consultant Liaison Psychiatrist,  
Cork University Hospital 
Clinical Professor, University  
College Cork
Mr Dave Drohan
Former General Manager, HSE South
Dr Margaret Kelleher
General Practitioner, Cork
Medical Director, National Suicide 
Research Foundation
Mr James McCarthy (Chairman)
Director, Transaction Advisory Services, 
Ernst & Young Cork  
Mr Barry McGale
Former Suicide Liaison Officer at 
Western Health & Social Care Trust Derry 
Northern Ireland
Mr Mark O’Callaghan 
(appointed June 25th 2019)
Solicitor, Dublin
Professor Siobhan O’Neill 
(appointed July 3rd 2019)
Professor of Mental Health Sciences, 
University of Ulster
Mr Mike O’Sullivan 
(Resigned February 2019)
CEO Nano Nagle Place Cork
Personnel in 2019 
NOSP Funding
Ms Eileen Williamson
Chief Executive Officer
Dr Paul Corcoran
Head of Research
Dr Eve Griffin
Manager, National Self-Harm 
Registry Ireland, Research Fellow
(Resigned August 2019). Now HRB 
Emerging Investigators Award
Dr Mary Joyce
Manager, National Self-Harm  
Registry Ireland
Senior Post-Doctoral Researcher
(Commenced 0ctober 2019)
Dr Elaine Mc Mahon
Research Fellow, (Resigned February 
2019). Now HRB Applied Research into 
Policy and Practice Award
Dr Katerina Kavalidou
Post-Doctoral Researcher  
(commenced March 1st 2019)
Ms Caroline Daly
PhD Scholar
Research Officer International 
Association for Suicide Prevention
Mr Niall McTernan
Senior Research Officer
Data Manager, National Self-Harm 
Registry Ireland
Ms Sarah Nicholson (O’Meara)
Data Protection Officer/Research 
Support Officer
Ms Grace Cully
Research Officer 
(Resigned November 2019)
Mr Conal Wrigley
Senior Research Officer/ 
Research Psychologist 
(Resigned July 2019)
Ms Carolyn Holland
Research Officer  
(May to November 2019)
Ms Karen Mulcahy
Research Support Officer
(July to October 2019)
Mr Pawel Hursztyn
Research Support Officer
(April to August 2019)
Ms Emer McEvoy
Operations Manager
(Resigned October 2019)
Ms Clodagh Kiely
Operations Manager
(October to December 2019)
Ms Eileen Hegarty
Operations Manager (Finance)
Mr Leon Fan
IT Support Officer
Ms Ruth Benson
Research Officer International 
Association for Suicide Prevention
Donegal Project
Dr Colette Corry
Senior Research Officer 
HRB Research Leaders Award 
Professor Ella Arensman
Research Professor, Chief Scientist 
Ms Karen Mulcahy
Research Administrator
Dr Isabela Troya Bermeo
Post-Doctoral Researcher
(Commenced June 2019)
Dr Anvar Sadath
Post-Doctoral Researcher
(Commenced October 2019)
Dr Ana Paula Ramos Costa
Post-Doctoral Researcher
(Resigned May 2019)
Ms Grace Cully
PhD Scholar 
(Maternity leave from July 2019)
Ms Ruth Benson
PhD Scholar 
Ms Sarah Nicholson (O’Meara)
Research Support Officer
Ms Eunice T. Philip
Research assistant (Share Project)
(Commenced Feb 2019) 
HRB Emerging Investigators Award
Dr Eve Griffin
Research Fellow
(Commenced September 2019)
HRB Applied Research into Policy 
and Practice Award
Dr Elaine Mc Mahon
Research Fellow 
(Commenced March 2019)
National Dialectical Behaviour 
Therapy Project
Dr Mary Joyce
Project Co-Ordinator
(Resigned September 2019)
Dr Ailbhe Spillane
Project Co-Ordinator
(Maternity cover Jan – June 2019)
Mr Conal Wrigley
Senior Research Officer
(Resigned July 2019)
Ms Justina Hurley
Senior Research Officer
Ms Louise Dunne
Administrator
Ms Edel Gallagher
Research Officer  
(Resigned January 2019) 
National Suicide Research Foundation
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HSE West Region
Eileen Quinn  
Letterkenny General Hospital
Mary Nix 
Mayo General Hospital/Portiuncula Hospital 
Ballinasloe/Galway University Hospital
Catherine Murphy 
University Hospital Limerick/Ennis Hospital/ 
Nenagh Hospital/St. John’s Hospital, Limerick
Ailish Melia 
Sligo Regional Hospital
HSE South Region
Karen Twomey 
University Hospital, Kerry
Tricia Shannon 
University Hospital Waterford/Wexford General 
Hospital/St. Luke’s Hospital, Kilkenny/ South 
Tipperary General Hospital 
Una Walsh & Ursula Burke 
Bantry General Hospital/Cork University Hospital/
Mallow General Hospital/Mercy University Hospital, 
Cork
HSE Dublin/North East Region
Agnieszka Biedrycka & James McGuiggan 
Mater Misericordiae University Hospital, Dublin
Alan Boon 
Beaumont Hospital/Connolly Hospital, 
Blanchardstown/Children’s University Hospital, 
Temple Street
Rita Cullivan 
Cavan General Hospital/Our Lady of Lourdes 
Hospital, Drogheda/Our Lady’s Hospital, Navan
HSE Dublin/Midlands Region
Liisa Aula 
St. Columcille’s Hospital, Loughlinstown/St. Michael’s 
Hospital, Dun Laoghaire/St Vincent’s Hospital, Dublin
Edel McCarra, Sarah McMahon & Marie Lonergan 
Our Lady’s Children’s Hospital, Crumlin 
Laura Shehan & James McGuiggan 
St James’s Hospital 
Diarmuid O’Connor 
Midlands Regional Hospitals (Mullingar, Portlaoise, 
Tullamore)/Naas General Hospital/Tallaght University 
Hospital  
Data Registration Officers 
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World Health Organisation Collaborating Centre for Surveillance and Research in Suicide Prevention
In December 2015, the NSRF was initially 
designated as a WHO Collaborating Centre for 
Surveillance and Research in Suicide Prevention. 
Following a rigorous evaluation process in 2019, 
the redesignation has been approved for a further 
four years. 
The remit of WHO Collaborating centres is to con-
duct research and evaluation, and provide technical 
guidance to the WHO. The aim is to enhance coun-
tries’ capacity to develop and implement national 
policies and plans in line with the 2013–2020 global 
mental health action plan. 
Mental health promotion, prevention, treatment 
and recovery services improved through advoca-
cy, better guidance and tools on integrated mental 
health service are stated WHO outputs.
Project Aims
•  Development and implementation of surveillance 
systems of suicide and suicide attempts. 
•  Implementation and evaluation of national suicide 
prevention programmes. 
•  Training and education in suicide and suicide 
attempt surveillance, research and prevention. 
•  Increasing awareness of suicide prevention 
among governments, stakeholders and the gen-
eral public. 
•  Providing advice and sharing resources in suicide 
research and prevention with countries globally. 
Work plan
The agreed Work plan comprises three main Ac-
tivities: 
•  Activity 1: Establishing and Maintaining Surveillance 
Systems for Medically Treated Suicide Attempts. 
•  Activity 2: Enhancing Screening and Registration 
of Suicide Mortality Cases. 
•  Activity 3: Indicators for the Evaluation of National 
Suicide Prevention Programmes.
Project Deliverables 2019
During 2019, the following work was conducted 
under each of the three Activities:
Activity 1: Establishing and Maintaining Surveil-
lance Systems for Medically Treated Suicide At-
tempts. 
•  The NSRF developed an E-Learning Programme 
based on the WHO Practice Manual for Estab-
lishing and Maintaining Surveillance Systems for 
Suicide Attempts and Self-Harm. This E-Learning 
programme was launched in March 2019. Fur-
ther information about this project is available on 
page 13.
•  Technical support was provided in establishing 
and maintaining surveillance systems for suicide 
attempts and self-harm in Russia. In March, the 
NSRF contributed to a two-day consultation 
meeting in Moscow, Russia, organised by WHO. 
•  On 28th-30th October, the NSRF contributed to 
WHO Technical Meetings on Suicide and Self-
Harm Monitoring and Prevention in the Russian 
Federation, in Stavropol State Medical University, 
Russia, including a keynote lecture and an 
8-hour training workshop on Establishing and 
Maintaining a Suicide Attempt and Self-Harm 
Surveillance System; Report: Arensman E. Report 
on WHO activities related to strengthening 
suicide and self-harm surveillance systems in 
the Russian Federation. NSRF-WHOCC, 3rd 
December 2019.
•  On 12th-13th December, the NSRF contributed 
to WHO Technical meetings in Moscow on 
establishing a Multi-Centre Suicide Attempt/Self-
Harm Surveillance System in three pilot regions in 
Russia. 
•  The NSRF facilitated the Russian translation of 
the WHO E-Learning Programme on Establishing 
and Maintaining Surveillance Systems for Suicide 
Attempts and Self-Harm. 
World Health Organisation Collaborating Centre for 
Surveillance and Research in Suicide Prevention 
National Suicide Research Foundation
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Activity 2: Enhancing Screening and Registration 
of Suicide Mortality Cases. 
•  In December, a manuscript was submitted to 
Frontiers in Psychiatry: Corry C, Williamson E, 
Haley C, Benson R, Arensman E. A study of per-
sons who died by suicide while in care of mental 
health services in an Irish region.
•  Publication: Arensman, E, Larkin, C, McCarthy, 
J, Leitao, S, Corcoran, P, Williamson, E, et al. 
(2019). Psychosocial, psychiatric and work-
related risk factors associated with suicide in 
Ireland: optimised methodological approach of a 
case-control psychological autopsy study. BMC 
Psychiatry, 19(1). 
•  The NSRF conducted a feasibility study of the 
SSHO to implement a real-time suicide mortality 
surveillance system in Cork City and County.
•  The NSRF commenced an international compar-
ative study on surveillance systems for real-time 
suicide mortality, involving partners from Ireland, 
Queensland and Victoria (Australia), New Zealand 
and England.
Activity 3: Indicators for the Evaluation of National 
Suicide Prevention Programmes.
•  In February, the NSRF completed the 2nd Nation-
al Strategic Action Plan for Suicide Prevention in 
Namibia in collaboration with the WHO Country 
Office in Windhoek and the Ministry of Health and 
Social Services (MoHSS), Namibia. 
•  In May, the NSRF and WHO conducted a work-
shop on the implementation and evaluation of 
national suicide prevention strategies, which was 
attended by representatives of more than 20 
countries in the PAHO region, in conjunction with 
the 3rd IASP regional Symposium on Suicide Pre-
vention in the Caribbean Region, Port of Spain, 
Trinidad & Tobago, 2nd-4th May 2019.
•  In September, the NSRF and WHO conducted 
a day-long workshop on the implementation 
and evaluation of national suicide prevention 
strategies, which was attended by representatives 
of more than 40 countries globally, in conjunction 
with the 30th IASP World Congress in Derry, 17th-
21st September 2019.
•  In September, the NSRF facilitated updates on 
the Irish National Strategy for the Reduction of 
Suicide, Connecting for Life, for the WHO World 
Suicide Prevention Day programme on 10th Sep-
tember.
•  5-6th November: Following a request from WHO, 
the NSRF co-facilitated workshops in Geneva to 
improve the implementation and evaluation of 
national suicide prevention strategies. 
Personnel Involved
Prof Ella Arensman, Ms Carolyn Holland, Mr Niall 
McTernan, Ms Fenella Ryan, Mr Leon Fan, Ms Eileen 
Williamson.
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WHO Commissioned Work
Study Overview 
The WHO’s report “Preventing suicide: a global 
imperative” published in 2014, identified a need 
for many countries to have guidance on the sur-
veillance of suicide attempts presenting to general 
hospitals. Currently, the number of countries that 
have established a surveillance system for suicide 
attempts is limited, and comparison between es-
tablished systems is often hindered by differences 
between systems. 
Each year, close to 800,000 people die due to 
suicide, and for each suicide, there are likely to 
have been more than 20 suicide attempts. Having 
engaged in one or more acts of attempted suicide 
or self-harm is the single most important predictor 
of death by suicide. Consequently, long-term 
monitoring of the incidence, demographic patterns 
and methods involved in cases of attempted suicide 
and self-harm presenting at hospitals in a country 
or region provides important information that can 
assist in the development of suicide prevention 
strategies. 
In 2018, the WHO commissioned the NSRF, be-
cause of its status of WHO Collaborating Centre for 
Surveillance and Research in Suicide Prevention, to 
develop an E-Learning Programme, based on the 
WHO Practice Manual for Establishing and Main-
taining Surveillance Systems for Suicide Attempts 
and Self-Harm (WHO, 2016).
Project Aims
The aims of the E-Learning Programme are to 
facilitate surveillance of suicide attempts and self-
harm at global level and to improve the accuracy 
of hospital based suicide attempts and self-harm. 
Work Plan 2019
The NSRF, in collaboration with the Department of 
Mental Health and Substance Abuse of the WHO, 
produced the E-Learning Programme, based on the 
WHO Practice Manual. The work involved preparing 
different modules, including a training module with 
additional test vignettes. 
It was required for the Programme to facilitate 
training and capacity building in places where face-
to-face training can be challenging. 
Project Deliverables 2019 
1. Modules approved by WHO (January, 2019).
2.  E-Learning Programme launched (February, 2019).
Personnel involved
Prof Ella Arensman, Ms Fenella Ryan, Mr Leon Fan. 
WHO Commissioned Work
E-Learning Programme for Establishing and Maintaining 
Surveillance Systems for Suicide Attempts and Self-Harm 
National Suicide Research Foundation
14
Study Overview 
Suicide is a serious global public health problem 
that occurs throughout the lifespan. Furthermore, 
suicide is one of the leading causes of premature 
mortality among young people in many countries. 
Suicides are preventable, but preventing suicide 
is no easy task. Interventions range from training 
young persons in skills to cope with stressors in 
life, through accurate and timely assessment, diag-
nosis and effective treatment of mental disorders, 
to responsible reporting of suicide by the media, 
restricting access to suicide methods and the envi-
ronmental control of risk factors.
This booklet is one of a series of resources aimed 
at specific groups of people who are in a position 
where they can contribute to suicide prevention. 
Suicide prevention involves the concerted efforts 
of many sectors of society, including professional 
groups – national and local government, legislators, 
law enforcers, health workers, educators, social 
agencies, the media, families, schools, workplaces 
and communities.
Project Aims 
This resource is intended to help filmmakers and 
others involved in the development and production 
of suicide and self-harm content for television, 
cinema and theatre to maximize the positive 
impact of their work and reduce the risk of potential 
harmful effects, in particular among those who are 
vulnerable or have mental health conditions. This 
resource was developed to apply to portrayals 
of actual suicides that have occurred, as well as 
fictional portrayals of suicide – e.g. in television, 
films, documentaries and theatre.
Work Plan 2019 
Between May and October 2019, the NSRF worked 
with WHO and international colleagues to develop 
the resource. 
Project Deliverables 2019 
This resource was published by WHO on World 
Mental Health Day, 10th October 2019, and 
presented by the NSRF at the NSRF Early-Mid 
Career Researcher’s Seminar on the same day.
Personnel involved
Prof Ella Arensman, Mr Niall McTernan, Ms Carolyn 
Holland.
Preventing Suicide: A Resource for Filmmakers and Others 
Working on Stage and Screen 
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Surveillance Systems
The National Self-Harm Registry Ireland is a 
national system of population monitoring for the 
occurrence of self-harm. The Registry collects data 
based on persons presenting to hospital emergency 
departments as a result of an episode of self-harm, 
as defined by the Registry. As of 2006, the Registry 
has obtained full coverage of all general and 
paediatric hospital emergency departments in the 
Republic of Ireland. Please see the annual reports 
of the registry at www.nsrf.ie/reports 
The Registry Aims
•  To establish the extent and nature of hospital-
treated self-harm in Ireland.
• To monitor trends over time and by area.
•  To contribute to policy and development in the 
area of suicidal behaviour.
• To help the progress of research and prevention.
Articles
•  Griffin E, Bonner B, O’Hagan D, Dillon CB, 
Corcoran P. The association between self-harm 
and area-level characteristics in Northern Ireland: 
An ecological study. European Journal of Public 
Health, Volume 29, Issue 5, October 2019, Pages 
948–953.
•  Cully G, Corcoran P, Leahy D, Griffin E, Dillon CB, 
Cassidy E, Shiely F, Arensman E. Method of self-
harm and risk of self-harm repetition: findings 
from a national self-harm registry. Journal of 
Affective Disorders 246: 843-850.
•  Griffin E, Bonner B, O’Hagan D, Kavalidou K, 
Corcoran P. Hospital-presenting self-harm and 
ideation: Comparison of incidence, profile and 
risk of repetition. General Hospital Psychiatry, Vol 
51, 76-81.
Reports
•  National Self-Harm Registry Ireland Interim 
Report 2018. Cork: National Suicide Research 
Foundation, February 2019.
•  Connecting for Life: Ireland’s National Strategy to 
Reduce Suicide – Interim Strategy Review. HSE 
NOSP, January 2019. 
•  A Focus on Alcohol and Health in Cork and 
Kerry: A Report of the Director of Public Health. 
Chapter 2 Alcohol and Harm in Cork and Kerry. 
Department of Public Health, HSE South, May 
2019.
•  Griffin E, McTernan N, Wrigley C, Nicholson S, 
Arensman E, Williamson E, Corcoran P (2019) Na-
tional Self-Harm Registry Ireland Annual Report 
2018. Cork: National Suicide Research Foundation.
•  National Self-Harm Registry Ireland Community 
Healthcare Organisation (CHO) 1-9 Reports 2018. 
Cork: National Suicide Research Foundation. 
Evidence Brief
•  Evidence Brief: The association between self-
harm and area-level factors. National Suicide 
Research Foundation, July 2019.
Oral/ poster communications
Oral presentations
•  Arensman E, Cully G, Ramos Costa AP, Leahy D, 
O’Meara S. Identifying subgroups of self-harm: 
Implications for assessment and treatment. Lec-
ture at the Australian Research Workshop on Su-
icide and Self-Harm, AISRAP, Griffith University, 
Brisbane 7-8th February 2019.
•  Hilmi H. Alcohol involvement in hospital treated 
self-harm of patients under 25 years of age in 
Ireland from 2013-2016. Student Medical Summit, 
Dublin, 8th February 2019.
•  Griffin E, et al. ‘Self-Harm in Ireland: Priority 
groups and opportunities for intervention.’ Self-
Harm Awareness Conference, Dublin, 1st March 
2019.
•  Griffin E, et al. National Self-Harm Registry Ire-
land. ROSP Training Day, Dublin, 28th March 2019.
•  Griffin et al. Increasing rates of self-harm among 
children, adolescents and young adults: a 10-year 
national registry study 2007-2016. 9th Europae-
diatrics Conference. 13th-15th June 2019.
•  Arensman E. Surveillance of Suicide Attempts 
and Self-harm: WHO practice manual for estab-
lishing and maintaining surveillance systems for 
suicide attempts and self-harm. Department of 
Health and Human Services Seminar, Melbourne, 
Australia, 21st June 2019.
Surveillance Systems 
National Self-Harm Registry Ireland 
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•  Daly et al. A national case fatality study of drugs 
taken in intentional overdose. Society of Social 
Medicine and Population Health 63rd Annual 
Scientific Meeting, 4th September 2019.
•  Griffin et al. Increasing rates of self-harm among 
children, adolescents and young adults: a 10-year 
national registry study 2007-2016. Society of So-
cial Medicine and Population Health 63rd Annual 
Scientific Meeting, 5th September 2019.
•  Corcoran et al. Release of 13 Reasons Why 
and hospital-presenting self-harm and suicidal 
ideation in Ireland. Society of Social Medicine and 
Population Health 63rd Annual Scientific Meeting, 
6th September 2019. (Rapid-fire presentation).
•  Barrett et al. Self-harm among the homeless 
population in Ireland: A national registry based 
study of incidence and associated factors. 30th 
World Congress of the International Association 
for Suicide Prevention, 18th September 2019.
•  Daly et al. A national case fatality study of drugs 
taken in intentional overdose. 30th World Congress 
of the International Association for Suicide Preven-
tion, 18th September 2019.
•  Corcoran et al. Release of 13 Reasons Why and hos-
pital-presenting self-harm and suicidal ideation in 
Ireland. 30th World Congress of the International 
Association for Suicide Prevention, 19th September 
2019.
•  Daly et al. Intentional Drug Overdose Among 
Homeless People in Ireland. Irish Street Medicine 
Symposium. 27th September 2019.
•  Corcoran, et al. ‘National Self-Harm Registry Ire-
land Annual Report 2018’. Registry Annual Report 
Launch, Cork, 10th October 2019.
•  Daly et al. A national case fatality study of drugs 
taken in intentional overdose. RAMI Jacqueline 
Horgan Bronze Medal Award, 7th November 2019.
Poster presentations
•  Birchall et al. Has there been a reduction in codeine-
related intentional drug overdose presentations to 
Irish hospitals following national guidance in 2010? 
New Horizons Research Conference, University 
College Cork, December 5th, 2019.
Meetings
•  Meeting of Data Registration Officers, University 
College Cork, 6th March 2019.
•  Meeting of Data Registration Officers, University 
College Cork, 6th June 2019.
•  Meeting of Data Registration Officers (joint meeting 
with Northern Ireland Self-Harm Registry), Naas, 
6th – 7th November 2019.
Personnel Involved
Head of Registry: Dr Paul Corcoran
Registry Manager: Dr Eve Griffin (Jan-Sep) / Dr Mary 
Joyce (Oct-Dec)
Personnel Involved: Niall McTernan, Conal Wrigley, 
Sarah Nicholson, Professor Ella Arensman, Eileen 
Williamson, Leon Fan. 
Data Registration Officers: Liisa Aula, Agnieszka 
Biedrycka, Alan Boon, Ursula Burke, Rita Cullivan, 
James McGuiggan, Ailish Melia, Mary Nix, Catherine 
Murphy, Diarmuid O’Connor, Eileen Quinn, Tricia 
Shannon, Laura Shehan, Karen Twomey, Una Walsh.
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Findings at a glance
2018 findings at a glance
Presentations
12,588  
210
per 100,000 
1 in every 476
had a self-harm act
Female: 15-19 year-olds
(766 per 100,000)
1 in every 131
Male: 20-24 year-olds
(543 per 100,000)
1 in every 184
Rates in young people
aged 10-24 years increased
by 29% between 2007-2018
PEAK
RATES
WERE
AMONG
YOUNG
PEOPLE
Persons
9,785  
2018 Statistics at a Glance
Monday, Tuesday and Sunday
had the highest number
of self-harm presentations
Peak time
11pm
Men Women
Almost half (44%) 
of presentations were made
between 7pm-3am
7pm
3am
2 in every 3 
involved overdose
72%
received an assessment in the ED
79% received a follow-up 
recommendation after discharge 
13% left ED before a 
recommendation was made
3 in every 10
involved alcohol
3 in every 10
involved self-cutting 
M T W
F S S
T
62%
34% 27% 30%
RATES:
TIME:
METHOD:
TREATMENT:
1 in 7
persons
had a repeat
attendance in 2018
20182007
+29%
National Suicide Research Foundation
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Registry Review 
The HSE National Office for Suicide 
Prevention (NSOP) commissioned a 
review of the NSHRI in September 
2017 as part of Connecting for Life 
(CfL) strategic objective “To improve 
access to timely and high quality data 
on suicide and self-harm (CfL 7.2)”. 
The review was completed in Feb-
ruary 2018 and a number of findings 
and recommendations were outlined 
for consideration. The following are 
progress updates on some of the key 
recommendations from the Registry 
Review:
Data Protection and IT-related 
issues
During 2019, GDPR training was pro-
vided to all Registry staff including 
office-based staff and Data Registra-
tion Officers who conduct data col-
lection at hospitals across Ireland. All 
processes of the Registry were also 
reviewed and updated as required to 
ensure they are in line with GDPR. 
In 2019, the data collection applica-
tion for the Registry was upgraded 
to a web-based system. A series of 
tests of this new system was com-
pleted during 2019 with a view to 
data collection being moved over to 
this system from 2020 onwards. All 
Data Registration Officers will input 
data into this new system from 2020.
Data quality assurance
In order to assess data quality as-
surance for the Registry, data com-
pleteness was reviewed during 2019. 
In particular, cross-checking exercis-
es between pairs of DROs were in-
troduced and missing data analyses 
were conducted across hospitals. 
Monitoring of data quality assurance 
will continue to be reviewed and re-
fined beyond 2019.
Comparison with HIPE
As recommended, a comparison 
was made in 2019 between the 
number of self-harm presentations 
recorded by the Registry as resulting 
in admission to the general hospital 
and the number of general hospital 
admissions record in the Hospital In-
Patient Enquiry (HIPE) database with 
a diagnosis code related to intentional 
self-harm. Overall, and for most 
hospitals there were relatively small 
discrepancies but the differences 
were notable for some hospitals. This 
highlighted the need for all Registry 
Data Registration Officers to seek 
to ascertain cases from HIPE data 
records, something which is done 
more now than previously.
Specific to data collection
A number of specific actions were 
undertaken in 2019 to improve meth-
ods of data collection for the Reg-
istry. More specifically, following the 
Registry review, where possible, Data 
Registration Officers have moved to 
electronic means of processing data. 
Standardised forms for the transcrip-
tion of paper records have also been 
introduced for all DROs. 
In addition, all Data Registration 
Officer laptops were reviewed and 
updated as appropriate so that 
the most up-to-date software was 
available to each staff member. 
Staff laptops were upgraded where 
necessary during 2019. 
Study Overview
The Northern Ireland Registry of Self-Harm was estab-
lished by the Public Health Agency. In 2012 the Self Harm 
Registry initiative was extended to all 12 acute hospitals 
in Northern Ireland, as part of the action plan to address 
self-harm and suicide prevention under the Protect Life 
Strategy. The regional introduction of the Registry fol-
lowed an initial piloting of the service in the Western 
Health and Social Care Trust from 2007 to 2012. The Na-
tional Suicide Research Foundation provides statistical 
analysis, support and independent verification of data 
recorded by the Northern Ireland Registry of Self-Harm.
Project deliverables
•  Data from Q4 (Jan-Mar 2019) to Q3 (Oct-Dec 2019) 
were processed for Department of Health, Social Ser-
vices and Public Safety (DHSSPS) summary reports in 
2019. These reports are published for Northern Ireland 
and each Health and Social Care Trust (HSCT) on a 
quarterly basis.
•  Summary reports for each HSCT area for 2018/19 were 
published. 
• Annual Report for 2018/19 was published. 
• Six-year Reports were compiled for each HSCT. 
•  A total of 14 data requests were prepared in 2019 and 
an additional Freedom of Information request was pre-
pared. 
Articles published
•  Griffin E, Bonner B, Dillon C, O’Hagan D, Corcoran P 
(2019). The association between self-harm and area-
level characteristics in Northern Ireland: an ecological 
study. European Journal of Public Health, 29(5). 
•  Griffin E, Bonner B, O’Hagan D, Kavalidou K, Corcoran 
P (2019). Hospital-presenting self-harm and ideation: 
Comparison of incidence, profile and risk of repetition. 
General Hospital Psychiatry, 61.
Oral/ poster communications
•  Griffin E et al. Patterns of repetition following pres-
entation to hospital with suicidal ideation. International 
Association for Suicide Prevention Conference, Derry, 
17-21 September 2019.
NSRF Personnel
Dr Eve Griffin, Dr Paul Corcoran, Dr Katerina Kavalidou 
and Ms Grace Cully. 
Northern Ireland Registry of Self-Harm
Statistical analysis and independent verification of Northern Ireland Registry of  
Self-Harm 
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Surveillance Systems
Study Overview 
As part of its role in Connecting for Life, Ireland’s National 
Suicide Reduction Strategy, The Irish Prison Service 
(IPS) has committed to reviewing, analysing and learning 
from each episode of self-harm within the prison estate. 
The SADA project provides robust information relating 
to the incidence and profile of self-harm within prison 
settings, identifies individual- and context-specific 
risk factors relating to self-harm, as well as examining 
patterns of repeat self-harm. Such information can be 
used as an evidence base to inform the identification 
and management of prisoners who engage in or who 
are at-risk for self-harm, and to develop effective 
prevention initiatives. Findings from this project are 
disseminated back to the Irish Prison Service National 
Suicide and Harm Prevention Steering Group (NSHPG) 
on a quarterly basis. This project is supported by the 
National Office for Suicide Prevention and The National 
Suicide Research Foundation coordinates the data 
management, data analysis and reporting of findings 
from the SADA Project.
Project Aims
1.  To collate, enter and analyse data from the Irish Prison 
Service’s Self-Harm/Suicide Surveillance & Monitoring 
System (led by NSRF). 
2.  To undertake a case-study to understand and 
document the design and implementation of the Self-
Harm/Suicide Surveillance and Monitoring system 
(led by NOSP).
Work Plan
In October 2018, the first report from the SADA project, 
covering 2017 data, was launched in Dublin.
Data collection of 2018 data continued in 2019 according 
to the standard operating procedures outlined in the 
SADA manual which was updated and finalised in 
October 2018. The 2018 report will be published in early 
2020 and presented to the IPS National Suicide and 
Harm Prevention Steering Group. In collaboration with 
the NSRF, during 2019 the IPS further updated the data 
collection form and the NSRF are currently exploring the 
capacity of using online software ‘Castor’ to improve the 
data collection process. Initial findings from the SADA 
project were presented the 30th World Congress of the 
International Association for Suicide Prevention in Derry, 
in September. 
Project deliverables for 2019
1. Full year summary report for 2018 (February 2020).
2.  Presentation to IPS National Suicide and Harm Pre-
vention Steering Group (March 2020).
3.  Preparation of a form on Castor (new software) based 
on the prisons dataset to improve the data collection 
process (Ongoing).
4.  Development of a sustainability plan (with IPS and 
NOSP) (Ongoing).
Oral Presentations
•  Griffin E, Cully G, Hume S, Kelly ET, O’Reilly D, Corcoran 
P. The development and implementation of a national 
reporting system for self-harm in Irish prisons. The 
SADA Project. 30th World Congress of the International 
Association for Suicide Prevention, Derry, 17th - 21st 
September. 
Personnel Involved 
NSRF: Dr Paul Corcoran, Mr Niall McTernan, Dr Eve Griffin, 
Ms Grace Cully.
Irish Prison Service: Ms Sarah Hume, Mr Enda Kelly, Ms 
Deirdre O’Reilly
National Office for Suicide Prevention: Dr Gemma Cox. 
 
Improving surveillance and monitoring of self-harm in Irish Prisons: 
The Self-Harm Assessment and Data Analysis (SADA) Project
National Suicide Research Foundation
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Project Overview 
The Suicide Support and Information System (SSIS) 
is a suicide surveillance system that was developed 
in 2008 to provide access to support for those be-
reaved by suicide, while also, collecting information 
on risk factors associated with suicide and deaths 
classified as open verdicts.
 The SSIS aims to:
•  Improve the support available to people bereaved 
by suicide. 
•  Identify and better understand the causes of 
suicide. 
•  Better define the incidence and pattern of suicide 
in Ireland. 
•  Identify and improve the response to clusters of 
suicide and murder-suicide e.g. (filicide-suicide 
and familicide). 
A unique element of the SSIS is that it accesses 
multiple sources of information relating to 
consecutive cases of suicide and open verdicts upon 
completion of an inquest conducted by a coroner. 
The SSIS obtains information on all consecutive 
cases of suicide in the HSE Southern region from 
multiple sources including coroner’s records, health 
care professionals and family informants using a 
psychological autopsy approach. The SSIS has 
been proven to effectively identify suicide clusters 
by accessing information from multiple sources and 
hence establishing direct and indirect relationships 
among suicide cluster cases. 
Project Aims
•  To improve the support available to people be-
reaved by suicide.
•  To identify and better understand the causes of 
suicide.
•  To identify and improve the response to clusters 
of suicide and murder-suicide e.g. (filicide-suicide 
and familicide).
•  To better define the incidence and pattern of 
suicide in Ireland.
•  To identify persons who present for medical treat-
ment following self-harm and who subsequently 
die by suicide.
Work Plan
Specific objectives of the SSIS in 2019-2020 are 
to ensure the continuation of the SSIS. In addition, 
further objectives relating to wider dissemination, 
implementation and exploitation of the SSIS 
approach was pursued, with the SSIS template 
being used for the analysis of information obtained 
from a murder-suicide case, and the SSIS approach 
being adopted by other regions and countries, 
including The Netherlands. In collaboration with 
the Centre for Geocomputation at Maynooth 
University, geospatial analyses were conducted 
using the SSIS data.
Project Deliverables 
1.  Evidence brief on locations in Cork City and 
County where people frequently die by suicide 
involving drowning for Connecting for Life Cork 
and Cork City Council (March 2019). 
2.  Workshop on the SSIS enhanced psychological 
autopsy approach at the IASP Regional Sympo-
sium in Port of Spain (May 2019).
3.  Updated SSIS data collection for North, South, 
East and West Cork (September 2019).
4.  Geospatial analysis conducted on SSIS data 
(October 2019).
5.  Application of SSIS approach in analysing mur-
der-suicide case in collaboration with Garda Na-
tional Bureau of Criminal Investigation (October 
2019).
6.  Application of SSIS approach in Psychological 
Autopsy Study on Suicide in young people aged 
10-19 years in The Netherlands (Report complet-
ed, December 2019). 
7.  Paper based on SSIS data: ‘The mental and 
physical health profile of people who died by 
suicide: findings from the Suicide Support and 
Information System’, Leahy D, Larkin C, Leahy D, 
McAuliffe C, Corcoran P, Williamson E, Arensman 
E. Accepted for publication by Social Psychiatry 
and Psychiatric Epidemiology (March 2020).
Personnel Involved 
Prof Ella Arensman, Dr Paul Corcoran, Ms Eileen 
Williamson, Ms Ruth Benson, Dr Daniel Leahy, Ms 
Karen Mulcahy, Prof Jan Rigby, Prof Chris Brunsdon.
Suicide Support and Information System 
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Surveillance Systems
Study Overview 
The Suicide and Self-Harm Observatory (SSHO) was 
established in Cork City and County in December 2018, 
based on the need for real-time suicide data collection 
due to a delay in the availability of official suicide mortal-
ity statistics that are released approximately every two 
years by the Irish Central Statistics Office (CSO). The 
process of verification, registration and classification of 
sudden premature deaths (including deaths by suicide) 
in Ireland is often delayed due to the requirement of 
an inquest and the involvement of coroners, An Garda 
Síochána, registrars and pathologists. A reliance on mor-
tality statistics published by the CSO two years after the 
calendar year in which they took place results in delays 
to reviews and modifications of suicide prevention plans. 
Having access to a real-time surveillance system which 
can be measured against CSO statistics may assist in the 
implementation of timely response and support plans, 
and the prevention of further cases of suicide and self-
harm during this time period. This research builds on the 
Suicide Support and Information System (SSIS), which 
has been implemented and evaluated successfully in 
Cork City and County since September 2008. The SSHO 
is funded by the Health Research Board as part of the 
5-year research programme: Individual and Area Level 
Determinants of Self-Harm and Suicide in Ireland: En-
hancing Prediction, Risk Assessment and Management 
of Self-Harm by Health Services. Between 1st December 
2018 and 31st December 2019, the SSHO obtained data 
on 47 cases of suspected suicide in the Cork region.
Project Aims 
•  To ensure accuracy and reliability of reported suicide 
statistics.
•  To facilitate early detection of emerging suicide 
contagion and clustering.
•  To identify at risk groups and implement targeted 
intervention in a timely manner.
•  To facilitate effective and timely support for families 
bereaved by the sudden death of a family member.
Work Plan 2019-2020 
The SSHO pilot phase in Cork City and County was 
completed in December 2019, and the National 
Office for Suicide Prevention has requested a review 
report including a proposal for upscaling and wider 
implementation of the SSHO (in progress). Preparations 
are currently in place in additional CHO areas across 
Ireland, with the aim of wider implementation. Wider 
implementation of the SSHO will require liaison with 
key stakeholders and the establishment of advisory 
panels in each county in order to guide and support the 
implementation of the SSHO, as well applications for 
ethical approval for the implementation of the SSHO 
within the respective counties to local ethics committees. 
A collaborative paper based on Best Practice of Real-
Time Suicide Surveillance is currently in draft with 
colleagues from Australia, New Zealand and the UK. 
It is anticipated that this paper will be submitted for 
publication in July 2020. 
Project Deliverables 
•  Four meetings of the Advisory Panel for the develop-
ment of the SSHO in Cork (February, July, November 
2019, February 2020).
•  Presentation for the Connecting for Life – Cork Suicide 
Prevention Steering Group: Outcomes of the SSIS and 
SSHO in relation to locations near waterways in Cork 
City and County where people frequently take their 
lives. Arensman E, Benson R, Rigby J, Brunsdon C, Ryan 
M, Corcoran P. (March, 2019).
•  Presentation of the SSHO at a Seminar for Resource 
Officers for Suicide Prevention (March, 2019).
•  Preparations for establishment of an Advisory Panel 
for the implementation of the SSHO in Donegal (May 
2019).
•  Presentation of first outcomes of the SSHO pilot study 
for the National Office for Suicide Prevention (June 
2019).
•  Lecture at the 30th IASP World Congress, Derry. 
Developing a real-time suicide surveillance system: 
the Suicide and Self-Harm Observatory, Arensman E, 
Benson R, Rigby J, Brunsdon C, Ryan M, Corcoran P. 
(September 2019). 
•  In four instances, the SSHO was effectively used to 
verify media reports including unverified numbers of 
suspected suicide / presumed suicide contagion with-
in areas of Cork County and City in December 2018, 
January, May and December 2019. 
•  Meeting with Cork City Council and An Garda Síochána 
about the SSHO data and locations near water ways 
in Cork City where people frequently die by suicide or 
attempt suicide (January 2020).
•  Re-introduction of the SSHO and establishment of an 
Advisory Panel for the implementation of the SSHO in 
Kerry (February 2020).
•  Keynote lecture SSHO: Developing and Implementing 
a Real-Time Suicide Surveillance System: the Suicide 
and Self-Harm Observatory. Arensman E, Benson R, 
Rigby J, Brunsdon C, Ryan M, Corcoran P. 2nd Austral-
asian Research Workshop on Suicide and Self-Harm 
(February 2020).
•  Presentation outcomes SSHO pilot study at meeting 
with NOSP and agreement on preparation of review re-
port SSHO pilot study and proposal for upscaling and 
wider implementation of the SSHO (February 2020).
Personnel Involved 
Prof Ella Arensman, Ms Ruth Benson, Prof Jan Rigby, 
Prof Chris Brunsdon, Dr Paul Corcoran, Mr Martin Ryan.
Suicide and Self-Harm Observatory 
National Suicide Research Foundation
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Study Overview 
This research will inform legislation and recommen-
dations for means restriction interventions related 
to suicidal behavior. This study affects Goal 6 of 
Connecting for Life, Irelands National Strategy to 
Reduce Suicide in Ireland: To reduce and restrict 
access to means of suicidal behavior, by inform-
ing goals 6.1: To reduce access to frequently used 
drugs in Intentional Drug Overdose (IDO) and 6.2: 
To reduce access to highly lethal methods used in 
suicidal behavior.
Project Aims
1.  To examine the profile of persons engaging in 
IDO, detail drugs used and to quantify the con-
tributions of alcohol involvement and multiple 
drug use;
2.  To describe the emerging use of a group of 
antiepileptic’s known as gabapentinoids in IDO 
in Ireland; to describe the characteristics of fatal 
and non-fatal IDO;
3.  To establish which drug types are linked with 
greater risk of a fatal outcome;
4.  To describe paracetamol-related IDO among 
young people; and 
5.  To explore repeat self-harm following IDO 
among young people.
Work Plan
This research is being conducted as part of a PhD 
programme (2015-2020) in collaboration with the 
University of Manchester. This research will involve 
the use of data from the National Self-Harm Registry, 
Ireland. Additional data was sourced from the 
National Drug Related Death Index (Health Research 
Board). Other agencies involved in this work 
include The National Centre for Geocomputation, 
Department of Pharmacy, UCC and the Crisis Nurse 
Specialists within the HSE.
Project Deliverables
1.  Publication: Intentional Drug Overdose Involving 
Pregabalin and Gabapentin: Findings from the 
National Self-Harm Registry Ireland, 2007-2015. 
Clinical Drug Investigation (December 2017).
2.  Publication: Frequently used drug types and 
alcohol involvement in intentional drug overdoses 
in Ireland: a national registry study. European 
Journal of Public Health (March 2018).
3.  Publication: A national case fatality study of 
drugs taken in intentional overdose (December 
2019).
4.  Publication: Paracetamol-related intentional drug 
overdose among young people: A national study 
of characteristics, incidence and trends (May 
2020).
5.  Publication: Repeat self-harm following inten-
tional drug overdose among young people (May 
2020).
Personnel Involved
PhD Researcher: Ms Caroline Daly
PhD Supervisors: Prof Ella Arensman, Dr Eve Griffin
Official advisors: Prof Ivan Perry (University College 
Cork), Prof Darren Ashcroft and Dr Roger Webb 
(University of Manchester). 
 
Individual and Ecological Factors Associated  
with Intentional Drug Overdose 
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Study Overview 
Each year, there are approximately 11,500 
presentations to hospital emergency departments 
as a result of self-harm, recorded by the National 
Self-Harm Registry Ireland (Griffin et al, 2018). 
However, internationally, there are indications that 
a considerable number of self-harm acts present 
to primary care settings, without further referral to 
hospital emergency departments (Carr et al, 2016). 
In Ireland, no reliable data are available on the 
prevalence of self-harm, suicidal ideation or related 
mental health problems presenting to primary care.
The Health Service Executive Suicide Crisis 
Assessment Nurse (HSE SCAN) service was 
developed to link general practitioners (GPs) 
directly to a specialist mental health nurse so that 
individuals experiencing a suicidal crisis could be 
referred for prompt assessment. In 2017, the NSRF 
were commissioned by the National Office for 
Suicide Prevention, to conduct an evaluation of the 
SCAN service. 
Project Aims
1.  To describe the operational structure of the 
SCAN service. 
2. To review referrals made to services.
Ethical approval for the project was granted in 
February 2018 and the evaluation was conducted 
throughout the remainder of 2018. In April 2019, 
a final project report for the National Office for 
Suicide Prevention was completed. 
The results from this project will estimate the 
prevalence of mental health-related referrals to 
and from the HSE SCAN Service and such data 
may inform recommendations regarding further 
development of the service. In particular, findings 
from this project will inform the statement of 
purpose for the service as well as the alignment of 
the service with that of the National Clinical Care 
Programme. The findings may identify potential 
improvements for the treatment of individuals at 
risk of suicidal behaviour. The findings will also raise 
awareness of the significance and range of mental 
health problems among the general population that 
presents to primary care services. Such findings 
may inform general population mental health 
promotion initiatives.
Personnel Involved
Dr Paul Corcoran, Dr Eve Griffin, Mr Niall McTernan. 
Review of the Health Service Executive Suicide 
Crisis Assessment Nurse (HSE SCAN) Service 
National Suicide Research Foundation
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Study Overview
In 2018, a service improvement project called 
‘Improving Suicide Bereavement Supports’ was 
established by HSE Mental Health in order to address 
actions 4.3.1 (To deliver enhanced bereavement 
support services to families and communities 
affected by suicide of those people known to 
mental health services) and 4.3.2 (To commission 
and evaluate bereavement support services) in 
Connecting for Life. As part of this working group, 
the National Suicide Research Foundation were 
asked to complete a review of literature in order 
to identify key research published in the area 
of suicide bereavement support, to review the 
literature on evidence-based interventions, and to 
identify examples of current practice in Ireland and 
internationally. The literature review was completed 
and published in April 2019.
Summary of findings
As well as informing the priorities for bereavement 
services in Ireland, the literature review highlighted 
the lack of research on suicide bereavement, in 
particular around the effectiveness of bereavement 
support interventions. There is a need for high-
quality, trial-based research examining suicide 
bereavement supports. For young people in 
particular, the evidence around the appropriateness 
of supports and interventions is limited, as is our 
understanding of how suicide bereavement differs 
for young children compared with adolescents. 
In recent years, there has been some qualitative 
research exploring individuals’ experiences of 
suicide bereavement. This type of research is 
imperative in developing appropriate community 
responses, and research that involves bereaved 
persons in the design should be prioritised. 
Reference
Griffin E and McMahon E (2019). Suicide 
bereavement support: A literature review. Cork: 
National Suicide Research Foundation. https://
www.hse.ie/eng/services/list/4/mental-health-
services/connecting-for- l i fe/publ icat ions/
suicide-bereavement-support-a-literature-review-
april-2019.pdf
Suicide bereavement support: A literature review
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Study Aim
This project aimed to explore the nature, causes, 
and consequences, of cyberbullying from the per-
spective of young people with a view to informing 
the development of evidence-based prevention 
and intervention strategies. 
Work Plan
This work was funded by the Health Research Board 
through the SPHeRE (Structured Population Health 
and Health Services Research Education) PhD 
Programme. Qualitative and participatory research 
methods were employed. In the first instance 
a systematic review and meta-ethnographic 
synthesis of qualitative studies related to young 
people’s conceptualisations of cyberbullying was 
conducted. Secondly, a rights-based model was 
developed to facilitate the active involvement of 
young people in the research process. A Young 
Person’s Advisory Group comprising 16 Transition 
Year students from four schools was purposefully 
formed. The Advisory Group collaborated 
with researchers in the design, conduct, and 
interpretation of a qualitative study of young 
people’s perspectives on cyberbullying as well as 
in priority setting for intervention development. 
Young People’s involvement in the Advisory Group 
was evaluated to determine the effectiveness of the 
model in facilitating young people’s participation 
in the research process and the acceptability of 
the approach. The co-designed qualitative study 
comprised focus groups with 64 secondary school 
students across the four participating schools.
Project Deliverables
•  The final version of a paper describing and eval-
uating young people’s involvement in this project 
was published in Health Expectations in January 
2019.
•  A meta-ethnography of young people’s concep-
tualisations of the nature of cyberbullying was 
prepared and submitted for publication (March 
2020).
•  A paper based on findings related to the mental 
health impact of cyberbullying was submitted for 
publication. (April 2020). 
•  Findings related to the non-consensual distribu-
tion of nude images were prepared for submission 
to a relevant academic journal. Expected publica-
tion mid-2020.
•  A policy brief will be disseminated when all re-
sults have been published.
Personnel Involved
Prof Ella Arensman (NSRF), Dr Rebecca Dennehy 
(School of Public Health, UCC), Ms Mary Cronin 
(School of Public Health, UCC), Dr Sarah Meaney 
(National Perinatal Epidemiology Centre, UCC). 
1. Dennehy R, Cronin M and Arensman E. Involv-
ing young people in cyberbullying research: The 
implementation and evaluation of a rights-based 
approach. Health Expectations. 2019; 22: 54-64.
Cyberbullying and Young People: Behaviours, Experiences, 
Resolutions (CY:BER)
National Suicide Research Foundation
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Study Overview
Mental ill-health is the major source of burden of 
disease in otherwise healthy young people. It is 
estimated that up to 50% of young people will 
experience at least one diagnosable episode of 
mental ill-health with a major impact on earning 
potential, educational outcomes, and social 
integration in adulthood. From puberty, with the 
associated biological upheavals, young people face 
a series of challenges including forming a stable 
identity, negotiating educational environments, 
forming secure relationships, managing the drive 
to risk-taking and finding a vocational pathway. 
Adolescent self-harm is a major public health 
problem, with a prevalence of approximately 10% 
based on community-based studies and with 
higher rates among girls than boys. Internationally, 
hospital-treated self-harm has greatly increased 
in frequency among adolescents over the past 50 
years. Due to high rates of self-harm and suicide 
among young people in Ireland, those aged 15-
24 years have been identified as a priority group 
at whom to target approaches to reduce suicidal 
behaviour and improve mental health. The overall 
aim of this research programme is to use existing 
high quality population-based datasets, including 
the Saving and Empowering Young Lives in Europe 
(SEYLE) study and the National Self-Harm Registry 
Ireland to address important research questions 
relating to youth mental health and self-harm. 
Project Aims
1.  To examine the prevalence and correlates of 
mental ill-health, risk behaviors and self-harm in 
European adolescents.
2.  To examine patterns of hospital-treated self-
harm among young people aged 10 to 24 years 
in Ireland.
3.  To examine the risk and protective factors for 
psychotic experiences in Irish adolescents.
4.  To identify predictors of onset and escalation of 
self-harm and suicide in adolescents. 
Work Plan
Collaboration with the ten centres of the interna-
tional Saving and Empowering Young Lives in Eu-
rope (SEYLE) consortium continued throughout 
2019, with ongoing dissemination of study findings. 
Manuscripts were prepared by the group for pub-
lication on a number of topics including predicting 
onset of adolescent self-harm and longitudinal as-
sociations between bullying and suicidal behaviour.
Dissemination continued on the findings of the 
2018 national study examining increasing rates of 
self-harm among children, adolescents and young 
adults: 2007–2016 (Griffin et al, 2018).
Collaboration with the Psychiatric Epidemiology 
Research across the Lifespan (PERL) at RCSI on 
population-based research into the prevalence and 
correlates of adolescent mental ill-health contin-
ued in 2019.
In early 2019, work began on the HRB-funded pro-
ject “Investigating the iceberg model of self-harm 
and suicide in children, adolescents and young 
adults: a multi-methods study of predictors of on-
set, escalation and premature mortality” led by Dr 
Elaine McMahon. The first work package involves a 
national longitudinal cohort study of long-term risk 
of suicide and other premature mortality among 
young people following hospital-treated self-harm.
A study of risk and protective factors for 
psychotic experiences in Irish adolescents was 
completed and prepared for publication in a high-
impact journal, as part of the SEYLE study. Few 
modifiable protective factors have been identified 
for psychotic experiences in young people. In this 
study analyses examined associations between a 
range of psychopathological, adverse life event, 
coping and social support factors and psychotic 
experiences in a general population sample of Irish 
adolescents.
Project Deliverables 
Ethical approval was granted by the Clinical Re-
search Ethics Committee of the Cork Teaching 
Hospitals for the new study “Investigating mortal-
ity risk through suicide and other external causes 
following hospital-treated self-harm” in August 
2019. Applications were submitted to the CSO to 
access suicide mortality data for the purpose of 
data linkage with the National Self-Harm Registry 
Ireland and analysis. 
Young People’s Mental Health: a population-based 
research programme
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Four articles arising from this work were accepted 
for publication or published in peer-reviewed jour-
nals in 2019, with one article under review. 
Publication details are as follows:
•  Risk and Protective Factors for Psychotic Ex-
periences in Adolescence: a population-based 
study. Elaine M. McMahon, Paul Corcoran, Hel-
en Keeley, Mary Clarke, Helen Coughlan, Danuta 
Wasserman, Christina W. Hoven, Vladimir Carli, 
Marco Sarchiapone, Colm Healy, Mary Cannon. 
accepted Psychological Medicine. 
•  Influence of coping strategies on the efficacy of 
YAM (Youth Aware of Mental Health): a universal 
school-based suicide preventive program. Kahn 
JP, Cohen RF, Tubiana A, Legrand K, Wasserman 
C, Carli V, Apter A, Balazs J, Banzer R, Baralla F, 
Barzilai S, Bobes J, Brunner R, Corcoran P, Cos-
man D, Guillemin F, Haring C, Kaess M, Bitenc 
UM, Mészàros G, McMahon E, Postuvan V, Saiz 
P, Varnik A, Varnik P, Sarchiapone M, Hoven CW, 
Wasserman D. accepted European Child and Ad-
olescent Psychiatry. 
•  Bi-directional longitudinal associations between 
different types of bullying victimization, suicide 
ideation/attempts, and depression among a 
large sample of European adolescents. Brunstein 
Klomek A, Barzilay S, Apter A, Carli V, Hoven CW, 
Sarchiapone M, Hadlaczky G, Balazs J, Kereszteny 
A, Brunner R, Kaess M, Bobes J, Saiz PA, Cosman 
D, Haring C, Banzer R, McMahon E, Keeley H, 
Kahn JP, Postuvan V, Podlogar T, Sisask M, Varnik 
A, Wasserman D. Journal of Child Psychology 
and Psychiatry. 2019 Feb;60(2):209-215.
•  A longitudinal examination of the interpersonal 
theory of suicide and effects of school-based 
suicide prevention interventions in a multinational 
study of adolescents. Barzilay S, Apter A, Snir A, 
Carli V, Hoven CW, Sarchiapone M, Hadlaczky 
G, Balazs J, Kereszteny A, Brunner R, Kaess M, 
Bobes J, Saiz PA, Cosman D, Haring C, Banzer 
R, McMahon E, Keeley H, Kahn JP, Postuvan V, 
Podlogar T, Sisask M, Varnik A, Wasserman D. 
Journal of Child Psychology and Psychiatry. 2019 
Oct;60(10):1104-1111. 
The findings of this research programme were 
presented at national and international conferences 
in 2019, including the Society for Social Medicine, 
Cork, September 2019, and International Association 
of Suicide Prevention, Derry, September 2019. The 
award for Best Abstract at the Society for Social 
Medicine conference was awarded for the abstract 
“Increasing rates of self-harm among children, 
adolescents and young adults: a 10-year national 
registry study 2007–2016” (Griffin et al).
Personnel Involved
Dr Elaine McMahon, Dr Eve Griffin, Dr Paul Corcoran, 
Prof Ella Arensman, Dr Helen Keeley, Ms Eileen 
Williamson; HRB ARPP collaborators.
National Suicide Research Foundation
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Study Overview 
The media may have both a positive and negative 
influence in the development of self-harm and 
suicidal behaviour. While the copycat and imitation 
effects of media reporting are well established, 
recently there is an increasing evidence base 
in relation to using the media in a positive way - 
the so called ‘Papageno’ or preventative effect 
(Niederkrotenthaler et al 2010).
The first study in this project sought to examine 
the quality of media reporting of four cases of 
suicide in Ireland between September 2009 and 
December 2012, and investigated the degree 
to which the media guidelines for reporting of 
suicide were adhered to for each of the four cases 
examined. The second study sought to obtain 
people’s perceptions on the impact of a television 
documentary on awareness of mental health, 
wellbeing and help-seeking behaviour. 
Project Aims
1.  Examine the quality of media reporting of suicide 
and adherence to media guidelines in Ireland.
2.  Identify specific guidelines which require rein-
forcement.
3.  Examine if the media can have a positive impact 
in terms of reducing stigma related to mental 
health, addressing common misconceptions and 
encouraging help seeking behaviour.
Work Plan
In 2018, the NSRF published a paper on media 
reporting of suicide and adherence to guidelines 
in Ireland. In 2019, the findings of this paper 
were disseminated nationally via media briefings, 
organised by the Regional Officers for Suicide 
Prevention in Limerick, Dublin and Tipperary. In 
addition, in line with the increasing evidence base 
in relation to using the media in a positive way, 
the NSRF conducted a survey, aimed to obtain 
people’s perceptions on the impact of a television 
documentary on awareness of mental health, 
wellbeing and help-seeking behaviour, following 
the airing of the documentary ‘My Other Life: 
Ireland’s Young and Their Mental Health’ on RTÉ. In 
2019, a paper, based on the findings, was prepared 
for a peer reviewed journal and published in March 
2020. The outcomes were also presented at the 
International Association for Suicide Prevention 
World Congress in Derry.
Project Deliverables
1.  Preparation of a paper based on the outcomes 
of the ‘Our Mental Health’ survey for submission 
to the Irish Journal of Psychological Medicine 
(July 2019).
2.  Presentation of key findings at the International 
Association for Suicide Prevention World Con-
gress (September 2019).
3.  Preparation of briefing documents and infor-
mation booklets for circulation among relevant 
stakeholders in government, media and the vol-
untary sector if and when required (Ongoing 
throughout 2019).
4.  Work with statutory and non-statutory agencies, 
the Press Ombudsman and media organisations 
to promote the implementation of media guide-
lines using a pro-active approach (Ongoing 
throughout 2019).
5.  Work with stakeholders as outlined in Connect-
ing for Life to explore ways of restricting access 
to sites that primarily exist to promote suicide or 
self-harm (Ongoing throughout 2019).
6.  Ensure that the dialogue between journalists and 
representatives from other relevant disciplines is 
on-going, via presentations in different regions 
in collaboration with the Regional Officers for 
Suicide Prevention (Ongoing throughout 2019). 
Personnel Involved
Mr Niall McTernan, Prof Ella Arensman, Ms Fenella 
Ryan, Ms Eileen Williamson.
The Role of the Media in Suicide Prevention
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Study Overview
Psychological autopsy studies have become more 
widely used in suicide research, however, most 
studies fail to include a control group. Where 
controls are used, methodological shortcomings 
include absence of a matched comparison and 
an imbalance of data sources. This case-control 
psychological autopsy study examined the 
predictive value of psychiatric, psychological, 
psychosocial and work-related factors associated 
with suicide and high-risk self-harm.
Two interlinked case-control studies were conducted: 
1) Main case-control study, comparing consecutive 
suicide cases to GP controls (n=133 cases with 
coroners’ data completed; n=33 completed 
psychological autopsy interview) to GP controls 
(n=53); 2) Comparative study between suicide cases 
and patients with high-risk self-harm (n=52). Males 
were overrepresented among both the suicide cases 
and GP controls: 71.4% vs. 71.7%; mean age: 48.8 
years vs. 46.7 years. Factors significantly associated 
with suicide included history of previous self-harm, 
symptoms of depression and mania, history of 
psychiatric treatment (inpatient and outpatient), 
dysfunctional impulsivity, unemployment and 
low decision latitude at work. High-risk self-harm 
patients and suicide cases shared many risk factors.
Project Aims
The main aim of the SSIS-ACE study is to examine 
the predictive value of psychiatric, psychological, 
psychosocial and work-related factors associated 
with suicide and high-risk self-harm.
Work Plan
A key priority for 2019-2020 as underlined by 
the Steering Group and Advisory Panel, was the 
completion of the main outcomes paper, reporting 
on three different groups, suicide cases, high-
risk self-harm cases and GP controls, allowing for 
specific comparisons to be made.
In addition, a methodological paper was completed 
and published in BMC Psychiatry in 2020, detailing 
the unique design of SSIS-ACE integrating different 
data sources (primary health practitioner, coroners 
and family informants). A particular methodological 
strength of the SSIS-ACE case control study design 
is the matching of suicide cases with controls 
from the same GP practices, thereby controlling 
for confounders, such as socio-economic aspects 
and neighbourhood effects. Moreover, the study 
design pays careful consideration to the potential 
effects of proxy report on ascertainment of risk 
and protective factors. 
In addition, analyses were conducted to obtain first 
outcomes, which were disseminated via conference 
presentations and training programmes. 
Project Deliverables 
1.  SSIS-ACE outcomes presented as part of a 
training programme for GPs in Letterkenny 
(March, 2019).
2.  SSIS-ACE outcomes presented as part of a 
training programme for GP trainees in Cork (May 
2019).
3.  SSIS-ACE Methodological paper published 
in BMC Psychiatry: Arensman E, Larkin, C., 
McCarthy, J., Leitao, S., Corcoran, P., & Williamson, 
E. et al. (2019). Psychosocial, psychiatric and 
work-related risk factors associated with suicide 
in Ireland: optimised methodological approach 
of a case-control psychological autopsy study. 
BMC Psychiatry, 19(1). (August, 2019).
4.  Presentation of outcomes at the 30th IASP World 
Congress, Derry: Arensman E et al. Psychiatric, 
psychosocial and work-related risk factors asso-
ciated with suicidal behaviour in Ireland. 
5.  Outcomes of a case-control study (September 
2019).
6.  Data cleaning completed for the Masterfile for 
the SSIS-ACE outcomes paper (November, 2019).
Personnel Involved 
Prof Ella Arensman, Dr Birgit Greiner, Dr Elaine 
McMahon, Dr Celine Larkin, Ms Jacklyn McCarthy, 
Dr Sara Leitao, Dr Paul Corcoran, Ms Eileen 
Williamson, Dr Dorothy Leahy, Ms Grace Cully, Dr 
Eve Griffin, Dr Christina Dillon C, Mr Niall McTernan, 
Dr Carmel McAuliffe, Prof Ivan Perry, Prof Eugene 
Cassidy, Prof Colin Bradley, Prof Nav Kapur, Prof 
James Kinahan, Dr Anne Cleary, Dr Tom Foster, 
Prof John Gallagher and Prof Kevin Malone. 
Psychosocial, psychiatric and work-related risk factors associated 
with suicide in Ireland: A case-control study (SSIS-ACE) 
National Suicide Research Foundation
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Study Overview
The European Alliance Against Depression (EAAD) 
is an international non-profit organisation based in 
Leipzig, Germany, with several members and more 
than 100 regional network partners in Europe, Can-
ada, South America and Australia. 
Specific objectives of the EAAD 4-level approach 
include: 
1.  Primary care and mental health care GPs will be 
invited to educational workshops on how to rec-
ognise and treat depression and explore suicidal 
tendency in the primary care setting. 
2.  General public: Depression awareness cam-
paign. The aim is to improve knowledge about 
adequate treatments of depression in general 
and to reduce the stigmatization of the topic 
“depression” and the affected individuals. 
3.  Patients, high-risk groups and relatives: Emer-
gency Cards will be handed out to high risk 
groups (first of all young people in adolescent 
crisis and persons after suicide attempt) guar-
anteeing direct access to professional help in a 
suicidal crisis. Partnerships with patient associa-
tions will be established and intensified. 
4.  Community facilitators and stakeholders: Educa-
tional workshops will be held with various target 
groups playing an important role in disseminat-
ing knowledge about depressive disorders and 
suicidal behaviour. 
The iFightDepression programme was developed 
as an additional resource to the four-level interven-
tion programme of the European Alliance Against 
Depression.
The main objectives are:
1.  To provide internet-based guided self-manage-
ment protocols for depression in young people 
and adults with mild forms of depression: the 
iFightDepression programme.
2.  To increase awareness of depression among 
health professionals and community facilitators 
working with adolescents and young adults in 
order to improve early identification of depres-
sion and adequate treatment referral for young 
people with depression in order to improve early 
identification of depression and adequate treat-
ment referral for young people with depression.
Project Aims
The main aim of the European Alliance Against 
Depression is to improve care and optimise 
treatment for patients with depressive disorders 
and to prevent suicidal behaviour. 
Work Plan 2019-2020
Key priorities for 2019-2020 were a) ongoing 
implementation of EAAD training among health 
and community-based professionals, b) research 
development and innovation and preparing new 
grant applications, c) dissemination of peer review 
papers and dissemination of EAAD outcomes via 
policy briefs and newsletters, and re-instating the 
implementation of the optimised iFightDepression 
programme.
Project deliverables 2019-2020
1.  EAAD based training programme for trainee 
GPs (May, 2019).
2.  EAAD-related grant application for EU Horizon 
2020 and consortium: MENTUPP, submitted in 
April and successful in August 2019.
3.  Submission of Expression of Interest for the 
iFightDepression programme to the Ireland 
Funds (August, 2019).
4.  Contributed to EAAD Press Releases on Euro-
pean Depression Day (1st October) and World 
Mental Health Day (10th October 2019). 
5.  Co-facilitation and presentations at the EAAD 
Annual General Meeting in Leuven, Belgium (No-
vember 2019).
6.  Published paper on Prevention of Suicidal Behav-
iour: Results of a Controlled Community-based 
Intervention Study in Four European Countries, 
Hegerl U, Maxwell M, Harris F, Koburger N, Mergl 
R, Szekely A, Arensman E, Van Audenhove C, et 
al. PLoS One. 2019 Nov 11;14(11):e0224602.
7.  Co-applicant with EAAD on application for the 
implementation and dissemination of the iFight-
Depression programme, with the EU Health Pro-
gramme – CHAFEA (May 2020).
Personnel Involved
Prof Ella Arensman, Ms Eileen Williamson, Mr Niall 
McTernan, Prof Ulrich Hegerl, Prof Victor Perez, 
Ms Juliane Hug, Ms Pia Driessen, and Dr Ilinca 
Serbanescu. 
European Alliance Against Depression (EAAD) 
& The iFightDepression programme 
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Study Overview
This study is part of the HRB funded 5-year research 
programme, in particular: Improving Prediction and Risk 
Assessment of Suicide and Self-Harm (IMPRESS).
IMPRESS part 1: Risk of self-harm repetition has 
consistently been shown to be higher following self-
cutting compared to intentional drug overdose (IDO) 
and other self-harm methods. The utility of previous 
evidence is limited due to the large heterogeneous 
method categories studied. This study examined risk 
of hospital presented self-harm repetition according to 
specific characteristics of self-harm methods. 
IMPRESS part 2: The IMPRESS part 2 study employs an 
infrastructure that has been established as part of the 
SSIS-ACE study in the Cork hospitals for developing 
procedures to approach consecutive patients with high 
risk self-harm (high lethality self-harm presentations 
and low lethality self-harm presentations with high level 
of suicide intent) and those who have engaged in five or 
more previous acts of self-harm (i.e. major repeaters). 
Each patient that fulfils the inclusion criteria will be invit-
ed to take part in a baseline interview shortly after the 
index self-harm presentation and a follow-up interview 
six months after the index presentation. 
Project Aims
The objectives of this study are: 1) to examine psychosocial, 
psychiatric and work related factors associated with 
repeated self-harm among major repeaters (i.e. those 
with five or more previous self-harm acts) and patients 
with high risk self-harm; 2) to examine the sensitivity and 
specificity of risk factors associated with repeated self-
harm, and 3) to develop a risk assessment procedure 
for repeated self-harm and suicide for use in a general 
hospital setting. The recruitment for the IMPRESS study 
was ongoing until September 2018. 
Work Plan
In terms of the IMPRESS research (part 1), in 2019-2020, 
the main emphasis was on data analyses involving con-
secutive self-harm presentations to hospital emergency 
departments (2010–2016) were obtained from the Na-
tional Self-Harm Registry Ireland. Associations between 
self-harm method and repetition were analysed using 
survival analyses, and a first paper was published in a 
peer review journal. For part 2 of the IMPRESS research, 
in 2019-2020, the main focus was on completing base-
line and follow-up interviews were conducted among 
high risk self-harm patients and major self-harm repeat-
ers. First findings were presented to key stakeholders.
Project Deliverables
1.  Peer review publication: Cully G, Corcoran P, Leahy 
D, Griffin E, Dillon C, Cassidy E, Shiely F, Arensman E. 
Method of self-harm and risk of self-harm repetition: 
findings from a national self-harm registry. Journal of 
Affective Disorders (March 2019).
2.  Completion of IMPRESS baseline interviews (Febru-
ary, 2019).
3.  Submission of manuscript: Patients’ experiences of 
engagement with healthcare services following a high 
risk self-harm presentation to a hospital emergency 
department: a mixed methods study, to Archives of 
Suicide Research (July, 2019) (accepted for publica-
tion in June, 2020). 
4.  Completion of IMPRESS follow-up interviews (Sep-
tember, 2019).
5.  Presentation of first outcomes of the IMPRESS study 
at seminar of the National Clinical Programme For the 
Assessment and Management of Patients Presenting 
to Emergency Departments following Self-Harm 
(October, 2019).
6.  Presentation of first outcomes of the IMPRESS study 
at the firs SAMAGH training in the UCC ASSERT Centre 
(November, 2019). 
Personnel Involved
Prof Ella Arensman, Ms Karen Mulcahy, Ms Grace Cully, 
Ms Ruth Benson, Dr Isabela Troya, Dr Anvar Sadath, Ms 
Sarah Nicholson, Dr Paul Corcoran, Ms Eileen Williamson, 
Dr Eve Griffin, Prof Eugene Cassidy, Prof John Browne, 
Prof Jan Rigby, Prof Chris Brunsdon Prof Joe Eustace, Dr 
Frances Shiely, Dr Anne Jeffers.
Examination of predictive factors associated with short- and 
long-term risk of repetition of non-fatal self-harm and suicide 
and high risk groups 
National Suicide Research Foundation
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Study Overview 
This study is part of the HRB funded 5-year research pro-
gramme: Individual and Area Level Determinants of Self-
Harm and Suicide in Ireland: Enhancing Prediction, Risk 
Assessment and Management of Self-Harm by Health 
Services. This research builds on exploratory geograph-
ical analysis using data from the Suicide Support and 
Information System (SSIS) and the National Self-Harm 
Registry Ireland that has revealed a significant associa-
tion between suicide and self-harm clustering in terms of 
space-time proximity amongst the male population. Ad-
vanced geospatial methods are applied to suicide mortal-
ity data to establish the presence of suicide clusters in a 
population. Probable suicide clusters in locations such as 
Bridgend, Wales and New Zealand have previously been 
verified using geospatial analysis (Jones, 2012; Larkin & 
Beautrais, 2012). Patterns of clustering, in terms of space 
and time, can also be assessed using this form of analy-
sis. Geocoding software, which translates residential ad-
dresses to their point locations on a map, will be utilised 
in the analysis of such patterns in Ireland. The need for 
enhanced understanding of suicide clustering is neces-
sary because strategies to manage and contain clusters 
are lacking. Research examining socio-ecological and ar-
ea-level factors is warranted to ensure the development 
of appropriate intervention and postvention strategies. 
Project Aims 
1.  To identify geographic areas in Ireland with recurrent 
clusters of suicide and self-harm over a specific period 
(2006-2017).
2.  To examine the association between clustering of 
self-harm and suicide.
3.  To identify area-level and individual factors associated 
with clustering of suicide and self-harm.
4.  To develop a real-time surveillance system for suicide: 
Suicide and Self-Harm Observatory. 
Work Plan 2019-2020
For identifying geographic areas in Cork with suicide 
clusters, data from the Suicide Support and Information 
System (SSIS), established by the NSRF in 2008, will be 
accessed. The SSIS obtains information on all consec-
utive cases of suicide in the HSE Southern region and 
accesses information from coroner’s records, health care 
professionals and family informants using a psychologi-
cal autopsy approach. The association between recurring 
clusters of suicide and individual factors, such as psy-
chosocial and psychiatric factors will be examined. The 
geocoded data will be analysed using a series of spatial 
analytical techniques in order to examine the spatial and 
temporal patterning of suicide. The geospatial approach 
will also enable research into associations with socio-en-
vironmental data e.g. neighbourhood quality, distance to 
services. This research is conducted in collaboration with 
the Centre for Geocomputation, Maynooth University 
(Professor Jan Rigby and Professor Chris Brunsdon). 
A real-time suicide surveillance system, the Suicide and 
Self-Harm Observatory (SSHO) has been developed 
and implemented in Co. Cork. An interactive dashboard 
based on data collected by the SSHO will be designed 
collaboratively with Prof. Brunsdon. This confidential 
resource will record live suspected suicide data, incor-
porating key features such as data mapping, seasonal 
trends, demographic breakdowns, etc. This valuable re-
source will be used to inform resource allocation and 
deliver early interventions to the bereaved and at-risk 
populations. It is intended that the SSHO and interac-
tive dashboard will be rolled out nationally, based on the 
outcomes of the pilot phase. 
A systematic review of quantitative techniques applied 
in the statistical analysis of suicide and self-harm clus-
tering is near completion and planned for publication in 
2020. The findings of this review were presented at sev-
eral conferences and seminars in 2019. A study based on 
best practices in the development and implementation 
of surveillance of real-time suicide mortality data is also 
currently underway and will be published in 2020. 
Project Deliverables 
1.  Completion of pilot phase of the implementation of 
the SSHO in Cork City and County (December 2019). 
2.  Continuation of data collection for North, South, East 
and West Cork based on the SSIS.
3.  Meetings of the Advisory Panel for the Implementation 
of the Suicide and Self-Harm Observatory (January 
2019, May 2019, November 2019).
4.  Presentation: The Suicide and Self-Harm Observatory: 
real-time surveillance data in Ireland. National meeting 
of the HSE Resource Officers for Suicide Prevention, 
Dublin, March 2019.
5.  Presentation: The quantitative analysis of suicide & 
self-harm clustering: A systematic review. International 
Association for Suicide Prevention World Congress 
2019, Derry-Londonderry, September 2019.
6.  Presentation: Suicide and self-harm surveillance 
– From local to global. National Suicide Research 
Foundation World Mental Health Day, Cork, October 
2019.
7.  Presentation: Suicide and self-harm clusters: Effective 
quantitative techniques to detect clusters & the 
value of real-time surveillance data in identifying and 
responding to them. The 26th British Isles Research 
Workshop on Suicide & Self-Harm. Oxford, October 
2019.
Personnel Involved
Ms Ruth Benson, Prof Ella Arensman, Prof Jan Rigby 
Prof Chris Brunsdon, Dr Paul Corcoran, Ms Grace Cully, 
Dr Tiffany Too. 
Socio-ecological and geo-spatial analysis of suicide 
and self-harm clustering 
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Study Overview
This study is part of the HRB funded 5-year research 
programme: Individual and Area Level Determinants of 
Self-Harm and Suicide in Ireland: Enhancing Prediction, 
Risk Assessment and Management of Self-Harm by 
Health Services.
SAMAGH has a specific focus on managing and 
supporting major self-harm repeater, high-risk 
and challenging behaviour patients based on the 
evidence from the IMPRESS Study as well as following 
suggestions from the consultation meetings and focus 
groups.
Project Aims
The objectives of this study are to develop the Self-
Harm Assessment and Management programme for 
General Hospitals (SAMAGH).
Work Plan
The SAMAGH training programme comprises two 
sections - first an online E-learning Programme (www.
suicideresearchpreventionelearning.com) where key 
concepts and background to self-harm and suicide 
prevention are explained to healthcare practitioners. 
Second, after successful completion of the E-learning, 
a two-day face to face interactive training course will 
be delivered, including simulation training in the UCC 
Centre for Enabling Better Safer Healthcare (ASSERT).
The SAMAGH Training Programme includes:
• E-Learning Module components which include:
 –  Overview of self-harm and suicide including at risk 
groups and why do people self-harm
 – Self-harm and suicide risk assessment 
 –  Clinically relevant factors associated with self-
harm presentations
 –  Self-harm Management: Safety planning and fol-
low-up
 –  Self-care amongst healthcare professionals sup-
porting self-harm patients.
•  Guidelines for conducting a biopsychosocial assess-
ment among self-harm patients including simulation 
training. 
Project Deliverables
1.  Completion of the consultations with mental health 
professionals related to the development of the 
SAMAGH training programme (April, 2019).
2.  Submission of the SAMAGH training implementation 
and evaluation application to the CREC (September, 
2019).
3.  Completion of SAMAGH training manual (November, 
2019).
4.  First SAMAGH training programme delivered to 
mental health professionals in the UCC ASSERT 
Centre (November, 2019).
5.  Study protocol based on the SAMAGH training 
implementation and evaluation submitted to BMC 
Health Services Research: Study Protocol for the 
Implementation and Evaluation of the Self-harm 
Assessment and MAnagement for General Hospitals 
Programme in Ireland (SAMAGH). BMC Health 
Services Research. In Press (December, 2019).
6.  Second SAMAGH training programme delivered 
to mental health professionals in the UCC ASSERT 
Centre (January, 2020).
Personnel Involved
Prof Ella Arensman, Dr Isabela Troya, Dr Anvar Sadath, 
Ms Sarah Nicholson, Ms Karen Mulcahy, Prof Eugene 
Cassidy, Dr Anne Jeffers. 
Development of a Self-Harm Assessment and Management 
programme for General Hospitals (SAMAGH)
National Suicide Research Foundation
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Study overview
SHARE is based on outcomes of the HRB funded 
research programme: Improving Prediction and Risk 
Assessment of Suicide and Self-Harm (IMPRESS). 
The IMPRESS study aims to improve the knowledge 
base on predictive risk factors associated with 
repeated self-harm and suicide among high-risk 
groups of self-harm patients in Ireland. During the 
study, it has become clear that family members of 
self-harm patients are in need of more information 
and support, which highlights a major gap in 
Ireland and internationally. The current application 
proposes to develop an information leaflet for 
family members, and to offer a psychoeducational 
programme for family members. The leaflet 
and group sessions will include plain language 
information addressing the risk and protective 
factors associated with self-harm and information 
on effective treatments. IMPRESS has also identified 
a need for increased awareness of self-harm, suicide 
and associated risk and protective factors among 
first responders, including paramedics, emergency 
technical staff and emergency department staff. 
The needs of first responders are addressed via 
interactive workshops of knowledge exchange and 
skills enhancement. To enhance dissemination, it is 
proposed to improve the content of the existing 
Suicide Support and Information website (http://
suicidesupportandinformation.ie/) by including 
recent findings from IMPRESS study regarding 
two subgroups of patients that were identified i.e. 
people with high-risk self-harm and those with a 
history of multiple acts of self-harm, who require 
different therapeutic approaches. A seminar will 
be organised for relevant stakeholders at national 
level to disseminate the deliverables developed 
under IMPRESS and SHARE. 
Project Aims
The main aims of the SHARE project are to a) Develop, 
implement and evaluate a psychoeducational 
programme for family members of people who have 
engaged in self-harm, b) Develop, implement and 
evaluate an interactive training programme for first 
responders addressing their needs and challenges 
relating to working with self-harm patients. The 
SHARE project commenced in February 2019.
Project Deliverables 2019-2020
1.  Submission of the SHARE ethics application for 
the implementation and evaluation of the inter-
active training programme for first responders 
to the SREC (June, 2019).
2.  Submission of the SHARE ethics application for 
the implementation and evaluation of the inter-
active training programme for first responders 
to the NAS (August, 2019).
3.  Submission of the SHARE ethics application for 
the psychoeducational support programme for 
family members of individuals who engage in 
self-harm to the CREC (October, 2019).
4.  Completion of the SHARE leaflet for psychoed-
ucational support groups for family members of 
individuals who engage in self-harm (November, 
2019).
5.  First interactive workshop with first responders 
in Ballinasloe, delivered by Prof Ella Arensman 
and Ms Eunice Philip (December, 2019).
6.  Second interactive workshop with first respond-
ers in Dublin, delivered by Prof Ella Arensman 
and Ms Eunice Philip (January, 2020).
Personnel Involved 
Prof Ella Arensman, Ms Eunice Philip, Prof Eugene 
Cassidy, Ms Karen Mulcahy.
Self-Harm and Suicide AwaREness - SHARE 
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Health Research Board 
Emerging Investigators Award 
Study overview
In 2019, funding was awarded as part of the Health 
Research Board’s Emerging Investigators Award 
programme, for a four year programme to examine 
outcomes for individuals who present to hospital as 
a result of self-harm. The project is a collaboration 
between University College Cork, National Suicide 
Research Foundation and the Irish Health Service 
Executive. The project commenced in September 
2019, and will be funded until August 2023.
Project aims
The aims of the project are to:
•  Examine the clinical management of self-harm 
and its impact on risk of repeat self-harm, suicide 
and premature mortality.
•  Examine the impact of a National Clinical 
Programme for self-harm on patient outcomes, 
processes of care and economic savings.
•  Identify the determinants contributing to the im-
plementation of this Clinical Programme across 
Irish hospitals.
This project will maximise the use of routinely-
available national data. A mixed-methods approach 
will deliver actionable findings which will contribute 
to optimising services and outcomes for individuals 
who engage in self-harm, ultimately reducing deaths 
by suicide and other external causes. Findings will 
directly inform service delivery and contribute to 
national policy.
Work Plan
This project is organised across three distinct work 
packages, aligned to the project aims. 
Work package 1 (2019-2021) will use data from the 
National Self-Harm Registry Ireland to identify the 
factors which contribute to the clinical manage-
ment of self-harm in acute hospital settings. Data 
from the Registry will also be linked with national 
mortality data to establish the risk of subsequent 
suicide following hospital-presenting self-harm and 
whether the clinical management of self-harm at 
the time of presentation to hospital is associated 
with subsequent risk of repetition, suicide and pre-
mature mortality.
The National Clinical Programme for the Assessment 
and Management of Patients Presenting to the 
Emergency Department following Self-harm (NCP-
SH) was one of the first Irish clinical programmes 
to be introduced in the area of mental health. It 
specifically addresses the care and treatment 
required for people who present to hospital 
emergency departments following self-harm. 
Work package 2 (2019-2022) will use a natural 
experiment approach to assess the impact of this 
clinical programme on patient outcomes, including 
repeat attendance to hospital, as well as processes 
of care. This work package will also examine the 
economic impacts of this programme on reducing 
costs related to self-harm.
Work package 3 (2021-2023) will use an 
implementation research framework to identify 
the determinants and facilitators associated with 
implementing such a programme nationally. Data 
from relevant stakeholders will be gathered via 
semi-structured interviews, using the Consolidated 
Framework for Implementation Research. This 
component will be used to inform the longer-
term integration of mental health services in acute 
hospital settings, as well as to identify factors which 
may inform the roll-out of such a programme in 
other health services internationally.
Personnel involved
Principal investigator: Dr Eve Griffin
Post-doctoral Researcher: Dr Eimear Ruane-McAteer
Co-applicants: Dr Paul Corcoran; Prof Ella Arensman; 
Prof Ivan J Perry; Dr Sheena McHugh; Dr Anne Jeffers; 
Prof David Gunnell.
PRoviding Improved care for Self-harM: a mixed-methods 
study of intervention, economic and implementation 
outcomes from a national clinical programme – PRISM 
National Suicide Research Foundation
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Health Research Board 
Applying Research into Policy 
and Practice Award
Study overview
In 2018, funding was awarded to Dr Elaine McMa-
hon as part of the Health Research Board Applying 
Research into Policy and Practice programme, for 
a five-year programme to examine self-harm and 
suicide among children, adolescents and young 
adults. The project commenced in February 2019, 
and Dr McMahon will be funded until January 2024 
on a part-time basis.
The aim of the project is to examine three key 
stages of the self-harm process; onset of self-harm 
among adolescents in the community; high-risk 
hospital-treated self-harm, and long-term risk of 
suicide following self-harm. 
Work Plan
Work package 1 is a national cohort study which 
will examine long-term risk of suicide and other 
premature mortality among young people who 
have presented to hospital following self-harm. 
Work package 2 is a mixed methods study of 
engagement with health services among young 
people with high risk self-harm and associations 
with subsequent repeated self-harm. 
Work package 3 examines risk and protective 
factors for onset of suicidal behaviour among 
adolescents in the community in large representative 
longitudinal cohorts of young people.
Personnel involved
Dr Elaine McMahon; Prof Ella Arensman; Collabo-
rators: Dr Eve Griffin, Dr Paul Corcoran, Prof Mary 
Cannon, Dr Fiona McNicholas, Mr Derek Chambers, 
Prof Gwendolen Portsky, Dr Anne Jeffers, Prof 
Danuta Wasserman, Dr Helen Keeley, Dr Sheena 
McHugh.
Investigating the iceberg model of self-harm and suicide in 
children, adolescents and young adults: a multi-method study 
of predictors of onset, escalation and premature mortality 
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Collaborations
Study Overview
This research was commissioned by the Donegal 
Mental Health Service (DMHS). The study examined 
untimely sudden deaths and those who took their 
lives while in the care of Donegal Mental Health Ser-
vice between October 2011 and May 2015. Informa-
tion was obtained in accordance with the principles 
of the Suicide Support and Information System – 
Psychological Autopsy Model, SSIS-PAM (Arensman 
et al, 2016). A key component of the SSIS-PAM is its 
capacity to collect information from multiple sourc-
es to corroborate the clinical history of the deceased 
while also reaching out to family members who 
may need support in the aftermath of such a tragic 
event. A total of 34 deaths were included. Of these, 
24 family informant interviews took place. Over 92% 
of those approached agreed to take part. The study 
report was launched on 26th April 2016 (Corry et 
al, 2016). As a result of the current research, DMHS 
now has a ‘real-time’ database of information on so-
cio-demographic, psychosocial and psychiatric risk 
factors which may have contributed to the deaths 
of those in their care through untimely events or su-
icide. Since May 2016, actions arising from the re-
port have been implemented in the Donegal Mental 
Health Services, funded by the HSE Donegal.
2019 Deliverables
1.  Ongoing monitoring of deaths by suicide amongst 
those in the care of Donegal Mental Health Ser-
vices and facilitating support for bereaved family 
members.
2.  Training sessions for Non-Consultant Doctor 
(NCHDs) and Senior House Officers using the Ad-
vanced Suicide Awareness Programme (ASAP) 
integrated as a formal training component.
3.  ASAP programme adapted modified to address 
concerns specific to General Practice in County 
Donegal and has been given priority position in 
the mental health training of Trainee GPs. 
4.  An audit of discharge policy and follow up 
was conducted within the Acute Psychiatric 
Unit, examining compliance with Mental Health 
Commission directives on patient care and 
community mental health outreach on discharge. 
5.  The SCAN service is Donegal was audited and 
a report provided for management. A poster on 
these findings was delivered at the State Medical 
Safety Conference in Dublin mid-2019.
6.  With support from the Donegal coroner, Depart-
ment of Psychiatry and General Practice, a mock 
inquest was held in Donegal in late December 
funded by the Irish GP Council. More than 100 
General Practitioners attended, both established 
and newly qualified. 
7.  Supervision: with support from the Donegal Cor-
oner, supervision was provided to a GP trainee 
conducting his final dissertation which involved 
the examination of cases of young male suicides 
in Donegal over a two-year period; supervision 
was provided for a Clinical Nurse Manager in the 
Acute Unit undertaking a Masters in Psychology. 
This dissertation was awarded the Irish Psychiat-
ric Nursing Thesis Medal of Excellence. 
8.  As part of an Audit procedure, one-to-one educa-
tional sessions were arranged with Clinical Nurse 
Specialists and Psychiatric Nurses throughout 
2019. At management request, individual sessions 
were provided for NCHDs to address issues such 
as lack of confidence, and to help improve com-
munication with patients and their families. 
9.  Masterclass on the SSIS-PAM psychological 
autopsy approach at the Early to Mid-Career 
Researchers Conference in October 2019, Corry C 
& Arensman E.
10.  Presentation NSRF/HSE Donegal work to the Sa-
maritans Staff Conference, Corry C. 
Personnel Involved
Dr Colette Corry, Prof Ella Arensman, Ms Eileen 
Williamson.
Donegal Suicide Support and Information System – 
Psychological Autopsy Model (SSIS-PAM)
National Suicide Research Foundation
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Project Overview
The National Dialectical Behaviour Therapy (DBT) 
Project, Ireland was established in 2013 through 
funding provided by the National Office for Suicide 
Prevention. The HSE and NSRF collaborated on 
the implementation and evaluation of the DBT 
programme across Ireland. From 2013-2018 an 
extensive evaluation of the national implementation 
was conducted to examine clinical effectiveness, 
cost effectiveness and the implementation process 
of DBT and allied DBT programmes in the Irish 
context. 
This resulted in 16 peer reviewed publications and 
a five year programme report, all of which found 
DBT to be an effective treatment for individuals with 
BPD attending community mental health services 
in Ireland. The coordinated implementation process 
was found to be both viable and sustainable. An 
economic evaluation found DBT to be cost effective 
when compared to treatment-as-usual for managing 
BPD for the duration of the programme (one year) 
and one year follow-up. The probability of DBT being 
cost-effective after one year is 72%. DBT continues to 
be cost effective at 3, 5 and 10 years. The probability 
of DBT being cost-effective at 10 years is 79%.
Project Deliverables 2019
Training
•  A Family Connections training event was held 
in Galway in June, where 42 mental health 
professionals and family members were trained to 
facilitate family connections programmes. 
•  In November, an additional 45 mental health 
professionals were trained as DBT therapists to 
supplement existing DBT teams. 
•  Four Clinicians Connections training events were 
conducted for Clinicians, Emergency Department 
personnel and Junior Doctors who routinely work 
with clients presenting with emotion dysregulation. 
Presentations
•  September: 30th World Congress of the Interna-
tional Association for Suicide Prevention (IASP) 
Derry, Northern Ireland.
•  October: Health and Social Care Professionals 
Conference, Dublin.
•  November: Society for Dialectical Behaviour 
Therapy (SfDBT) Conference in Newcastle, UK.
Awards
•  November 2018: HSCP Best Practice and Innova-
tion Awards - Professional Leadership Award to 
Daniel Flynn, Mary Kells, Mary Joyce and Louise 
Dunne for the coordinated implementation and 
evaluation of dialectical behaviour therapy in adult 
and child/ adolescent mental health services at a 
national level across Ireland.
•  October 2019: HSE Open Access Research Award 
– Mental Health category for: Flynn, D., Joyce, M., 
Spillane, A. et al. Does an adapted Dialectical Be-
haviour Therapy skills training programme result 
in positive outcomes for participants with a dual 
diagnosis? A mixed methods study. Addict Sci Clin 
Pract 14, 28 (August 2019).
Publications
1.  Kells, M., Joyce, M., Flynn, D. et al. Dialectical be-
haviour therapy skills reconsidered: applying skills 
training to emotionally dysregulated individuals 
who do not engage in suicidal and self-harming 
behaviours. Bord Personal Disord Emot Dysregul 
7, 3 (Jan 2020). 
2.  Flynn, D., Gillespie, C., Joyce, M., & Spillane, A. 
An evaluation of the skills group component of 
DBT-A for parent/guardians: A mixed methods 
study. Irish Journal of Psychological Medicine, 1-9. 
(Jan 2020).
3.  Murphy, A., Bourke, J., Flynn, D. et al. A cost-
effectiveness analysis of dialectical behaviour 
therapy for treating individuals with borderline 
personality disorder in the community. Ir J Med 
Sci 189, 415–423 (August 2019).
4.  Flynn, D., Joyce, M., Spillane, A. et al. Does an 
adapted Dialectical Behaviour Therapy skills 
training programme result in positive outcomes 
for participants with a dual diagnosis? A mixed 
methods study. Addict Sci Clin Pract 14, 28 (Au-
gust 2019).
5.  Gillespie, C., Joyce, M., Flynn, D., & Corcoran, 
P. (2019). Dialectical behaviour therapy for 
adolescents: a comparison of 16-week and 
24-week programmes delivered in a public 
community setting. Child and Adolescent Mental 
Health, 24(3), 266-273.
6.  Burke, L., Kells, M., Flynn, D., & Joyce, M. (2019). 
Exploring staff perceptions of the utility of Clinician 
Connections when working with emotionally 
dysregulated clients. Borderline Personality 
Disorder and Emotion Dysregulation, 6(1), 12.
NSRF Personnel Involved
Dr Mary Joyce, Ms Louise Dunne, Ms Justina Hurley, 
Dr Ailbhe Spillane, Mr Conal Wrigley, Ms Eileen 
Hegarty, Ms Eileen Williamson. 
The National Dialectical Behaviour Therapy (DBT) Project
39
Publications
Publications
Peer Review Papers / Reports / Briefings 
Papers published/in press 2019
How suicide-bereaved family members 
experience the inquest process: a 
qualitative study using thematic analysis
Spillane A, Matvienko-Sikar K, Larkin C, 
Corcoran P, Arensman E.
International Journal of Qualitative 
Studies on Health and Well-being
How do people experience a family 
member’s high-risk self-harm? An 
interpretative phenomenological analysis
Spillane A, Matvienko-Sikar K, Larkin C, 
Arensman E. 
Archives of Suicide Research, 1-23
Method of self-harm and risk of self-harm 
repetition: findings from a national self-
harm registry 
Cully G, Corcoran P, Leahy D, Griffin E, 
Dillon C, Cassisy E, Shiely F, Arensman E.
Journal of Affective Disorders 246: 
843-850
The association between self-harm and 
area-level characteristics in Northern 
Ireland: an ecological study 
Griffin E, Bonner B, Dillon CB, O’Hagan D, 
Corcoran P.
European Journal of Public Health 
 National Suicide Prevention Strategies – 
Progress and Challenges. 
Platt S, Arensman E, Rezaeian M.
The Journal of Crisis Intervention and 
Suicide Prevention 40(2):75-82
International Study of Definitions of 
English-Language Terms for Suicidal 
Behaviours: protocol of an opinion survey 
Goodfellow B, Kõlves K, De Leo D, 
Silverman M, Berman A, Mann J, 
Arensman E, Hawton K, Phillips M, 
Vijayakumar L.
BMJ Open 9:e025770
Psychosocial Interventions for People 
Who Self-Harm: Methodological Issues 
Involved in Trials to Evaluate Effectiveness
Witt K, Townsend E, Arensman E, Gunnell 
D, Hazell P, Taylor Salisbury t, Van 
Heeringen K, Hawton K. 
Archives of Suicide Research
Innovations in Practice: Dialectical 
behaviour therapy for adolescents: 
multisite implementation and evaluation 
of a 16-week programme in a public 
community mental health setting
Flynn D, Kells M, Joyce M, Corcoran 
P, Gillespie C, Suarez C, Swales M, 
Arensman E.
Child and Adolescent Mental Health 
24:1, 76-83
Dialectical behaviour therapy for 
adolescents: a comparison of 16-week and 
24-week programmes delivered in a public 
community setting. 
Gillespie C, Joyce M, Flynn D,  
Corcoran P.
Child and Adolescent Mental Health 
24:3, 266–273
Does an adapted Dialectical Behaviour 
Therapy skills training programme result in 
positive outcomes for participants with a 
dual diagnosis? A mixed methods study. 
Flynn D, Joyce M, Spillane A, Wrigley C, 
Corcoran P, Hayes A, Flynn M, Wyse D, 
Corkery B, Mooney B.
Addiction Science and Clinical 
Practice, 14:28
Exploring staff perceptions of the utility of 
Clinician Connections when working with 
emotionally dysregulated clients. 
Burke L, Kells M, Flynn D, & Joyce M.
Borderline Personality Disorder and 
Emotion Dysregulation, 6(1), 12.
Psychosocial, psychiatric and work-
related risk factors associated with suicide 
in Ireland: optimised methodological 
approach of a case-control psychological 
autopsy study. 
Arensman E, Larkin C, McCarthy J, Leitao 
S, Corcoran P, Williamson E et al. 
BMC Psychiatry, 19:275
Hospital-presenting self-harm and 
ideation: Comparison of incidence, profile 
and risk of repetition. 
Griffin E, Bonner B, O’Hagan D, 
Kavalidou K, Corcoran P. 
General Hospital Psychiatry  
(In press)
A cost-effectiveness analysis of dialectical 
behaviour therapy for treating individuals 
with borderline personality disorder in the 
community. 
Murphy A, Bourke J, Flynn D, Kells M, 
Joyce M. 
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(In press)
Prevention of suicidal behaviour: Results 
of a controlled community-based 
intervention study in four European 
countries. 
Hegerl U, Maxwell M, Harris F, Koburger 
N, Mergl R, Szekely A, Arensman E, Van 
Audenhove C, Larkin C et al. 
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Reports 2019
National Self-Harm Registry Ireland Annual Report 2018
Griffin E, McTernan N, Wrigley 
C, Nicholson S, Arensman E, 
Williamson E, Corcoran P
National Suicide  
Research Foundation
NSRF Annual Report 2018
National Suicide Research 
Foundation
National Suicide  
Research Foundation
Suicide Bereavement Support: a Literature Review Griffin E, McMahon E
National Suicide  
Research Foundation
The Effectiveness of Dialectical Behaviour Therapy 
(DBT) in Ireland 2013-2018
Flynn D, Joyce M, Hurley J,  
Dunne L
National DBT Project / National 
Suicide Research Foundation
Focus on Alcohol and Health in Cork and Kerry:  
A Report of the Director of Public Health
Griffin E
Department of Public Health,  
HSE South
Connecting for Life: Ireland’s National Strategy to 
Reduce Suicide – Interim Strategy Review
Arensman E, Williamson E,  
Griffin E, Corcoran P
HSE NOSP
Briefing documents 2019
Briefing statement in connection  
with the “Momo challenge”
National Suicide Research Foundation / Suicide Awareness Voices 
of Education / International Association of Suicide Prevention
February 2019
Briefing: The association between  
self-harm and area-level factors
National Suicide Research Foundation July 2019
JANUARY
Arensman E. Leadership in Public 
Health, Masterclass, UCC, 11th 
January.
FEBRUARY
Arensman E. Identifying subgroups 
of self-harm: Implications for 
assessment and treatment. Lecture. 
Australian Research Workshop on 
Suicide and Self-Harm, AISRAP, 
Griffith University, Brisbane 7-8th 
February.
Hilmi H and Griffin E: Alcohol 
involvement in hospital-treated 
self-harm of those under 25. Poster 
Presentation. Student Medical 
Summit in Dublin, 9th February.
Corry C. The importance of good 
practice recording clinical notes. 
CAMHT, Carrickmacross Cavan, 11th 
February.
Corry C. Findings from the 
SSIS PAM in County Donegal. 
The National Office for Suicide 
Prevention, Dublin, 19th February.
Arensman E. Global Mental Health 
and Mental Health Promotion. 
Lecture, UCC, 21st February.
MARCH
Arensman E. Self-harm and suicide 
in young people: Associated 
risk factors and evidence based 
interventions. St Patrick’s and 
Pieta House 4thAnnual Self-Harm 
Awareness Conference, St Patrick’s 
University Hospital Dublin, 1st 
March.
Griffin E. Self-harm in Ireland: 
Priority groups and opportunities 
for intervention. St Patrick’s and 
Pieta House 4thAnnual Self-Harm 
Awareness Conference, St Patrick’s 
University Hospital Dublin, 1st 
March.
McTernan N. Media reporting of 
suicide and adherence to media 
guidelines. HSE Mid-West Media 
briefing on suicide reporting, 
Limerick, 1st March.
Griffin E. Suicide and self-
harm: Trends, risk factors and 
opportunities for prevention’. 
Lecture for NU3078/NU3050 
School of Nursing, University 
College Cork, 7th March.
Arensman E. Core elements of 
a comprehensive multi-sectoral 
response to prevent suicide and 
Progress in implementing suicide 
prevention programmes at global 
level. Lecture. WHO Technical 
Meeting, Moscow, 20th March.
Arensman E. WHO tools for 
strengthening suicide and self-
harm monitoring and surveillance 
systems. Lecture. WHO Technical 
Meeting, Moscow, 20th March.
Griffin E. National Self-harm 
Registry Ireland. Workshop for 
Resource Officers for Suicide 
Prevention, Dublin, 28th March.
Presentations 
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APRIL
Corry C. Exploring the 
characteristics of those who died 
by suicide while in the care of 
DMHS. Samaritans Conference, 
Derry, 6th April.
Corry C. Implementing 
recommendations from the 
NSRF Donegal Report ‘A study 
of sudden, untimely deaths 
including suicide, among those in 
the care of Donegal Mental Health 
Services.’ Connecting for Life 
Service Implementation Group, 
Letterkenny, 12th April.
Arensman E. Suicide Prevention 
in International Context: Progress 
and Challenges. The 2019 Suicide 
Prevention Summit, 13th April. 
Webinar, Mental Health Academy, 
Australia.
Arensman E. Guidelines for 
reporting and communicating 
about suicide in the media. 
Workshop, Seminar CHO 
Communication Managers and 
Resource Officers for Suicide 
Prevention, Dublin, 29th April.
MAY
Corry C. Suicide in Donegal: What 
have we learned? Findings from a 
service review following the death 
of a service user in Inishowen. 
Community Mental Health Team, 
Buncrana, 2nd May.
Arensman E. ‘Surveillance’ 
(workshop). 3rd IASP Caribbean 
Regional Symposium, Port of 
Spain, Trinidad, 2nd - 4th May.
Arensman E. ‘National Strategies’ 
(workshop). 3rd IASP Caribbean 
Regional Symposium, Port of 
Spain, Trinidad, 2nd - 4th May.
Arensman E. ‘Self-harm and suicide 
in young people: risk and protective 
factors, and evidence-based 
interventions’. 3rd IASP Caribbean 
Regional Symposium, Port of Spain, 
Trinidad, 2nd - 4th May.
Arensman E. ‘Enhanced 
psychological autopsy approach’ 
(workshop). 3rd IASP Caribbean 
Regional Symposium, Port of 
Spain, Trinidad, 2nd - 4th May.
Corry C. Findings from the 
Discharge Audit of the Acute 
Unit, Letterkenny Hospital. The 
Consultants Quarterly meeting, 
Letterkenny, 17th May.
Arensman E. Suicide and self-
Harm. Lecture, GP Trainee Training 
Programme, UCC, Cork, 18th May.
JUNE
Arensman E. Surveillance of 
Suicide Attempts and Self-Harm. 
Lecture, Department of Health 
and Human Services Seminar, 
Melbourne, Australia, 21st June.
Arensman E. The implementation 
of the Suicide and Self-Harm 
Observatory: First outcomes. 
Presentation for the National Office 
for Suicide Prevention, Dublin, 24th 
June. 
JULY
Corcoran P. The role of the media 
in suicide prevention, suicide 
clustering and contagion. IV 
National Congress of Psychology 
and International Symposium, 
Vitoria-Gasteiz, Spain, 21st - 24th 
July. 
Arensman E. ‘Examples of 
countries where the development 
and implementation of national 
suicide prevention programmes 
recently has been initiated.’ 
International Symposium on 
Psychological Prevention, Vitoria-
Gasteiz, Spain, 21st -24th July.
Corry C. An overview of findings 
from the SSIS PAM in Donegal and 
implications for future policy. CHO1 
Management Meeting, Sligo, 16th 
July.
AUGUST 
Corry C. Sharing initiatives from 
Donegal. Connecting for Life 
Ireland Working Group, Sligo 
Hospital, 16th August.
SEPTEMBER 
Arensman E (on behalf of Cully G). 
‘Patient experience of engagement 
with healthcare services following 
an episode of high risk self-harm: 
a mixed methods study’. Society 
for Social Medicine and Population 
Health Annual Scientific Meeting 
and International Epidemiology 
Association 2019, University College 
Cork, Ireland, 4th - 6th September.
Griffin E, McMahon E, McNicholas 
F, Corcoran P, Perry IJ, Arensman 
E. Increasing rates of self-harm 
among children, adolescents and 
young adults: A ten-year national 
registry study. The Society for 
Social Medicine & Population Health 
and International Epidemiology 
Association European Congress 
Joint Annual Scientific Meeting, 
UCC, 4th - 6th September. 
Daly C. A national case fatality 
study of drugs taken in intentional 
overdose. The Society for Social 
Medicine & Population Health 
and International Epidemiology 
Association European Congress 
Joint Annual Scientific Meeting, 
UCC, 4th - 6th September.
McMahon E. Risk and protective 
factors for psychotic experiences 
in adolescence: a population 
based study. The Society for Social 
Medicine & Population Health 
and International Epidemiology 
Association European Congress 
Joint Annual Scientific Meeting, 
UCC, 4th - 6th September.
Corcoran P. Release of 13 Reasons 
Why and hospital presenting 
self-harm in Ireland. The Society 
for Social Medicine & Population 
Health and International 
Epidemiology Association 
European Congress Joint Annual 
Scientific Meeting, UCC, 4th - 6th 
September.
Arensman E. ‘Identifying 
subgroups of self-harm: 
Implications for assessment and 
treatment’, Keynote lecture, 
World Suicide Prevention Day 
Forum AISRAP, Griffith University, 
Brisbane, 10th September.
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Arensman E. ‘Suicide Prevention 
in International Context: Progress 
and Challenges’. The 2019 
Suicide Prevention Summit, 14th 
September, Webinar, Mental Health 
Academy, North America. 
Arensman E. ‘Suicide clustering 
and contagion: How can we 
provide a timely response?’ 
Keynote lecture, 30th World 
Congress of the International 
Association of Suicide Prevention 
(IASP), Derry, Northern Ireland, 
17th - 21st September.
Arensman E. Psychiatric, 
psychosocial and work-related risk 
factors associated with suicidal 
behaviour in Ireland: Outcomes of 
a case-control study. 30th World 
Congress of the International 
Association of Suicide Prevention 
(IASP), Derry, Northern Ireland, 
17th - 21st September.
Kavalidou K. The Protective 
Role of physical and mental 
multimorbidity in the risk of 
suicidal thoughts and behaviours: 
a 20 year prospective cohort 
study. 30th World Congress of the 
International Association of Suicide 
Prevention (IASP), Derry, Northern 
Ireland, 17th - 21st September.
Spillane A. How suicide-bereaved 
family members experience the 
inquest process: A qualitative 
study. 30th World Congress of the 
International Association of Suicide 
Prevention (IASP), Derry, Northern 
Ireland, 17th - 21st September.
McMahon E. Factors associated 
with psychotic experiences 
in adolescence: a population 
based study of suicide attempt, 
psychopathology, lifestyle, adverse 
events and parental support. 
30th World Congress of the 
International Association of Suicide 
Prevention (IASP), Derry, Northern 
Ireland, 17th - 21st September.
Corcoran P. Release of 13 Reasons 
Why and hospital presenting 
self-harm and suicidal ideation 
in Ireland. 30th World Congress 
of the International Association 
of Suicide Prevention (IASP), 
Derry, Northern Ireland, 17th - 21st 
September.
Arensman E. Development, 
Implementation and Evaluation 
of National Suicide Prevention 
Programmes. 30th World Congress 
of the International Association 
of Suicide Prevention (IASP), 
Derry, Northern Ireland, 17th - 21st 
September.
McTernan N. Using a television 
programme as a tool to increase 
perceived awareness of mental 
health and wellbeing – Findings 
from the ‘Our Mental Health’ 
survey. 30th World Congress of the 
International Association of Suicide 
Prevention (IASP), Derry, Northern 
Ireland, 17th - 21st September.
Troya Bermeo I. The role of 
primary care in supporting older 
adults with self-harm behaviour: 
a qualitative study. 30th World 
Congress of the International 
Association of Suicide Prevention 
(IASP), Derry, Northern Ireland, 
17th - 21st September.
Benson R. Quantitative analyses of 
suicide and self-harm clustering: 
A systematic review. 30th World 
Congress of the International 
Association of Suicide Prevention 
(IASP), Derry, Northern Ireland, 
17th - 21st September.
Arensman E. The development of a 
Suicide and self-harm Observatory 
(SSHO). 30th World Congress 
of the International Association 
of Suicide Prevention (IASP), 
Derry, Northern Ireland, 17th - 21st 
September.
Arensman E. ‘Profile of patients 
presenting to emergency 
departments in Ireland following 
frequent self-harm repetition’. 
30th World Congress of the 
International Association of Suicide 
Prevention (IASP), Derry, Northern 
Ireland, 17th - 21st September.
Griffin E, Cully G, Hume S, Kelly 
ET, O’Reilly D, Corcoran P. The 
development and implementation 
of a national reporting system 
for self-harm in Irish prisons. 
The SADA Project. 30th World 
Congress of the International 
Association for Suicide Prevention, 
Derry, 17th- 21st September.
Griffin E, Kavalidou K, Bonner B, 
O’Hagan D, Corcoran P. Patterns 
of repetition following presentation 
to hospital with suicidal ideation. 
30th World Congress of the 
International Association for 
Suicide Prevention, Derry, 17th - 
21st September.
Corry C. An overview of the 
SCAN Service in County Donegal. 
State Medical Safety. Personal 
Injury Claims & Compensation 
Conference 2019. State Claims 
Agency Annual Meeting, Dublin, 
19th September.
OCTOBER
Arensman E. Multidisciplinary 
perspective on the risk and 
protective factors associated with 
self-harm and suicide. EU Safety 
Conference, Luxembourg, 3rd- 4th 
October. 
Arensman E, Holland C, McTernan 
N, Fleischmann A, Reidenberg 
D, Pirkis J, Niederkrotenthaler 
T. Launch of the WHO Resource: 
Preventing Suicide: A Resource for 
Filmmakers and Others Working 
on Stage and Screen. Early-Mid 
Career Researchers Seminar, Cork, 
10th October.
Corry C. Suicide in Donegal: What 
have we learned? Masterclass. 
Early-Mid Career Researchers 
Seminar, held to mark World 
Mental Health Day, held to mark 
World Mental Health Day, Cork, 
10th October.
Arensman E. ‘Grant writing – Do’s 
and Don’ts’. NSRF Early-Mid Career 
Researchers Seminar, held to mark 
World Mental Health Day, Cork, 
10th October.
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Presentations
McTernan N. Using a television 
programme as a tool to increase 
perceived awareness of mental 
health and wellbeing – Findings 
from ‘Our Mental Health’ 
Survey. NSRF Early-Mid Career 
Researchers Seminar, held to mark 
World Mental Health Day, Cork, 
10th October.
Troya Bermeo I. Understanding 
self-harm in older adults: a 
qualitative study. NSRF Early-Mid 
Career Researchers Seminar, held 
to mark World Mental Health Day, 
Cork, 10th October.
Corcoran P and Benson R. 
Suicide surveillance – From local 
to global. NSRF Early-Mid Career 
Researchers Seminar, held to mark 
World Mental Health Day, Cork, 
10th October.
Corry C. Implementing the 
psychological autopsy approach 
within a mental health setting. 
NSRF Early-Mid Career 
Researchers Seminar, held to mark 
World Mental Health Day, Cork, 
10th October.
Benson R. Effective quantitative 
techniques to detect suicide 
clusters and the value of real-time 
surveillance data. The British Isles 
Research Workshop, University of 
Oxford, 16th October.
Arensman E. Mental Health 
Promotion. Lecture, Structured 
Population and Health Services 
Research Education (SPHeRE), 
Cork, 23rd October.
Arensman E. Increasing Awareness 
of Depression & Suicidal Behaviour. 
Mental Health Construction Safety 
Awareness Week, Cork, 23rd 
October. 
Arensman E. Suicide and self-
harm in Ireland: Data collection 
systems and recent outcomes. 
Keynote lecture. WHO Technical 
Meeting on Suicide and Self-Harm 
Monitoring and Prevention in the 
Russian Federation, Stavropol 
State Medical University, Russia, 
28th October.
Arensman E. Implementing a 
surveillance system for suicide 
and suicide attempts/self-harm. 
Workshop: WHO Technical 
Meeting on Suicide and Self-Harm 
Monitoring and Prevention in the 
Russian Federation, Stavropol 
State Medical University, Russia, 
29th - 30th October.
NOVEMBER
Arensman E, Platt S, Corcoran 
P, Crowley P, Dooley B, Hickey 
C, Higgins A. Implementation 
and Evaluation of Connecting 
for Life, National Strategy for the 
Reduction of Suicide in Ireland. 
WHO Seminar on Implementing 
National Suicide Prevention 
Programmes, Geneva, 5th 
November.
Arensman E. Implementation 
of National Suicide Prevention 
Strategies and Programmes. 
Keynote Lecture, Annual General 
Meeting for the National Suicide 
Prevention Programme in Germany, 
Berlin, 7th November.
Arensman E, Troya I, Sadath A, 
Nicholson S, Cully G, Ramos Costa 
A, Leahy D, Benson R, Mulcahy 
K. Clinical subgroups associated 
with major self-harm repetition 
and high suicide risk – Self-Harm 
Assessment and Management 
in General Hospitals (SAMAGH), 
Lecture, Seminar National Clinical 
Programme for the Assessment and 
Management of Patients Presenting 
to Emergency Departments 
following Self-Harm. Dublin, 12th 
November.
Arensman E. What are the 
ingredients of evidence-based 
suicide prevention practice for 
young people? Keynote lecture 
for the Australian Youth Suicide 
Prevention Summit. Webinar, 
Australian Youth Suicide 
Prevention Summit, Melbourne, 
13th November.
Corry C. Understanding suicide in 
a community setting. Donemana 
Medical Centre Staff Training Day, 
County Tyrone, 13th November.
Arensman E. Suicide and Self-
Harm: Evidence based intervention 
and prevention programmes. 
Lecture DCLIN Trainees Clinical 
Psychology, UCC, Cork, 15th 
November.
Griffin E. ‘Determinants of Health: 
Mental Health’. Lecture for EH1009 
School of Public Health UCC, 20th 
November.
Arensman E. Mental Health 
Promotion and Intervention in 
Occupational Settings (MENTUPP), 
Lecture, EAAD AGM, Leuven, 
Belgium, 21st November.
DECEMBER
Birchall E, Perry IJ, Griffin E. Has 
there been a reduction in codeine-
related intentional drug overdose 
presentations to Irish hospitals 
following national guidance in 
2010? Poster Presentation. New 
Horizons Conference, University 
College Cork, 5th December.
Arensman E. Establishing a 
Multicentre Self-Harm System 
in the Russian Federation – 
Progress and Implications for 
Intervention and Prevention. 
Lecture, WHO Technical Meeting 
on Suicide and Self-Harm 
Monitoring and Prevention in the 
Russian Federation, Moscow, 13th 
December.
McTernan N, Ryan F, Williamson 
E, Chambers D, Arensman E. Using 
a television programme as a tool 
to increase perceived awareness 
of mental health and wellbeing 
– Findings from the ‘Our Mental 
Health’ survey. Poster Presentation. 
New Horizons Conference, 
University College Cork, 5th 
December.
Arensman E, Philip E. Optimising 
Self-Harm and Suicide Awareness 
- Workshop for First Responders. 
Ballinasloe, 19th December. 
Corry C. ‘Coronial law and General 
Practitioner accountability when 
recording suicidality: A mock 
inquest.’ Irish College of GPs Winter 
Meeting, Donegal, 14th December.
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Public Engagement 
Professor Ella Arensman and Dr Eve Griffin both 
presented at the St Patrick’s and Pieta House 
4th Annual Self-Harm Awareness Conference, St 
Patrick’s University Hospital Dublin, 1st March. 
Members of the NSRF joined forces with UCC 
School of Public Health to mark International 
Women’s Day in March. 
Professor Ella Arensman visited Moscow in March 
to participate in a consultation on implementing 
and strengthening suicide prevention activities in 
Russia. The visit was arranged as part of the NSRF’s 
designation as a WHO Collaborating Centre for 
Surveillance & Research in Suicide Prevention. 
During the month of May, NSRF team members 
supported the Green Ribbon Campaign run by See 
Change, which aims to end mental health stigma. 
Members of the NSRF team attended the IASP 
conference in Derry in September. 
In September, Dr Angela Nicholas from the School 
of Population & Global Health at the University 
of Melbourne presented her research on suicide 
prevention media campaigns to the NSRF Team. 
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Public Engagement
Ms Eileen Williamson and Professor Ella Arensman 
welcoming delegates to the Early-Mid Career 
Researcher’s Seminar, held in Nano Nagle Place, 
Cork, to mark World Mental Health Day in October. 
Members of the NSRF National Self-Harm Registry 
Ireland team marking the launch of the 2018 
Registry Report in October. 
In December, Professor Ella 
Arensman travelled to Moscow, 
to present at a WHO Seminar 
on establishing a Multi-Centre 
Self-Harm Surveillance System 
in three pilot regions in Russia. 
In November, Professor Ella Arensman 
travelled to Geneva to co-facilitate WHO 
workshops aimed at improving the 
implementation and evaluation of national 
suicide prevention strategies. 
On 18th December, NSRF team members held a 
Christmas Jumper Day in aid of Cork Simon Community. 
National Suicide Research Foundation
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Membership of Committees and Steering Groups
Dr Margaret Kelleher
Irish Association of Suicidology Director
International Academy for Suicide Research Member
Professor Ella Arensman
International Association for Suicide Prevention - College of Presidents Representative
European Alliance Against Depression Vice-President
EuroSafe Task Force on Suicide and Deliberate Self Harm Coordinator
World Health Organisation Advisor
Steering Group HRB 5-year Programme Chair
IASP Special Interest Group - Clusters and Contagion in Suicidal Behavior Co-Chair
Crisis, The Journal Of Crisis Intervention and Suicide Prevention Co-Editor and Reviewer
CSO Liaison Group on Suicide Mortality Statistics Member
National Cross Sectorial Steering and Implementation Group for Connecting for Life Member
Graduate Studies and Research Committee, School of Public Health, University College Cork, Ireland Member
IASP Special Interest Group on National Suicide Prevention Programs Member
Programme Steering Group for the UK study on suicide and self-harm funded by the National 
Institute for Health Research, UK
Member
National Steering Group of the Mental Health Awareness Campaign - Ireland Member
National Steering Group for the Implementation of the National Suicide Bereavement Liaison Service Member
Steering Group for the evaluation of the Pieta House Intervention Model Member
Steering Group for the Study of Untimely Sudden Deaths and People who Took their Lives while in 
the care of the Donegal Mental Health Service
Member
Cork Connecting for Life Suicide Prevention Forum Member
Connecting for Life Evaluation Advisory Group Member
Executive Committee, School of Public Health Member
Working Group Mental Health Triage Audit and Research Committee Member
Working Group Research and Audit – National Clinical Programme for the Assessment and 
Management of Patients presenting to Emergency Departments following Self-Harm
Member
Steering Group of A Psychological Autopsy Study of Suicide Deaths among Children and 
Adolescents aged 10-20 years in The Netherlands
Member
Advisory Group for the National Suicide Prevention Programme in Germany Member
Scientific Committee for the 17th European Symposium on Suicide and Suicidal Behavior Member
Scientific Committee for the 30th IASP World Congress in Derry Londonderry Member
Local Organising Committee for the 30th IASP World Congress in Derry Londonderry Member
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Membership of Committees and Steering Groups
Dr Paul Corcoran
Graduate Studies Board Committee, Department of Obstetrics and Gynecology and School of 
Epidemiology and Public Health, University College Cork
Member
CSO Liaison Group on Suicide Mortality Statistics Member
Evaluation Advisory Group for Connecting for Life Member
School of Public Health Social Research Ethics Committee Member
School of Public Health Medical Training Committee Member
School of Medicine Graduate Entry Medicine Oversight Committee Member
Dr Colette Corry
Connecting for Life Implementation Group Donegal Member
Learning Community Practice Group CHO1 Member
HSE NOSP Coronial Data Project Technical Advisory Group Member
HSE National Strategy Group Member
Donegal Mind and Wellness Member
Donegal Suicide and Self-Harm Awareness And Response Project Member
Dr Eve Griffin
HSE evaluation of Bereavement Services Working Group Member
Northern Ireland Self-harm Registry Steering Group Member
National Clinical Programme for the Assessment and Management of Self-harm in Emergency 
Departments Research and Audit Group
Member
Justina Hurley
Cork Healthy Cities – PSYCHED, Mental Health Promoting Workplace initiative Member
Mr Niall McTernan
Headline’s Expert Advisory Panel Member
Society for Social Medicine & IEA European Congress 2019 Local Organising Committee Member
Ms Eileen Williamson
CSO Suicide Mortality Statistics Liaison Group Co-chair and Member
Association for Child and Adolescent Mental Health, Special Interest Group Member
International Association for Suicide Prevention Member
Local Organising Committee for the 30th IASP World Congress Derry Londonderry Member
Steering Group for the Study of Untimely Sudden Deaths and People who Took their Lives while in 
the care of the Donegal Mental Health Service
Member
Board of Management NICHE Health Project (Cork) CLG Member
Steering Group HRB 5-year Programme Member
MENTUPP Steering Group Member
HEA Connecting for Life Cross Sectoral Working Group Member
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Awards and Achievements 
Dr Isabela Troya Bermeo 
received a prize for best Oral 
Presentation for Mid-Career 
Researcher at the World 
Mental Health Day Early–Mid 
Career Researchers’ Seminar 
held in Nano Nagle Place, 
Cork on October 10th. Pres-
entation Title: Understanding 
Self-Harm Behaviour in older 
adults.
In September 2019, it was announced that the MENTUPP Consortium was successful in securing funding 
from the European Union’s Horizon 2020 research and innovation programme. The MENTUPP Consortium, 
coordinated by Professor Ella Arensman, School of Public Health and National Suicide Research Foundation 
and Dr Birgit Greiner, School of Public Health, University College Cork, consists of 17 international partners, 
including the European Alliance Against Depression. The project aims to improve mental health and 
wellbeing in the workplace by developing, implementing and evaluating a comprehensive, multilevel 
intervention targeting both clinical and non-clinical mental health issues. The NSRF will lead the MENTUPP 
pilot, implement the MENTUPP intervention in Ireland and contribute to the pilot and cluster randomised 
controlled trial analysis, as well as support project management.  
Dr Eve Griffin was awarded a HRB Emerging Investigator 
Award 2019. The funding from this award will be used for a 
four year project, co-hosted by the NSRF and the School of 
Public Health, UCC, titled “PRoviding Improved care for Self-
harM: a mixed-methods study of intervention, economic and 
implementation outcomes from a national clinical programme”. 
Dr Mary Joyce received an award 
in the Mental Health Category at 
the HSE Open Access Research 
Awards which took place in Dr 
Steeven’s Hospital in Dublin on 
December 4th. 
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Dr Eve Griffin was awarded the Highest Scoring 
Abstract Prize, Social Science and Medicine 
Conference, University College Cork, September 
2019, in collaboration with Dr Elaine McMahon. 
UCC Medical Student Emma Birchall, 
supervised by Dr Eve Griffin, won Best Poster 
Prize, New Horizons Conference, University 
College Cork, December 2019. 
The Conferring of Dr Ailbhe Spillane took place 
on 22nd February 2019. PhD thesis: The Impact of 
Suicidal Behaviour on Family Members in Ireland: 
A Mixed Methods Study. Supervisor: Prof Ella 
Arensman, Co-supervisors: Dr Paul Corcoran, Dr 
Karen Matvienko-Sikar. External Examiner: Prof 
Kari Dyregrov, University of Bergen, Norway. 
Internal Examiner: Prof Colin Bradley, UCC. 
The Viva Voce for Rebecca Dennehy’s PhD 
took place on 6th December 2019. PhD 
thesis: The CY:BER Study: Cyberbullying and 
Young People: Behaviours, Experiences, and 
Resolutions. Rebecca was awarded her PhD 
without corrections. Supervisor: Prof Ella 
Arensman. Co-supervisors: Dr Mary Cronin, 
Dr Sarah Meaney. External Examiner: Prof 
Faye Mishna, University of Toronto, Canada. 
Internal Examiner: Dr Margaret Curtin, UCC. 
Awards and Achievements
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Members
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The  directo rs present their report and financial statements for the financial year ended 31 December 2019. 
Introduction 
The financial statements have been prepared by Suicide Research Foundation Company Limited by Guarantee 
in accordance with accounting standards issued by the Financial Reporting Council, including FRS 102, the 
Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)) as modified by the 
Statement Of Recommended Practice "Accounting and Reporting by Charities" effective 1 January 2015 . 
The organisation is a charitable company with a registered office at 1 Perrott Avenue, College Road, Cork (the 
charity trades under the name National Suicide Research Foundation). The company's registered number is 
224676. The Registered Charity Number (RCN) of the charity is 20030889. 
The charity has been granted charitable tax status under sections 207 and 208 of the Taxes Consolidation Act 
1997, Charity number CHY 11351 and is registered with the Charities Regulatory Authority. 
Objectives and activities 
The  Suicide Research Foundation Company Limited by Guarantee (National Suicide Research Foundation) 
(NSRF) is an independent, multi-disciplinary research unit established in Cork, in 1994, by the late Dr Michael J 
Kelleher. 
Suicide Research Foundation Company Limited by Guarantee investigates the causes of suicide, self-harm and 
related mental health and social factors in Ireland.  Suicide Research Foundation Company Limited by 
Guarantee  has a long-standing link with the School of Public Health in University College Cork and is a 
constituent part of the National Health Services Research Institute and has signed a research collaboration 
agreement with University College Cork .  Suicide Research Foundation Company Limited by Guarantee works 
collaboratively with the Health Service Executive’s National Office for Suicide Prevention in relation to providing 
research and evidence in line with the objectives of Connecting for Life, Ireland’s National Strategy to Reduce 
Suicide 2015-2020. 
Suicide Research Foundation Company Limited by Guarantee ’s principal aims are to build capacity in 
knowledge and expertise to achieve greater understanding of the causes of suicide and self-harm in Ireland, 
and to improve evidence-informed programmes in self-harm intervention, suicide prevention and mental health 
promotion. 
Suicide Research Foundation Company Limited by Guarantee is a W orld  H ealth  O rganisation (WHO) 
Collaborating Centre for Surveillance and Research in Suicide Prevention and, as such, fulfils an advisory role 
to the WHO, and, additionally, provides guidance to countries internationally in developing and implementing 
registration systems and prevention programmes for self-harm and suicide. Furthermore,  Suicide Research 
Foundation Company Limited by Guarantee ’s research contributes to international policy development in suicide 
prevention. 
The members of  Suicide Research Foundation Company Limited by Guarantee research team represent a 
broad range of disciplines, including psychology, psychiatry, medicine, epidemiology, public health, biostatistics, 
sociology, and health services research. 
Suicide Research Foundation Company Limited by Guarantee undertakes research into a wide range of topics 
relating to suicide and self-harm and, accordingly, provides the knowledge base for suicide prevention, 
intervention and postvention strategies. 
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Suicide Research Foundation Company Limited by Guarantee ’s specialist areas of expertise include: 
• Surveillance of self-harm and suicide 
• Evidence-based treatments for self-harm and depression 
• Guiding the implementation and evaluation of national suicide prevention programmes 
• Development of the evidence base for the implementation of multi-level suicide prevention programmes 
Suicide Research Foundation Company Limited by Guarantee ’s research and publications provide an evidence-
base on many key topics, including: 
• Risk and protective factors associated with self-harm and suicide 
• Self-harm and related mental health and social factors among young people 
• Impact of alcohol and drugs on self-harm and suicide 
• Assessment and treatment of self-harm and depression 
• Contagion and clustering of suicide and self-harm 
• Restricting access to lethal and frequently used methods of self-harm and suicide 
• Bereavement following suicide 
• Murder-suicide 
• Media reporting and suicide. 
Review of activities in 201 9 
National Self-Harm Registry Ireland 
The National Self-Harm Registry Ireland is a national system of population monitoring for the occurrence of self-
harm.  The Registry collects data based on persons presenting to hospital emergency departments as a result of 
an episode of self-harm, as defined by the Registry. As of 2006, the Registry has obtained full coverage of all 
general and paediatric hospital emergency departments in the Republic of Ireland. Please see the annual 
reports and interim reports of the registry at  www.nsrf.ie/reports. 
The Registry Aims 
 To establish the extent and nature of hospital-treated self-harm in Ireland. 
 To monitor trends over time and by area. 
 To contribute to policy and development in the area of suicidal behaviour. 
 To help the progress of research and prevention. 
Northern Ireland Registry of Self-harm 
The Northern Ireland Registry of Self-Harm was established by the Northern Ireland Public Health Agency in 
2012. It has coverage of all 12 acute hospitals in Northern Ireland, as part of the action plan to address self-
harm and suicide prevention under the Protect Life Strategy. The regional introduction of the Registry followed 
an initial piloting of the service in the Western Health and Social Care Trust from 2007 to 2012. The NSRF 
provides statistical analysis, support and independent verification of data recorded by the Northern Ireland 
Registry of Self-harm. A contract is agreed with the Public Health Agency who provides annual funding. 
National Suicide Research Foundation
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Projects funded by the National Office for Suicide Prevention 
Improving surveillance and monitoring of self-harm in Irish Prisons: The Self-harm Assessment and 
Data Analysis (SADA) Project 
As part of its role in  Connecting for Life,  Irelands National Strategy to Reduce Suicide , the Irish Prison Service 
has committed to reviewing, analysing and learning from each episode of self-harm within the prison estate. The 
SADA project provides robust information relating to the incidence and profile of self-harm within prison settings, 
identifies individual- and context-specific risk factors relating to self-harm, as well as examining patterns of 
repeat self-harm. Such information can be used as an evidence base to inform the identification and 
management of prisoners who engage in or who are at-risk for self-harm, and to develop effective prevention 
initiatives. Findings from this project are disseminated to the Irish Prison Service National Suicide and Harm 
Prevention Steering Group (NSHPG) on a quarterly basis. The NSRF coordinates the data management, data 
analysis and reporting of findings from the SADA Project. 
Review of the Health Service Executive Suicide Crisis Assessment Nurse Service (SCAN service) 
Project Aim 
-  To describe the operational structure of the SCAN service 
- T o review referrals made to services 
Specific objectives 
-  The results from this project estimated the prevalence of mental health-related referrals to and from the HSE 
SCAN Service and such data may be used to inform recommendations regarding further development of the 
service 
-  In particular, findings from this project will inform the statement of purpose for the service as well as the 
alignment of the service with that of the National Clinical Care Programme 
- The findings may identify potential improvements for the treatment of individuals at risk of suicidal behaviour 
The findings will also raise awareness of the significance and range of mental health problems among the 
general population that presents to primary care services. Such findings may inform general population mental 
health promotion initiatives. 
In April 2019, a final project report for the National Office for Suicide Prevention was completed. 
Individual and Ecological Factors Associated with Intentional Drug Overdose 
This research will inform legislation and recommendations for means restriction interventions related to suicidal 
behavio u r. This study affects Goal 6 of  Connecting for Life : To reduce and restrict access to means of suicidal 
behavio u r, by informing goals 6.1: To reduce access to frequently used drugs in Intentional Drug Overdose 
(IDO) and 6.2: To reduce access to highly lethal methods used in suicidal behavio u r. 
The specific objectives of this research are:  
• To examine the profile of persons engaging in IDO, detail drugs used and to quantify the contributions of 
alcohol involvement and multiple drug use 
• To describe the emerging use of a group of antiepileptic’s known as gabapentinoids in IDO in Ireland; to 
describe the characteristics of fatal and non-fatal IDO 
• To establish which drug types are linked with greater risk of a fatal outcome 
• To describe paracetamol-related IDO among young people, and  
• To explore repeat self-harm following IDO among young people. 
The NSRF has an Overall Agreement with the National Office for Suicide Prevention for the duration of the 
 Connecting for Life , and agrees the terms of a Service Arrangement annually in respect of funding for the 
National Self-Harm Registry Ireland and agreed research projects. 
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Additional NOSP-funded Project 
Coronial Data/Clinical Care Programme 
The Health Research Board/Health Service Executive Coronial Data Study is being carried out in order to fulfil 
five key strategic commitments made by the HSE NOSP and other key partners under Goal 7 of  Connecting for 
Life .  The aim of this study is twofold, firstly to improve access to timely and high-quality data on suicide and 
self-harm and secondly to review (and, if necessary, revise) current recording procedures for death by suicide. 
The study requires the secondment from the NSRF of a Post-Doctoral Researcher to a Data Analyst Post to 
work with the NOSP’s Evaluation Manager and the study’s Technical Advisory Group. 
This researcher also works on data analysis for the HSE National Clinical Programme for the Assessment and 
Management of Patients Presenting to Emergency Departments following Self-Harm. 
A Change Control note to the HSE NOSP/NSRF Service Arrangement has been agreed. 
A Study of Untimely Sudden Deaths and People who took their Lives while in the care of the Donegal 
Mental Health Service 
This research was commissioned by the Donegal Mental Health Service (DMHS). The study examined untimely 
sudden deaths and those who took their lives while in the care of Donegal Mental Health Service between 
October 2011 and May 2015.  Since the publication of the report in 2016, the focus of the work has been on the 
implementation of the evidence-informed recommendations. These include: 
- A service response, which is sent to family members on behalf of the HSE in the event of a service user fatality. 
- An information pack for family members at the time of admission of a family member to the Department of 
Psychiatry. 
- Awareness and skills training on self-harm and suicide as part of the induction of new mental health staff. 
- Development of an advanced suicide and self-harm risk-assessment training programme for all staff within 
Mental Health Services and beyond. 
A Service Arrangement is agreed annually between CHO1 and the NSRF. 
National Dialectical Behaviour Therapy Project 
The National Dialectical Behaviour Therapy (DBT) Project, Ireland was established in 2013 through funding 
provided by the NOSP. This project is a multi-year project which aims to train DBT teams in Community Mental 
Health settings across Ireland and to conduct an extensive evaluation of this national implementation. The 
Health Service Executive and the NSRF have come together as two organisations to collaborate in 
implementing and evaluating DBT programmes across Ireland. 
P roject Aims 
Co-ordinate and support the administration of a national implementation of DBT in Adult and Child/Adolescent 
Community Mental Health Services across Ireland. 
National Suicide Research Foundation
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GLOW Project 
The GLOW project, a follow-up programme was developed for behaviourally-stable participants with Borderline 
Personality Disorder who had completed a DBT programme in Cork. The four-month programme comprised one 
individual two-hour session per month and a group activity with all participants at the end of the programme. An 
evaluation is being undertaken to assess whether a coaching psychology intervention post-DBT will result in 
increased goal attainment and wellbeing. 
Funding for the DBT and GLOW Projects is provided by the HSE’s NOSP to HSE CHO4 and a Service 
Arrangement is agreed with the NSRF. 
World Health Organisation Collaborating Centre and WHO Commissioned Work 
As part of its designation as a WHO Collaborating Centre for Surveillance and Research in Suicide Prevention, 
the NSRF provides advice and information to the WHO and, at the request of the WHO, to countries interested 
in establishing systems of monitoring self-harm. The WHO provides funding for travel and subsistence to these 
countries.   
In addition, the WHO commissions the NSRF to undertake specific research-related projects.  In 2019, this 
involved the p reparation of a resource on preventing suicide specifically for filmmakers and others working on 
stage and screen, published by WHO in October 2019. 
Contracts are agreed with WHO for each individual undertaking. 
International Association for Suicide Prevention 
The IASP provides funding for a Research Officer, who from January to September 2019 worked on a one-day 
per week basis. During this time, this researcher acted as part of the Central Administration Office team, working 
on the IASP Special Interest Group on Decriminalisation and the Special Interest Group on the Development of 
Effective National Suicide Prevention Strategy and Practice in addition to co-ordinating the IASP Special Interest 
Groups and co-Chairing the IASP Early Career Group. The researcher ran the IASP Twitter account, responded 
to crisis e-mails directed to IASP and assisted with World Suicide Prevention Day content and graphics.  As of 
October 2019, this Researcher began to work on a half-day per week basis on IASP-related research acting as 
a co-Chair of the IASP Early Career Group, administrating the IASP Twitter account and coordinating responses 
to crisis e-mails directed to IASP. 
The IASP provides funding for a second Research Officer to work on a one-day per week basis on IASP-related 
research. The researcher acts as a coordinator of the IASP news bulletin, assistant to the IASP Executive 
Committee and Chairs/co-Chairs of the Special Interest Groups and coordinates the delivery and evaluation of 
training programmes. 
Funding is provided by IASP on submission of monthly invoices.  
Our Mental Health 
In 2018, the NSRF published a paper on media reporting of suicide and adherence to guidelines in Ireland. In 
2019, the findings of this paper were disseminated nationally via media briefings, organised by the Regional 
Officers for Suicide Prevention. Further to this, in line with the increasing evidence base in relation to using the 
media in a positive way, the NSRF conducted a survey, aimed at obtaining people’s perceptions on the impact of 
a television documentary on awareness of mental health, wellbeing and help-seeking behaviour, following the 
airing of the award-winning documentary  ‘My Other Life: Ireland’s Young and Their Mental Health’  on RTE. In 
December 2018, a briefing document outlining the initial findings was prepared for stakeholders . 
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Directors and secretary 
The directors who held office during the financial year and up to the date of signature of the financial statements 
were as follows: 
Margaret Kelleher 
James McCarthy 
Dave Drohan 
Michael O'Sullivan (Resigned 28 February 2019) 
Barry McGale 
Eugene Cassidy 
Siobhan O'Neill (Appointed 3 July 2019) 
Mark O'Callaghan (Appointed 25 June 2019) 
The secretary who held office during the financial year and up to the date of signature of the financial statements 
was Eileen Williamson. 
Financial Review 
Results for the financial year 
A summary of the  results for the financial year are set out on page 18. 
 The members have no beneficial interest in the company as there is no share capital and the company is 
limited by guarantee. 
The statement of financial activities shows net incoming funds for the financial year of € 5,705 (201 8 : € 6, 36 3 ) 
with total incoming resources  from the Health Service Executive and other agencies  amounting to €1, 201 , 034 
(201 8 :  €1,214,123 ) and total resources expended amounting to € 1,195,329 (201 8 : €1, 207,760 ). 
Reserves policy and financial position 
Reserves policy 
The charity has determined that it is not required to hold designated reserves given that it has significant cash 
reserves. 
Financial position 
The balance sheet shows total charity funds of € 210,107 (201 8 : € 204,402 ) all of which are required to: 
- Ensure that the charity can continue to provide the services that are listed as the charity's principal objectives; 
- Provide working capital when funding is paid in arrears; 
- Meet contractual obligations as they fall due; 
- Meet unexpected costs if these arise. 
Based on this, the directors are satisfied that the charity holds sufficient reserves to allow the charity to continue 
to operate successfully.  
National Suicide Research Foundation
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Structure, governance and management 
The organisation is a charitable company limited by guarantee. The company does not have a share capital and 
consequently the liability of members is limited, subject to an undertaking by each member to contribute to the 
net assets or liabilities of the company on winding up such amounts as may be required , not exceeding €1.00 
per member. 
The charity was established under a constitution which established the objects and powers of the charitable 
company and is governed by its constitution and managed by a board of directors.  T he Registrar of Business 
Names in the Companies Registration Office  has  granted the company permission to use the name of National 
Suicide Research Foundation. 
Board of Directors 
The National Suicide Research Foundation  is governed by a  b oard of  d irectors with a minimum number of 5 and 
a maximum number of 11  directors .  The board meets at least five times each year.   Each  d irector’s term of 
office is three years.  A chairperson is elected by the board of directors whose term of office is also three years.  
At each  Annual General Meeting one third of the  d irectors elected from the membership retire by  rotation and 
 are eligible for re-election. The process for nominations and voting is laid out in the Election Rules document 
which is posted on the website and made available to all m embers. 
There is a clear division of responsibility in the company with the board retaining control over major decisions. 
The board of directors retain overall responsibility for the strategic development of the company. 
Policies and Procedures for the Induction and Training of board Members 
All new ly appointed  d irectors receive a Board Induction Folder on appointment.  This contains the following 
documentation: a  B oard Handbook, the Board-member Code of Conduct, the NSRF Governing Documents, the 
Strategic Plan, Board Minutes from the previous 12 months, Reports  of the Chief Executive Officer  from  the 
 previous 12 months, the annual  b udget and other relevant documentation.  Board Members also get complete 
information on how the NSRF demonstrates its full compliance with the Governance Code.  The Chief Executive 
Officer schedules a 2-hour Induction Meeting with each new ly appointed  d irector in the first month following 
appointment, at which a sub-set of information customised for each new member is made available. 
Board Subgroups 
The company has three Standing Board Sub-committees, namely: 
- Operations Sub-committee 
- Research Advisory Sub-committee 
- Audit, Finance and Risk Management Sub-committee. 
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Organisational Structure and How Decisions are Made 
The NSRF’s main office is in Cork and staff members are based in Cork or in locations throughout the country.  
The team is led by the Chief Executive Officer, the  Head of Research and the Chief Scientist who report to the 
 b oard. 
Although ultimate responsibility for the governance of the NSRF rests with the Board of Directors, certain duties 
and responsibilities are delegated from the Board to the Chief Executive Officer, the Director of Research and 
the Chief Scientist and through them to the members of the staff team. These duties include implementation of 
the strategic plan; leading and managing the NSRF’s staff members, programmes, projects, finances and all 
other administrative aspects so that the NSRF’s ongoing mission, vision, and strategies are fulfilled within the 
context of the NSRF’s values as approved by the Board of Directors. 
Certain decisions are specifically reserved for the Board and include: 
-  The Company’s strategic plans and annual operating Budgets 
-  Projects outside the scope of the strategic plan 
-  Business acquisitions and disposals 
-  Litigation 
-  Appointment/Removal of Subgroup Chairs and Members 
-  Appointment/Removal of the Chief Executive Officer, the Director of Research, Chief Scientist 
-  Appointment/Removal of Auditors 
-  Approval of Borrowing/Finance Facilities 
-  Approval of new staff positions 
-  Approval of HR Contracts exceeding €40,000 per annum 
-  Annual Review of Risk and Internal Contro l 
- Approval of policies and procedures and Board nominations. 
The Chief Executive Officer  is responsible for preparing materials for Board consideration and for preparing 
materials for any strategic planning process. 
When the NSRF agrees to co-operate formally with other organisations on specific projects or in specific work 
areas, the agreements are determined by a Memorandum of Understanding/Service Arrangement or a form of 
written agreement which is approved by the Board of Directors. 
Internal Controls 
The National Suicide Research Foundation conducts an annual Risk Review process that is assessed in detail 
by the Audit, Finance and Risk Management subgroup with senior management and ultimately reviewed and 
signed off by the Board of Directors.  This process involves identification of the major risks to which the NSRF is 
exposed, an assessment of their impact and likelihood of happening and risk mitigation actions for each. 
The quarterly report of the Operations Subcommittee to the board contains a section on risk analysis updating 
the board regarding the status of the most acute risks to the NSRF and this is reviewed at each meeting of the 
Board of Directors. 
Transparency and Public Accountability 
The Board believes that the National Suicide Research Foundation and all organisations with charitable status 
must be fully accountable to the general public, providing detailed information on where its funds come from and 
on what they are spent.  The NSRF’s annual Financial Statements when approved by the Board of Directors are 
submitted to the Companies Registration Office and are published on the website  www.nsrf.ie , under the About 
Us section. 
National Suicide Research Foundation
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Directors, trustees and other senior personnel 
Mr . James McCarthy, Chairman 
James is a Chartered Accountant and Director in Ernst and Young’s Corporate Finance practice in Cork.  He 
joined the NSRF Board as a Director in 2016 and has served as Chairman since early 2018.  James brings more 
than 15 years of financial services experience to his role on the board. 
Dr . Margaret Kelleher 
Margaret has been involved in the investigation of suicide since 1987 when Dr. Michael Kelleher and Dr. Maura 
Daly decided to investigate the high level of suicide in a particular area of Cork.  Margaret was a founding 
member of the NSRF in 1994, having helped secure funding that led to it's establishment. On the death of Dr. 
Michael Kelleher in 1998, she became the director with overall responsibility for the foundation. In 2001 she 
invited Professor Ivan Perry to become director of research with overall responsibility for the registry. She 
arranged the appointment of Dr. Ella Arensman to the NSRF in 2003. She continues as the m edical  d irector of 
the NSRF and pursues her own interest as a general practitioner in Cork, with a special interest in suicide 
prevention. She is a fellow of the International Association of Suicide Research (IASR)  .  She worked closely 
with the late Dr Michael Kelleher in having suicide decriminalised in 1993.  She is a General Practitioner in Cork 
who has had a lifelong interest in suicide prevention.  Margaret brings extensive clinical experience and insights 
to the  b oard. 
Mr . Dave Drohan 
Dave worked in the Public Health Service for more than 30 years serving with the Southern and North Western 
Health Boards and the Health Service Executive in Management/Administration roles. The services he worked in 
include Mental Health, Disabilities and Community Services generally, as Local Health Manager in Cork.  He 
also worked for a Private Health Care provider and currently works on behalf of the Mental Health Commission.  
He has been on the Board of the NSRF since its creation and was a founding member of the organisation.  Dave 
brings his extensive management experience to the  b oard. 
Mr . Barry McGale 
Barry is a retired mental health nurse and cognitive behavioural therapist. He is a suicide prevention consultant 
with Suicide Bereavement UK and Livingworks Canada.  He has been a member of the NSRF  b oard since 2013.  
Barry brings his vast experience of working with suicidal patients and bereaved families to the Board. 
Professor Eugene Cassidy 
Eugene graduated in Medicine (MBBChBAO) from UCD in 1992 and completed a Master of Medical Science 
(Physiology Hons) at UCD in 1995.  He is a Clinical Professor at University College Cork and Consultant Liaison 
Psychiatrist with the HSE at Cork University Hospital.  Eugene brings broad clinical and research experience to 
his position on the  b oard. 
Siobhan O'Neill 
Professor Siobhan O’Neill is a Professor of Mental Health Sciences at Ulster University. Siobhan is currently 
leading several research programmes on suicide prevention in public places, intergenerational trauma, the 
impact ZeroSuicide programmes in NI and crisis line caller behaviour. A member of IASP, Siobhan has over 120 
peer reviewed publications on mental health and suicide prevention. Siobhan has expertise in qualitative and 
quantitative (epidemiology and survey) research methods.  Prior to joining Ulster University in 2000, she 
completed a degree in psychology at the Queen's University of Belfast and a Masters in Health Psychology at 
NUI Galway. She has also worked as a Public Health Researcher, conducting evaluations of health services and 
users’ experience of care.  Siobhan brings her vast research experience to the board. 
Mark O'Callaghan 
Mr Mark O’Callaghan BCL LLB AITI FCCA, a Practising Solicitor for over 20 years has been practising in Dublin 
since 2005. He is also qualified as a Chartered Tax Adviser and an Accountant.  Mark has been the go-to person 
for professional legal advice to the National Suicide Research Foundation since 2001 and until his appointment 
to the Board in 2019.  Mark brings his extensive legal and financial experience to the board. 
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Eileen Williamson, Chief Executive Officer 
Eileen commenced employment with the late Dr . Michael J . Kelleher in 1994 and was a  founder member of the 
NSRF. She holds an MBS (Hons) Degree in Health Services Management from University College Cork.  Eileen 
overseas the daily management of the NSRF research team and has specific responsibility for finance, legal and 
human resource related issues. In particular, she protects the financial assets and formulates, negotiates and 
controls the annual budget.  She co-ordinates the Operations sub-group, and in this role contributes to the 
development of the NSRF's goals, policies and strategic focus. In addition, Eileen is the NSRFs Company 
Secretary. This role involves working with the  auditors in the preparation of the  statutory financial statements and 
audit and ensuring compliance with  all laws and regulations relevant to the company . 
Dr .  Paul Corcoran, Head of Research 
Paul is an epidemiologist with more than twenty years of experience in suicidal behaviour research. Paul is also 
a Senior Lecturer in Peri - natal Epidemiology with the National Peri - natal Epidemiology Centre in the Department 
of Obstetrics and Gynaecology and with the  School of  Public Health.  Paul’s degrees include a BSc in Statistics 
and Computer Science, a Master’s degree in Statistics and a PhD in Epidemiology, all obtained at UCC. For the 
academic year 2008/2009, he was Visiting Professor at the Department of Psychiatry at the University of Oviedo 
in Spain and he is Chair of the International Association for Suicide Prevention Special Interest Group on 
National Systems for c ertifying Suicide Deaths. He has more than 100 peer-reviewed scientific  publications and 
has contributed to international texts on suicide epidemiology as well as contributing to Irish national suicide 
prevention strategies. 
Dr.  Mary Joyce, Manager, National Self-Harm Registry Ireland and Senior Post-doctoral Researcher. 
Mary is a Research Psychologist and took up the post of Manager of the National Self-Harm Registry Ireland in 
October 2019. She is also a Senior Post-doctoral Researcher at the NSRF. Mary graduated with a PhD in 
Applied Psychology from University College Cork in 2013. She has since gained a number of years of 
experience in self-harm research having previously worked as coordinator of the National Dialectical Behaviour 
Therapy Project Ireland. Mary’s research interests include the evaluation of interventions for individuals with high 
risk self-harm and improving access to services for individuals who self-harm. Mary also collaborates with the 
Northern Ireland Public Health Agency on the Northern Ireland Registry of Self-Harm. 
Dr . Eve Griffin, Research Fellow 
Eve Griffin, PHD  HRB EIA Research Fellow, School of Public Health University College Cork and National 
Suicide Research Foundation Cork .  Eve holds a Health Research Board Emerging Investigator Award 
(2018-2023) and is Principal Investigator of the PRISM Project (Providing Improved Care for Self-harm: A mixed-
methods study of intervention, implementation and economic outcomes from a national clinical programme). She 
graduated with a PhD in Applied Psychology from University College Cork in 2011. Her research interests 
include epidemiological trends of self-harm and the management of self-harm in clinical settings. She has more 
than 35 peer-reviewed scientific publications on the topic of self-harm. Eve has previously worked as the 
Manager of the National Self-Harm Registry Ireland. She has been involved in a number of EU consortia 
including OSPI-Europe and is the national data administrator for the European Injury Database (IDB) in Ireland. 
In addition, she has over ten years’ lecturing experience and is a course writer for Dublin City University’s Open 
Education Unit. 
Professor Ella Arensman, Research Professor University College Cork and Chief Scientist National 
Suicide Research Foundation 
For over 30 years, Professor Ella Arensman, MSc, PhD (Leiden University, The Netherlands), has conducted 
research into suicide, self-harm and related mental health problems, with particular expertise in epidemiological 
research, randomised controlled trials, health services research, health information systems, and programme 
evaluation.  Since the early nineties, Ella has been involved in a large number of international research consortia 
including the WHO/Euro Multicentre study on Suicidal Behaviour, Child and Adolescent Self Harm in Europe, 
EAAD, Optimised Suicide Prevention programmes and their Implementation in Europe, Preventing Depression 
and Improving Awareness through Networking in the EU, and Mental Health Training through Research Network 
in Europe.  Ella leads the programme of work on the Health Research Board funded Research Leaders Award. 
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Principal risks and uncertainties 
The directors have ultimate responsibility for managing risk and are aware of the risks associated with the 
operating activities of the charity. The directors carry out an annual audit and review the risks on an ongoing 
basis. The directors are satisfied that adequate systems of governance, supervision, procedures and internal 
controls are in place to mitigate the exposure to major risks and that these controls provide reasonable 
assurance against such risks. The directors have identified that the key risks facing the company relate to the 
risk of a decrease in the level of grant funding , the potential impact of the COVID-19 Pandemic , the increase in 
compliance requirements in accordance with company, health and safety and general data protection legislation, 
and ensuring security of the company's sensitive data, reputational risk and other operational risks. 
The company mitigates these risks as follows: 
Financial risk 
-  The charity continually monitors the level of activity, prepares and monitors its budgets  and projections. The 
charity has a policy of maintaining significant cash reserves and it has also developed a strategic plan which will 
allow for the diversification of funding and activities 
- Financial information is subject to detailed review at board level allowing for continuous monitoring of the 
company's operations and financial status 
Operational/internal control risk 
- The risk is  minimised by the implementation of procedures for authorisation of all transactions and projects and 
the requirements for budgets covering all activities 
-  Procedures are in place to ensure compliance with health and safety of staff and clients . 
Reputational/compliance risk 
-  In common with many charities, the company’s principal risk is reputational damage. Reputation damage could 
be caused by an event either within or outside the company’s control. In order to mitigate this risk the charity 
continues to adopt best practices 
-  The charity closely monitors emerging changes to regulations and legislation on an on-going basis  by ensuring 
all accreditation is up to date . 
Accounting records 
The company's directors are aware of their responsibilities, under sections 281 to 285 of the Companies Act 
2014 as to whether in their opinion, the accounting records of the company are sufficient to permit the financial 
statements to be readily and properly audited and are discharging their responsibility by: 
1)  employing qualified and experienced staff,  
2)  ensuring that sufficient company resources are available for the task, 
3)  liaising with the company's auditors/seeking external professional accounting advice , and  
4)  arrang ing to guard against falsification of the records. 
The accounting records are held at the company's business premises, Room 4.36 Western Gateway Building, 
University College Cork, Cork. T12 YF9N 
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Post reporting date events 
Since the end of the financial year Ireland has been significantly affected by the Covid-19 Pandemic. As the 
company carries out its operations in University College Cork the impact of the Pandemic has necessitated 
significant operational changes. Whilst COVID-19 has necessitated changes to the main office set up, almost all 
aspects of the research programme can continue with staff members working at home whilst some adjustments 
to timeframes of field-based research have been necessary. 
In line with government advice, all third level institutes closed on 12 March 2020.  The team at the NSRF had 
anticipated the closure of the Western Gateway Building (WGB) in University College Cork where its office is 
located and had made preparations for staff to work at home.  All WGB-based staff members were set up and 
trained to work remotely and can access shared files and project documents using secure software. 
Operations Group meetings have been held weekly via Zoom initially, and more recently using Microsoft Teams.  
A weekly staff meeting with a focus on self-care is held and in addition, a weekly e-mail is sent to staff members 
outlining the most up-to date Irish and international research and resources relating to COVID-19.  All of the 
above measures are in addition to the Registry weekly team meetings and individual phone/Skype meetings that 
staff members are continuing to have with their supervisors.  The NSRF is at all times aware of the need to 
comply with the requirements of the General Data Protections Regulations while working at home. 
The work relating to the National Self-Harm Registry is continuing.  Whilst it is not possible for some Data 
Registration Officers to go in to hospitals to collect data at the present time, these individuals had collected data 
in advance and have been involved in trialling the new system of data uploading that was introduced for the 
Registry in March 2020.  Other Data Registration Officers continue to collect data electronically. 
In summary, the research programme is continuing in line with agreed objectives and the company has been 
asked to undertake additional research projects as outlined below in future developments. 
There has been no financial impact on the NSRF as a result of COVID-19.  In line with HSE policy, the 2020 
Service Arrangement and associated Programme of Work with the National Office for Suicide Prevention were 
agreed and signed before 28 February 2020.  The funding for the running of the Registry and the agreed 
programme of work has been increased to €907,000 for 2020.  The NSRF has an overall agreement with the 
HSE NOSP for the duration of the  Connecting for Life , Suicide Reduction Strategy 2015-2024. 
In summary, from a financial perspective, there is unlikely to be a change to the annual funding provided by the 
HSE NOSP. 
No other matters or circumstances have arisen since the end of the financial year which significantly affected or 
may significantly affect the operations of the company, the results of those operations or the state of the affairs of 
the company in the financial period subsequent to the financial year ended 31 December 2019 . 
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Future developments 
The company 's future plans include making applications to various organisations for new funding for a variety of 
research projects. From January 2020, the NSRF has commenced a new project entitled MINDUP that is funded 
by the EU’s Horizon 2020 Programme.  The funding will allow for the employment of one postdoctoral researcher 
and ancillary costs for four years.  
Furthermore, as a consequence of the Covid-19 Pandemic there is a recognition at government and HSE levels 
of the need to attend to the mental health welfare of the population in combination with the physical medical 
welfare both during and as we emerge from the Pandemic.  Accordingly, a COVID-19 Health Sector National 
Psycho-Social Response Plan is being developed by the HSE and the NSRF has been asked to be involved in 
order to provide the research evidence. 
As mentioned above the NSRF has been invited to be involved in the COVID-19 Health Sector National Psycho-
Social Response Plan.  More specifically the NSRF will be working with the HSE on Technical Support: 
Research, Measures and Stakeholder Engagement. 
The NSRF, at the request of NOSP, in collaboration with international colleagues, is undertaking a rapid review 
of research on the impacts of pandemics and epidemics on suicide and self-harm to inform the changes that will 
be needed in both the Irish and Scottish National Suicide Prevention Strategies post COVID-19. 
On account of its status as a WHO Collaborating Centre on Suicide Research and Surveillance, the NSRF has 
had many requests from the WHO for advice and information to be included in its briefing documents and official 
resources in relation to the impact of the pandemic on the mental health of populations. 
The NSRF contributed to an international consensus statement, led by Professor David Gunnell from the 
University of Bristol, involving 42 researchers, that was published in the Lancet in April 2020.  The consensus 
statement outlined that suicide is likely to become a more pressing concern as the pandemic spreads and has 
longer-term effects on the general population, the economy and vulnerable groups and urged that preventing 
suicide needs urgent consideration (Gunnell et al 2020). 
The NSRF was involved in a successful application to the HRB for a project entitled COVID-19: Estimating the 
burden of symptomatic disease in the community and the impact of public health measures on physical, mental 
and social wellbeing led by the UCC School of Public Health.  The NSRF will be involved in the rollout of the 
project. 
Auditor 
In accordance with  Section 383(2) of the Companies Act 2014, H&A Accountancy Services Limited t/a Hickey & 
Associates  will continue in office as auditors of the company. 
Statement on relevant audit information to auditor 
Each of the directors in office at the date of approval of this annual report confirms that: 
• so far as the director is aware, there is no relevant audit information of which the company's auditor is 
unaware, and 
• the director has taken all the steps that he / she ought to have taken as a director in order to make 
himself / herself aware of any relevant audit information and to establish that the company's auditor is 
aware of that information. 
This confirmation is given and should be interpreted in accordance with the provisions of section 330 of the 
Companies Act 2014. 
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On behalf of the board 
Margaret Kelleher Dave Drohan 
Director Director 
13 May 2020 
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General responsibilities 
The directors are responsible for preparing the Directors' Report and the financial statements in accordance with 
Irish law and regulations. 
Irish company law requires the directors to prepare financial statements for each financial year. Under that law, 
the directors have elected to prepare the financial statements in accordance with  the Companies Act 2014 and 
accounting standards issued by the Financial Reporting Council including  FRS 102  t he Financial Reporting 
Standard applicable in the UK and Republic of Ireland  (Generally Accepted Accounting Practice in Ireland) as 
modified by the Statement of Recommended Practice "Accounting and Reporting by Charities" effective 1 
January 2015 . Under company law, the directors must not approve the financial statements unless they are 
satisfied that they give a true and fair view of the assets, liabilities and financial position of the company as at the 
financial year end date and of the  profit or loss of the company for that financial year and otherwise comply with 
the Companies Act 2014. 
In preparing these financial statements, the directors are required to: 
• select suitable accounting policies for the company financial statements and then apply them 
consistently; 
• make judgements and estimates that are reasonable and prudent; 
• state whether the financial statements have been prepared in accordance with applicable accounting 
standards , identify those standards, and note the effect and the reasons for any material departure from 
those standards; and 
• prepare the financial statements on the going concern basis unless it is inappropriate to presume that 
the company will continue in business. 
The directors are responsible for ensuring that the company keeps or causes to be kept adequate accounting 
records which correctly explain and record the transactions of the company, enable at any time the assets, 
liabilities, financial position and  profit or loss of the company to be determined with reasonable accuracy, enable 
them to ensure that the financial statements and Directors' Report comply with the Companies Act 2014 and 
enable the financial statements to be audited. They are also responsible for safeguarding the assets of the 
company and hence for taking reasonable steps for the prevention and detection of fraud and other 
irregularities. 
On behalf of the board 
Margaret Kelleher Dave Drohan 
Director Director 
13 May 2020 
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Opinion 
We have audited the financial statements of Suicide Research Foundation Company Limited by Guarantee (the 
'company') for the financial year ended 31 December 2019 which comprise the Statement of  Financial Activities, 
t he Balance Sheet , the Statement of Changes in  Funds, th e Statement of Cash Flows and the related notes. 
The relevant financial reporting framework that has been applied in their preparation is the Companies Act 2014 
and FRS 102  t he Financial Reporting Standard applicable in the UK and Republic of Ireland ,  as modified by the 
Statement of Recommended Practice "Accounting and Reporting by Charities" effective 1 January 2015 . 
In our opinion the financial statements: 
• give a true and fair view of the state of the  assets, liabilities and financial position of the  company's at 31 
December 2019 and of its  result  for the financial year then ended; 
• have been properly prepared in accordance with FRS 102  t he Financial Reporting Standard applicable in 
the UK and Republic of Ireland, as modified by the Statement of Recommended Practice "Accounting and 
Reporting by Charities" effective 1 January 2015 ; and 
• have been prepared in accordance with the requirements of the Companies Act 2014. 
Basis for opinion 
We conducted our audit in accordance with International Standards on Auditing ( Ireland ) (ISAs ( Ireland )) and 
applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities 
for the audit of the financial statements  section of our report. We are independent of the company in accordance 
with the ethical requirements that are relevant to our audit of financial statements in  Ireland , including the Ethical 
Standard issued by the Irish Auditing and Accounting Supervisory Authority (IAASA) , and we have fulfilled our 
other ethical responsibilities in accordance with these requirements. 
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our 
opinion. 
Conclusions relating to going concern 
We have nothing to report in respect of the following matters in relation to which the ISAs ( Ireland ) require us to 
report to you where: 
• the directors' use of the going concern basis of accounting in the preparation of the financial statements is 
not appropriate; or  
• the directors have not disclosed in the financial statements any identified material uncertainties that may 
cast significant doubt about the company’s ability to continue to adopt the going concern basis of accounting 
for a period of at least twelve months from the date when the financial statements are authorised for issue . 
Other information 
The directors are responsible for the other information. The other information comprises the information included 
in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the 
financial statements does not cover the other information and, except to the extent otherwise explicitly stated in 
our report, we do not express any form of assurance conclusion thereon. 
In connection with our audit of the financial statements, our responsibility is to read the other information and, in 
doing so, consider whether the other information is materially inconsistent with the financial statements or our 
knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material 
inconsistencies or apparent material misstatements, we are required to determine whether there is a material 
misstatement in the financial statements or a material misstatement of the other information. If, based on the 
work we have performed, we conclude that there is a material misstatement of this other information, we are 
required to report that fact. 
We have nothing to report in this regard. 
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Opinions on other matters prescribed by the Companies Act 20 14 
Based solely on the work undertaken in the course of the audit, we report that in our opinion :  
• the information given in the Directors' Report is consistent with the financial statements;  
• the Directors' Report has been prepared in accordance with applicable legal requirements ; 
• w e have obtained all the information and explanations which we consider necessary for the purposes of our 
audit ; 
• the accounting records of the company were sufficient to permit the financial statements to be readily and 
properly audited, and ; 
• the financial statements are in agreement with the accounting records. 
Matters on which we are required to report by exception 
Based on the knowledge and understanding of the company and its environment obtained in the course of the 
audit, we have not identified any material misstatements in the directors' report.  We have nothing to report in 
respect of our obligation under the Companies Act 2014 to report to you if, in our opinion, the disclosures of 
director's remuneration and transactions specified by sections 305 to 312 of the Act are not made. 
Responsibilities of directors for the financial statements 
As explained more fully in the directors'  r esponsibilities  s tatement, the directors are responsible for the 
preparation of the financial statements and for being satisfied that they give a true and fair view, and for such 
internal control as the directors determine is necessary to enable the preparation of financial statements that are 
free from material misstatement, whether due to fraud or error. 
In preparing the financial statements, the directors are responsible for assessing the company’s ability to 
continue as a going concern, disclosing, as applicable, matters related to going concern and using the going 
concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, 
or have no realistic alternative but to do so. 
Auditor's responsibilities for the audit of the financial statements 
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free 
from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our 
opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in 
accordance with ISAs (Ireland)  will always detect a material misstatement when it exists. Misstatements can 
arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably 
be expected to influence the economic decisions of users taken on the basis of these financial statements. 
A further description of our responsibilities for the audit of the financial statements is located on the IAASA’s 
 website at: http://www.iaasa.ie/Publications/Auditing-standards/International-Standards-on-Auditing-for-use-in-
Ire/International-Standards-on-Auditing-(Ireland)/ISA-700-(Ireland). This description forms part of our auditor’s 
 report. 
The purpose of our audit work and to whom we owe our responsibilities 
This report is made solely to the company’s members, as a body, in accordance with  section 391 of the 
Companies Act 20 14 . Our audit work has been undertaken so that we might state to the company’s members 
those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest 
extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the 
company’s members as a body, for our audit work, for this report, or for the opinions we have formed. 
Owen Hickey 13 May 2020 
for and on behalf of: 
H&A Accountancy Services Limited Unit 2, Bowling Green 
t/a Hickey & Associates White Street 
Chartered Accountants Cork 
Statutory Auditors 
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Restricted Unrestricted Total Total 
funds funds 2019 2018 
Notes € € € € 
Incoming Resources from: 
Private donations - 100 100 1,120 
Investment income - 43 43 36 
Overhead funding - - - 22,470 
Generated income - lectures and fees - 562 562 - 
Grant income 1,200,329 - 1,200,329 1,190,461 
Total incoming resources 3 1,200,329 705 1,201,034 1,214,123 
Resources Expended on: 
Payroll costs including social insurance costs (940,258) - (940,258) (917,108) 
Pension costs (22,639) - (22,639) (22,717) 
Recruitment costs - - - (6,888) 
Data collection costs (7,742) - (7,742) (10,323) 
Data collection travel costs (43,191) - (43,191) (40,977) 
Travel, meetings and conferences (38,706) - (38,706) (48,743) 
Premises costs (33,454) - (33,454) (26,623) 
Professional and related fees (57,786) - (57,786) (68,471) 
IT costs (42,296) - (42,296) (44,897) 
Intern cost - - - (15,000) 
Other administration costs (9,257) - (9,257) (6,013) 
Total resources expended 4 (1,195,329) - (1,195,329) (1,207,760) 
Net movement in funds for the financial year 
before taxation 5,000 705 5,705 6,363 
Tax on net movement 9 - - - - 
Net movement in funds for the financial year 5,000 705 5,705 6,363 
Reconciliation of funds: € € € € 
Net movement in funds for the financial year 5,000 705 5,705 6,363 
Transfer at year end to unrestricted funds (5,000) 5,000 - - 
Balances brought forward - 204,402 204,402 198,039 
Balances carried forward - 210,107 210,107 204,402 
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2019 2018 
Notes € € € € 
Fixed assets 
Tangible assets 10 7,710 4,081 
Current assets 
Debtors 12 2,703 77,522 
Cash at bank and in hand 430,589 369,919 
433,292 447,441 
Creditors: amounts falling due within 
one year 
13 
(230,895) (247,120) 
Net current assets 202,397 200,321 
Total assets less current liabilities 210,107 204,402 
Funds of the charity 
Restricted funds - - 
Unrestricted funds 210,107 204,402 
Total charity funds 210,107 204,402 
The financial statements were approved by the board of directors and authorised for issue on 13 May 2020 and 
are signed on its behalf by: 
Margaret Kelleher Dave Drohan 
Director Director 
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Restricted 
reserves 
Unrestricted 
reserves 
Total 
€ € € 
Balance at 1 January 2018 - 198,039 198,039 
Financial year ended 31 December 2018: 
Net movement in funds for the financial year - 6,363 6,363 
Balance at 31 December 2018 - 204,402 204,402 
Financial year ended 31 December 2019: 
Net movement in funds for the financial year - 5,705 5,705 
Balance at 31 December 2019 - 210,107 210,107 
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2019 2018 
Notes € € € € 
Cash flows from operating activities 
Cash generated from operations 20 66,863 143,293 
Investing activities 
Purchase of tangible fixed assets (6,236) - 
Interest received 43 36 
Net cash (used in)/generated from investing 
activities (6,193) 36 
Net cash used in financing activities - - 
Net increase in cash and cash equivalents 60,670 143,329 
Cash and cash equivalents at beginning of 
financial year 369,919 226,590 
Cash and cash equivalents at end of financial 
year 430,589 369,919 
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1 Accounting policies 
Company information 
Suicide Research Foundation Company Limited by Guarantee  is primarily engaged in the investigation into 
the causes of suicide and self-harm in Ireland and undertaking research into various topics relating to 
suicide and self-harm in order to provide a knowledge base for suicide prevention, intervention and 
postvention and to provide training and positive mental health programmes. 
Suicide Research Foundation Company Limited by Guarantee is a company limited by guarantee without a 
share capital, and is domiciled and incorporated in Ireland ,  company registration number 224676 . The 
company is tax resident in Ireland. 
The registered office is 1 Perrott Avenue, College Road, Cork. The company's principal place of business is 
4.36 Western Gateway Building, University College Cork, Cork. 
The financial statements have been prepared by Suicide Research Foundation Company Limited by 
Guarantee in accordance with accounting standards issued by the Financial Reporting Council, including 
FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland as modified by the 
Statement of Recommended Practice "Accounting and Reporting by Charities" effective 1 January 2015. 
The significant accounting policies adopted by the company and applied consistently in the preparation of 
the financial statements are set out below.  
1.1 Basis of preparation 
The financial statements are prepared in accordance with applicable law and the accounting standards 
issued by the Financial Reporting Council and promulgated by Chartered Accountants Ireland (FRS 102, 
the Financial Reporting Standard applicable in the UK and Republic of Ireland as modified by the 
Statement of Recommended Practice "Accounting and Reporting by Charities" effective 1 January 2015), 
which have been applied consistently (except as otherwise stated). 
The financial statements are prepared under the historical cost convention and on a going concern basis, 
modified to include certain items at fair value. 
The financial statements are prepared in euros , which is the functional currency of the company.  Monetary 
a mounts  in these financial statements are  rounded to the nearest €. 
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1.2 Going concern 
Since the end of the financial year Ireland has been significantly affected by the COVID-19 Pandemic. As 
the company carries out its operations in University College Cork the impact of the Pandemic has 
necessitated significant operational changes. Whilst COVID-19 has necessitated changes to the 
company's set up, almost all aspects of the research programme can continue with staff members working 
at home whilst some adjustments to timeframes of field-based research have been necessary. 
There has been no financial impact on the NSRF as a result of the COVID-19 Pandemic.  In line with HSE 
policy, the 2020 Service Arrangement and associated Programme of Work with the National Office for 
Suicide Prevention were agreed and signed before 28 February 2020.  The funding for the running of the 
Registry and the agreed programme of work has been increased to €907,000 for 2020.  The NSRF has an 
overall agreement with the HSE NOSP for the duration of the  Connecting for Life , Suicide Reduction 
Strategy 2015-2024. 
In summary, from a financial perspective, there is unlikely to be a change to the annual funding provided by 
the NOSP. 
A t the time of approving the financial statements ,  t he directors have a reasonable expectation that the 
 company  has adequate resources to continue in operational existence for the foreseeable future. Thus  t he 
directors continue to adopt the going concern basis of accounting in preparing the financial statements. 
1.3 Incoming resources 
Incoming resources are recognised in the financial year in which the charity is entitled to the income, when 
the amount of income can be measured reliably and it is probable that the income will be received. 
Incoming resources represent grant income, private donations and investment income. 
Grants from government and other agencies have been included in income from activities in furtherance of 
the charity's objectives where these amount to a contract for services provided, for example monies 
received for core funding, but as donations where the funds are given with greater freedom of use. 
Income from government and other grants is recognised when the charity has entitlement to the funds, any 
performance conditions have been met, it is probable that the income will be received and the amount can 
be measured reliably. Grants, where related to performance and specific deliverables, are accounted for as 
the charity earns the right to consideration by its performance and included within grant income. 
Voluntary donations are recognised when the charity is entitled to the income, has certainty of receipt and 
the amount can be measured with sufficient reliability. 
Investment income is included when receivable and the amount can be reliably measured, which is 
normally upon notification of the interest paid or payable by the bank . 
Grants relating to expenditure to be incurred in a future accounting period received in advance are 
deferred and recognised in the financial period to which they relate. 
No incoming resources have been included in the statement of financial activities net of expenditure. 
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1.4 Resources expended 
Resources expended are recognised on an accruals basis as a liability is incurred. Resources expended 
include any VAT which cannot be recovered, and are reported as part of the expenditure to which it relates. 
Costs relating to a particular activity are allocated directly, others are apportioned on an appropriate basis, 
for example on estimated usage. 
Resources expended have been allocated to the categories listed on the statement of financial activities. 
Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and 
services for its beneficiaries. It includes both costs that can be allocated directly to such activities and 
those costs of an indirect nature necessary to support them. 
Professional and related fees, IT costs and other administration costs are costs associated with meeting 
the constitutional and statutory requirements of the charity and include audit and accountancy fees, costs 
of legal advice, maintenance of the data base and its security and costs linked to the strategic 
management of the charity including the cost of directors' meetings. 
Resources expended are allocated based on activity (no fund raising activities) and liabilities are 
recognised as soon as there is a legal or constructive obligation to make a transfer of value to a third party 
as a result of past transactions or events. 
1.5 Allocation of support and governance costs 
Support costs represent indirect charitable expenditure. In order to carry out the primary purposes of the 
charity it is necessary to provide support in the form of personnel development, financial procedures, 
provision of office services and equipment and a suitable working environment. 
Governance costs comprise the costs involving public accountability of the charity (including audit fees) 
and costs in respect of its compliance with regulation and good practice. 
Support and governance costs are apportioned directly to the activity to which they relate. 
1.6 Tangible fixed assets 
Tangible fixed assets  are initially measured at  historical  cost and subsequently measured at cost or 
valuation, net of depreciation and any impairment losses. 
Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset 
over its expected useful life, as follows:  
Computer equipment 20% Straight line basis 
The gain or loss arising on the disposal of an asset is determined as the difference between the sale 
proceeds and the carrying value of the asset, and  is credited or charged to  the statement of financial 
activities. 
The company's policy is to review the remaining useful economic lives and residual values of assets on an 
ongoing basis and to adjust the depreciation charge to reflect the remaining estimated useful economic life 
and residual value. 
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1.7 Impairment of fixed assets 
At each reporting end date, the  company  reviews the carrying amounts of its tangible and intangible assets 
to determine whether there is any indication that those assets have suffered an impairment loss. If any 
such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of 
the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual 
asset, the  company  estimates the recoverable amount of the cash-generating unit to which the asset 
belongs. 
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in 
use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that 
reflects current market assessments of the time value of money and the risks specific to the asset for 
which the estimates of future cash flows have not been adjusted. 
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying 
amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. 
An impairment loss is recognised immediately in surplus or deficit, unless the relevant asset is carried at a 
revalued amount, in which case the impairment loss is treated as a revaluation decrease. 
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have 
ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or 
cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the 
increased carrying amount does not exceed the carrying amount that would have been determined had no 
impairment loss been recognised for the asset (or cash-generating unit)  in  prior years. A reversal of an 
impairment loss is recognised immediately in surplus or deficit, unless the relevant asset is carried at a 
revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase. 
1.8 Cash at bank and in hand 
Cash and cash equivalents  are basic financial assets and include cash in hand, deposits held at call with 
banks, other short-term liquid investments with original maturities of three months or less, and bank 
overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 
1.9 Financial instruments 
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 
12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.  
Financial instruments are recognised in the company's balance sheet when the company becomes party to 
the contractual provisions of the instrument. 
Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when 
there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a 
net basis or to realise the asset and settle the liability simultaneously. 
Basic financial assets 
Basic financial assets, which include debtors and cash and bank balances, are initially measured at 
transaction price including transaction costs and are subsequently carried at amortised cost using the 
effective interest  method unless the arrangement constitutes a financing transaction, where the transaction 
is measured at the present value of the future receipts discounted at a market rate of interest. Financial 
assets classified as receivable within one year are not amortised. 
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Trade debtors , loans and other receivables that have fixed or determinable payments that are not quoted in 
an active market are classified as 'loans and receivables'. Loans and receivables are measured at 
amortised cost using the effective interest method, less any impairment. 
Interest is recognised by applying the effective interest rate, except for short-term receivables when the 
recognition of interest would be immaterial. The effective interest method is a method of calculating the 
amortised cost of a debt instrument and of allocating the interest income over the relevant period. The 
effective interest rate is the rate that exactly discounts estimated future cash receipts through the expected 
life of the debt instrument to the net carrying amount on initial recognition. 
Impairment of financial assets 
Financial assets, other than those  held  at  fair value through surplus and deficit , are assessed for indicators 
of impairment at each reporting end date. 
Financial assets are impaired where there is objective evidence that, as a result of one or more events that 
occurred after the initial recognition of the financial asset, the estimated future cash flows have been 
affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the 
present value of the estimated cash flows discounted at the asset’s original effective interest rate. The 
impairment loss is recognised in  the statement of financial activities . 
If there is a decrease in the impairment loss arising from an event occurring after the impairment was 
recognised, the impairment is reversed. The reversal is such that the current carrying amount does not 
exceed what the carrying amount would have been, had the impairment not previously been recognised. 
The impairment reversal is recognised in  the statement of financial activities . 
Derecognition of financial assets 
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire 
or are settled, or when  the company transfers the financial asset and substantially all the risks and rewards 
of ownership to another entity, or if some significant risks and rewards of ownership are retained but 
control of the asset has transferred to another party that is able to sell the asset in its entirety to an 
unrelated third party. 
Classification of financial liabilities 
Financial liabilities and equity instruments are classified according to the substance of the contractual 
arrangements entered into. An equity instrument is any contract that evidences a residual interest in the 
assets of the company after deducting all of its liabilities. 
Basic financial liabilities 
Basic financial liabilities, including creditors, bank loans, loans from  fellow group companies and 
preference shares that are classified as debt, are  initially recognised at transaction price unless the 
arrangement constitutes a  financing transaction, where the debt instrument is measured at the present 
value of  the future  paymen ts discounted at a market rate of interest. Financial liabilities classified as 
payable within one year are not amortised. 
Debt instruments are subsequently carried at amortised cost, using the effective  interest rate method. 
Trade creditors are obligations to pay for goods or services that have been acquired  in the ordinary course 
of business from suppliers. A m ounts payable are classified as  current liabilities if payment is due within 
one year or less. If not, they are presented  as non-current liabilities. Trade creditors are recognised initially 
at transaction price  and subsequently measured at amortised cost using the effective interest method. 
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Derecognition of financial liabilities 
Financial liabilities are derecognised when the company’s contractual obligations  expire or are discharged 
or cancelled. 
1.10 Taxation 
No charge to current or deferred taxation arises as the charity has been granted charitable status under 
sections 207 and 208 of the Taxes Consolidation Act 1997, Charity Number CHY 11351. 
1.11 Employee benefits 
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs 
are required to be recognised as part of the cost of stock or fixed assets.   
The cost of any unused holiday entitlement is recognised in the  financial year in which the employee’s 
services are received. 
Termination benefits are recognised immediately as an expense when the company is demonstrably 
committed to terminate the employment of an employee or to provide termination benefits. 
1.12 Retirement benefits 
The company contributes to various defined contribution pension plans for the benefit of its employees. 
The cost to the company of the contributions payable are charged to the  statement of financial activities  in 
the financial year they are payable. The pension plans are held in the names of the in di vidual employees/
members and thus the assets held in those plans are not included in the company's assets. 
1.13 Government grants 
Current re venue grants are  recognised at the fair value of the asset received or receivable when there is 
reasonable assurance that the grant conditions will be met and the grants will be received. Revenue grants 
are  credited to the  statement of financial activities  in the  financial year in which they are received, or when 
the relative expenditure takes place, whichever is the later . 
1.14 Foreign exchange 
Monetary assets and liabilities denominated in foreign currencies are translated into euro at the rates of 
exchange ruling at the  financial year end . Transactions in foreign currencies are recorded at the rate ruling 
at the date of the transaction payment or receipt.  All  differences in foreign currency translations between 
the rates ruling at the dates of the transactions and the dates of payment or receipt are credited or debited 
to the statement of financial activities .   
1.15 Borrowings 
Borrowings are recognised at the transaction prices (present value of cash payable to the creditors). 
Interest expenses are recognised in the statement of financial activities in the financial year in which they 
are charged. 
Borrowings are classified as appropriate, given that the company has a right to defer settlement of some of 
the liabilities for at least 12 months after the reporting date. 
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1.16 Fund accounting 
The following funds are operated by the charity: 
Restricted Funds 
Restricted Funds represent grants, donations and sponsorships received which can only be used for 
particular purposes specified by the donors or sponsorship programmes binding on the directors/trustees. 
Such purposes are within the overall aims of the charity. 
Unrestricted Funds 
Unrestricted Funds includes general funds and designated funds and it represent amounts which are 
expendable at the discretion of the  d irectors/ t rustees in furtherance of the objectives of the charity and 
which have not been designated for other purposes. Such funds may be held in order to finance working 
capital or capital expenditure. 
1.17 Services provided by directors/trustees 
For the purposes of these financial statements, no monetary value has been placed on the administrative 
and management services provided by the directors/trustees, except under contracts of employment by the 
company. 
2 Judgements and key sources of estimation uncertainty 
In the application of the company’s accounting policies, the directors are required to make judgements, 
estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent 
from other sources. The estimates and associated assumptions are based on historical experience and 
other factors that are considered to be relevant. Actual results may differ from these estimates. 
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting 
estimates are recognised in the  financial year in which the estimate is revised where the revision affects 
only that  financial year , or in the  financial year of the revision and future  financial years  where the revision 
affects both current and future  financial years . 
The estimates and assumptions which have a significant risk of causing a material adjustment to the 
carrying amount of assets and liabilities are outlined below. 
Critical judgements 
Debtors accruals and deferred income 
The company estimates the debtors accruals and deferred income liabilities in relation to projects on a 
basis of performance carried out under the contract before and after the financial year end. The basis for 
each debtor's accrual and deferred income liability is the contract term remaining as a proportion of the 
entire contract term in relation to the total funds received/receivable under the contract by the financial year 
end date less funding already received up to 31 December of each financial year. 
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3 Incoming resources 
The incoming resources of the company for the financial year have been wholly derived from its 
principal activity and is mostly undertaken in the Republic of Ireland. 
Grant income comprises restricted revenue grants made by the Health Service Executive (HSE) 
and other agencies to fund the provision of specific deliverables under performance related 
contracts with each of the agencies. The amounts of such grants received in the financial year from 
each agency is detailed below. All grants from the Health Service Executive and other agencies 
where performance conditions were attached are classified as grant income in the statement of 
financial activities.  
The incoming resources for the financial year have been derived from: 
2019 2018 
€ € 
Restricted Income 
HSE NOSP - National Suicide Research Foundation 300,000 300,000 
HSE NOSP - National Self-Harm Registry Ireland 591,219 552,779 
Donegal Mental Health Service - Donegal Study 74,937 69,055 
HSE NOSP/CHO 4 - National Dialectical Behaviour Therapy Project 118,545 155,580 
International Association for Suicide Prevention Project 13,737 8,847 
World Health Organisation Collaborating Centre 5,607 7,767 
Royal College of Surgeons in Ireland Health Research Board Project - 19,855 
HSE NOSP/CHO 4 GLOW Project - 6,168 
World Health Organisation Commissioned Work 6,576 10,239 
HSE NOSP - Coronial Data & Statistical Care Project 55,178 27,960 
Northern Ireland Registry of Self-Harm 34,530 32,247 
1,200,329 1,190,497 
Unrestricted Income 
Overhead funding - 22,470 
Generated income - lectures and fees 562 - 
Private donations 100 1,120 
662 23,590 
Total funding 1,200,991 1,214,087 
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4 Analysis of Resources Expended 
Foundation Registry 2019 2018 
and Research € € 
Wages and salaries including social 
insurance costs 445,605 494,653 940,258 917,108 
Pension costs 17,349 5,290 22,639 22,717 
Recruitment costs - - - 6,888 
Data collection costs - 7,742 7,742 10,323 
Data collection travel costs - 43,191 43,191 40,977 
Travel, meetings and conferences 28,268 10,438 38,706 48,743 
Fees and subscriptions 31,814 8,383 40,197 54,695 
Stationery, printing and postage 4,239 4,234 8,473 5,323 
Telephones 701 638 1,339 2,705 
Rent 10,767 10,766 21,533 15,400 
Insurance 3,940 4,035 7,975 7,158 
Bank charges 392 392 784 690 
Accountancy fees 5,104 5,105 10,209 6,396 
Audit fees 3,690 3,690 7,380 7,380 
Computer running costs 19,308 22,988 42,296 44,897 
Intern cost - - - 15,000 
Depreciation - 2,607 2,607 1,360 
571,177 624,152 1,195,329 1,207,760 
5 Auditor's remuneration 
2019 2018 
Fees payable to the company's auditors: € € 
For audit services 
Audit of the financial statements of the company 7,380 7,380 
For other services 
All other non-audit services 10,209 6,396 
6 Net Incoming Resources 
2019 2018 
Net Incoming resources are stated after charging: € € 
Depreciation of owned tangible fixed assets 2,607 1,360 
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7 Employees 
The average monthly number of persons (including directors) employed by the company during the 
financial year was: 
2019 2018 
Number Number 
Foundation 13 14 
Registry 15 14 
28 28 
Their aggregate remuneration comprised: 
2019 2018 
€ € 
Wages and salaries 862,929 840,197 
Social security costs 77,329 76,911 
Pension costs 22,639 20,253 
962,897 937,361 
No remuneration was paid to any director during the financial year and the directors had no financial 
interests in the company at any time during the financial year. There was one employee (201 8 : One)  who 
 received employee benefits excluding employer pension costs  of between €70,000 and €80,000 during the 
financial year . In addition t here was one employee (201 8 : One)  who  received employee benefits excluding 
employer pension costs  of between € 60,000 and € 7 0,000 during the financial year . 
8 Interest receivable and similar income 
2019 2018 
€ € 
Interest income 
Interest on bank deposits 43 36 
Investment income includes the following: 
Interest on financial assets not measured at fair value through statement of 
financial activities 43 36 
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9 Taxation 
The company has obtained exemption from the Revenue Commissioners in respect of corporation tax, it 
being a company not carrying on a business for the purpose of making a surplus. DIRT tax is payable on 
any interest income received in excess of €32. No provision has been made in these financial statements 
for corporation tax as the company is exempt from corporation tax. 
No provision has been made in the financial statements for deferred tax as the company is exempt from 
corporation tax.  
10 Tangible fixed assets 
Computer equipment 
€ 
Cost 
At 1 January 2019 31,064 
Additions 6,236 
At 31 December 2019 37,300 
Depreciation and impairment 
At 1 January 2019 26,983 
Depreciation charged in the financial year 2,607 
At 31 December 2019 29,590 
Carrying amount 
At 31 December 2019 7,710 
At 31 December 2018 4,081 
11 Financial instruments 
2019 2018 
€ € 
Carrying amount of financial assets 
Debt & other financial instruments measured at amortised cost 433,292 447,441 
Carrying amount of financial liabilities 
Measured at amortised cost 209,612 225,141 
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12 Debtors 
2019 2018 
Amounts falling due within one year: € € 
Accrued income 2,320 76,131 
Other debtors 383 1,391 
2,703 77,522 
13 Creditors: amounts falling due within one year 
2019 2018 
€ € 
PAYE and social security 21,283 21,979 
Accruals 127,355 105,704 
Deferred income 82,257 119,437 
230,895 247,120 
Deferred income relates to grants received under contracts where the performance conditions have not 
been completed by the financial year end as the periods of these contracts extend over more than one 
financial year. All such funding received is deferred until the performance conditions have been met in 
accordance with the contracts.  
14 Retirement benefit schemes 
2019 2018 
Defined contribution schemes € € 
Charge to statement of financial activities in respect of defined contribution 
schemes 22,639 22,717 
The company operates a defined contribution pension scheme for all qualifying employees. The assets of 
the scheme are held separately from those of the company in independently administered funds. 
15 Members' liability 
The company is limited by guarantee, not having a share capital and consequently the liability of members 
is limited, subject to an undertaking by each member to contribute to the net assets or liabilities of the 
company on winding up such amounts as may be required not exceeding €1 per member . 
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16 Analysis of Net Assets by Fund 
Fixed Current Current Closing 
Assets assets liabilities Balance 
€ € € € 
Unrestricted income 
Unrestricted Funds - 275,622 (21,747) 253,875 
Restricted income 
Restricted Funds 7,710 157,670 (209,148) (43,768) 
7,710 433,292 (230,895) 210,107 
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17 Events after the reporting date 
Since the end of the financial year Ireland has been significantly affected by the Covid-19 Pandemic. As the 
company carries out its operations in University College Cork the impact of the Pandemic has necessitated 
significant operational changes. Whilst COVID-19 has necessitated changes to the main office set up, 
almost all aspects of the research programme can continue with staff members working at home whilst 
some adjustments to timeframes of field-based research have been necessary. 
In line with government advice, all third level institutes closed on 12 March 2020.  The team at the NSRF 
had anticipated the closure of the Western Gateway Building (WGB) in University College Cork where its 
office is located and had made preparations for staff to work at home.  All WGB-based staff members were 
set up and trained to work remotely and can access shared files and project documents using secure 
software. 
Operations Group meetings have been held weekly via Zoom initially, and more recently using Microsoft 
Teams.  A weekly staff meeting with a focus on self-care is held and in addition, a weekly e-mail is sent to 
staff members outlining the most up-to date Irish and international research and resources relating to 
COVID-19.  All of the above measures are in addition to the Registry weekly team meetings and individual 
phone/Skype meetings that staff members are continuing to have with their supervisors.  The NSRF is at all 
times aware of the need to comply with the requirements of the General Data Protections Regulations while 
working at home. 
The work relating to the National Self-Harm Registry is continuing.  Whilst it is not possible for some Data 
Registration Officers to go in to hospitals to collect data at the present time, these individuals had collected 
data in advance and have been involved in trialling the new system of data uploading that was introduced 
for the Registry in March 2020.  Other Data Registration Officers continue to collect data electronically. 
In summary, the research programme is continuing in line with agreed objectives and the company has 
been asked to undertake additional research projects as outlined below in future developments. 
There has been no financial impact on the NSRF as a result of COVID-19.  In line with HSE policy, the 
2020 Service Arrangement and associated Programme of Work with the National Office for Suicide 
Prevention were agreed and signed before 28 February 2020.  The funding for the running of the Registry 
and the agreed programme of work has been increased to €907,000 for 2020.  The NSRF has an overall 
agreement with the HSE NOSP for the duration of the  Connecting for Life , Suicide Reduction Strategy 
2015-2024. 
In summary, from a financial perspective, there is unlikely to be a change to the annual funding provided by 
the NOSP. 
No other matters or circumstances have arisen since the end of the financial year which significantly 
affected or may significantly affect the operations of the company, the results of those operations or the 
state of the affairs of the company in the financial period subsequent to the financial year ended 31 
December 2019 . 
18 Related party transactions 
During the financial year no remuneration or reimbursement of expenses was made to directors in 
connection with their duties as directors. 
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19 Analysis of changes in net funds 
1 January 
2019 
Cash flows 31 December 
2019 
€ € € 
Cash at bank and in hand 369,919 60,670 430,589 
20 Cash generated from operations 
2019 2018 
€ € 
Net incoming resources for the financial year after tax 5,705 6,363 
Adjustments for: 
Investment income (43) (36) 
Depreciation and impairment of tangible fixed assets 2,607 1,360 
Movements in working capital: 
Decrease in debtors 74,819 53,563 
(Decrease)/increase in creditors (16,225) 82,043 
Cash generated from operations 66,863 143,293 
21 Approval of financial statements 
The directors approved the financial statements on the 13 May 2020 
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2019 2018 
€ € € € 
Foundation income 300,281 322,470 
HSE NOSP - National Suicide Research 
Foundation 300,000 300,000 
Lecture and fee income 281 - 
Overhead funding - 22,470 
Foundation costs 
Salaries & wages (200,580) (203,004) 
Social welfare costs (15,262) (16,761) 
Staff recruitment costs - (3,444) 
Staff pension costs defined contribution (9,475) (9,529) 
Rent (10,767) (11,400) 
Insurance (3,940) (3,579) 
Travelling expenses (3,589) (4,558) 
Meeting & conference costs (8,868) (7,877) 
Postage, printing & stationery (4,209) (1,003) 
Bank charges (392) (345) 
Fees, training & subscriptions (10,334) (6,011) 
Accountancy fees (5,104) (3,198) 
Audit fees (3,690) (3,690) 
Computer running costs (18,902) (20,765) 
Telecommunications (701) (733) 
(295,813) (295,897) 
4,468 26,573 
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2019 2018 
€ € € € 
International Association for Suicide Prevention 
Project - - 
Funding receivable 13,737 8,847 
Salaries & wages (13,099) (8,151) 
Social welfare costs (638) (696) 
Donegal Mental Health Service - Donegal Study 68 - 
Funding receivable 74,937 69,055 
Salaries & wages (55,352) (52,067) 
Social welfare costs (6,061) (5,649) 
Travel costs (4,404) (961) 
Fees & subscriptions (4,500) (4,694) 
Meetings & conferences (352) (1,484) 
Pension costs (4,200) (4,200) 
HSE NOSP - National Dialectical Behaviour 
Therapy Project - - 
Funding receivable 118,545 155,580 
Salaries & wages (91,439) (119,415) 
Social welfare costs (9,767) (12,365) 
Travel costs (756) (627) 
Stationery & supplies (13) (126) 
Fees & subscriptions (15,235) (11,745) 
Meetings & conferences (1,335) (11,302) 
World Health Organisation Collaborating Centre - - 
Funding receivable 5,607 7,767 
Travel costs (926) (1,235) 
Stationery & supplies (17) - 
Telephones - (1,255) 
Computer running expenses (206) - 
Fees and subscriptions (1,745) (3,816) 
Meetings & conferences (2,713) (1,461) 
Royal College of Surgeons in Ireland - - - 
Health Research Board Project 
Funding receivable - 19,855 
Salaries & wages - (13,167) 
Social welfare costs - (1,441) 
Fees & subscriptions - (4,124) 
Pension costs - (1,123) 
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2019 2018 
€ € € € 
HSE NOSP/CHO 4 GLOW Project - - 
Funding receivable - 6,168 
Salaries & wages - (2,819) 
Social welfare costs - (214) 
Travel & subsistence costs - 290 
Fees & subscriptions - 2,845 
World Health Organisation Commissioned Work - - 
Funding receivable 6,576 10,239 
Salaries & wages (5,765) (8,092) 
Social welfare costs (663) (791) 
Travel costs - (598) 
Meetings & conferences (148) (758) 
HSE NOSP - Coronial Data & Clinical Care 
Project - - 
Funding receivable 55,178 27,960 
Salaries & wages (42,343) (21,331) 
Social welfare costs (4,636) (2,603) 
Travel costs (1,728) (1,314) 
Computer running expenses (200) - 
Meetings & conferences (2,597) (248) 
Pension costs (3,674) (2,464) 
Our Mental Health - (15,000) 
Fees & subscriptions - (15,000) 
Private donations 100 1,120 
Foundation net movement in funds 4,636 12,693 
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2019 2018 
€ € € € 
HSE NOSP - National Self-Harm Registry Ireland 
Funding receivable 591,500 552,779 
National Self-Harm Registry costs 
Wages and salaries (454,351) (412,151) 
Social welfare costs (40,302) (36,391) 
Staff recruitment costs - (3,444) 
Staff pension costs defined contribution (5,290) (5,401) 
Data collectors (7,742) (10,323) 
Data collection travel costs (43,191) (40,977) 
Rent (10,766) (4,000) 
Fees to UCC - HRB scholar - (15,000) 
Insurance (4,035) (3,579) 
Travelling expenses (2,770) (2,335) 
Meetings & conferences (7,668) (11,625) 
Stationery, printing & postage (4,234) (4,194) 
Bank charges (392) (345) 
Fees, training & subscriptions (8,383) (6,460) 
Accountancy fees (5,105) (3,198) 
Audit fees (3,690) (3,690) 
Computer running costs (22,988) (24,132) 
Telecommunications (638) (717) 
Depreciation (2,607) (1,360) 
(624,152) (589,322) 
National Self-Harm Registry net movement in funds (32,652) (36,543) 
Northern Ireland Registry of Self-Harm 33,678 30,177 
Funding receivable 34,530 32,247 
Travel costs (198) (525) 
Meetings costs (654) (1,545) 
Northern Ireland Statistical Consultancy 33,678 30,177 
Overall National Self Harm Registry net movement in funds 1,026 (6,366) 
Overall operating net movement in funds 5,662 6,327 
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